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Carotenoids constitute a class of widespread unsaturated tetraterpenes with important biologi-
cal functions. Over 600 carotenoids with diff erent structures have been isolated from natural
sources.1 Carotenoids are well-known as natural colorants, ranging in color from yellow, orange
and red to deep purple.2,3 The color and other properties of carotenoids are closely related to
their structure. The long conjugated polyene chain of the carotenoids is responsible for the
absorption of visible light, giving carotenoids their vivid colors. Some examples of carotenoids
are given in Figure 1.
The ability to produce carotenoids de novo was developed at an early stage in evolution.
Only the chloroplasts in plant cells, algae, cyanobacteria and some other micro-organisms have
this capability.4,5 Isopentenyl diphosphate is the universal precursor of all isoprenoids, including
carotenoids. Recently it was found that the biosynthetic route of carotenoids in many bacteria,
some unicellular green algae and in the plant chloroplasts is diff erent from the route for all
other isoprenoids.4,6
Carotenes are a subclass of carotenoids that are built from carbon and hydrogen only.
Lycopene, the red pigment of the tomato, is the fi rst deeply colored carotene resulting from
biosynthesis. Enzymatic conversion of lycopene results in β-carotene with two six-membered
ring end groups. Via enzymatic reactions various oxygen containing groups may be introduced


















In plants further chemical conversion takes place leading to apocarotenoids that have shorter
carbon skeletons. Many aroma compounds of fl owers and fruit are apocarotenoids derived
from carotenoids.7
An essential function of carotenoids in plants is related to the conjugated polyene chain,
which makes carotenoids eff ective quenchers of excited triplet states and traps of radicals.8,9
Both the photosynthetic reaction centers I and II in plants and the reaction centers in bacteria
contain a tightly bound carotenoid that quenches the triplet states that are formed as side
products during photosynthesis and prevents the formation of destructive singlet oxygen.
Without this protection the photosynthetic reaction centers are destroyed and photosynthesis,
essential for life on earth, will not take place. This is demonstrated when plants are treated with
herbicides that prevent carotenoid biosynthesis. Exposure to light leads to complete destruc-
tion of these plants.10
Animals and man cannot produce carotenoids de novo and depend on carotenoids present
in their diet. Knowledge of the role of carotenoids in various aspects of the life processes in man
and animals is increasing at a rapid rate. Observational studies have shown quite consistently
a reduced risk of cancer in individuals with a high intake of carotenoids or high carotenoid
concentrations in blood.11,12 β-Carotene has been the most studied carotenoid for its role in
cancer prevention, but recently also other carotenoids that are present in our daily food
are investigated.13-19 Since carotenoids play a role in the protection against reactive oxygen,
carotenoids, mainly β-carotene, are studied for their role in prevention of damaging eff ects of 
UV-light on the skin, such as sunburn, skin aging and skin cancer.20-23 In recent epidemiological
studies, an inverse correlation was found between β-carotene concentrations in serum and the
risk of developing cardiovascular disease. Even though several risk factors play a role in the
mechanism leading to this disease, it appears that carotenoids play a role in the prevention
of cardiovascular disease, and these compounds are therefore of great interest for further
study.11
In animals and humans, carotenoids play an important role as vitamin A precursors. Vitamin
A, also known as retinol, is vital for growth, development and vision.24 The daily advised intake
of vitamin A is about 1.2 mg per day. Insuffi  cient vitamin A intake leads very rapidly to health
problems. This is dramatically demonstrated by the fact that annually about 10 million children
in developing countries become blind and subsequently die due to vitamin A defi ciency.25-27
Furthermore, recent research suggests that carotenoids reduce the risk of age-related macular
degeneration and cataract, the leading causes of blindness in the western world. 11,28-34
Another role of carotenoids is found in reproduction and fertility. Although the precise role
and actions of carotenoids in reproduction is not clear yet, there have been many reports over
the years of a positive eff ect of carotenoids on fertility and reproductive capacity in animals,
such as chickens and fl amingos.35
Since carotenoids have a benefi cial eff ect on health, but cannot be produced de novo in
humans and animals, carotenoids are of great commercial interest as food and feed additives.
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Many carotenoids are commercially available and are industrially produced at multi-ton scale
via total organic synthesis by DSM and BASF,36-39 or made by algae or yeasts in large-scale
bioreactors.40-42 For example, Haematococcus pluvialis, which is responsible for the striking
red color of so-called ‘blood rain’, and Haematococcus nivalis, the red color of ‘blood snow’, are
cultivated in large-scale bioreactors for the isolation of astaxanthin as a source for salmon and
trout farming.43-46
Carotenoids are also widely used as human food colorants, for which their non-toxicity and
bright colors make them well suitable. Examples of carotenoids as food colorants are β-carotene
in margarine, snacks, juices, cheese and ice cream. 
1.2 STUDY OF THE BLUE LOBSTER CAROTENOPROTEIN αCRUSTACYANIN 
In nature, many carotenoids are non-covalently bound to proteins. Proteins with stoichiometri-
cally bound carotenoids are known as carotenoproteins.47,48 A large class of carotenoproteins is
found in marine animals, particularly the crustacea.49 Most of these colored protein complexes
contain an astaxanthin chromophore which is shown in Figure 2. This C
40
-carotenoid has the
same carbon skeleton as β-carotene, with two six-membered end-rings. In addition astaxanthin
contains two carbonyl groups at the 4,4-positions and two hydroxyl groups at the 3,3’-posi-
tions. The hydroxyl groups induce chirality of the molecule. In nature all stereoisomers (RR’, SS’
and RS’) have been found, although (3S,3’S)-astaxanthin is most common.50 The presence of 
the carbonyl and hydroxyl groups in conjugation with the polyene chain cause a shift of color
of astaxanthin relative to β-carotene. β-Carotene is orange with λ
max
 = 450 nm in n-hexane
whereas astaxanthine has a deep red color with λ
max
= 469 nm in n-hexane.51
Binding of carotenoids to proteins can also induce a shift in the absorption maximum of 
the bound carotenoid. Protein complexes with colors ranging from yellow to deep blue have
been described.48 A widely studied protein complex is α-crustacyanin, the carotenoprotein that
is responsible for the dark blue color of the carapace of the lobster Homarus gammarus, also
known as the European or North Sea lobster. Upon heat treatment the dark blue protein com-
plex, with a λ
max
of 632 nm, denatures and astaxanthin is released, resulting in a color change








































spectrum of astaxanthin upon binding (163 nm; 5500 cm-1) is the largest shift known to occur
upon binding of a chromophore with a protein.
A similar shift as for α-crustacyanin can be seen for the slightly grey colored North Sea shrimp
Crangon crangon, which appears almost colorless to humans, as the λ
max
of the carotenoprotein
is outside the spectrum that can be detected by the human eye. Upon heating, the protein
denatures and the carotenoid is released, yielding the familiar reddish color.
The original interest in α-crustacyanin arose from the similarity of the spectral shift of astaxanthin
in α-crustacyanin to that of retinal in the rod visual pigment rhodopsin.52 Rhodopsin serves
as a paradigm for the superfamily of seven transmembrane helix G-protein coupled receptors
(GPCRs).53 The GPCRs mediate a broad array of important physiological and pharmaceutical
signal transduction processes that involve signaling by neurotransmitters, hormones and neu-
ropeptides.54 In rhodopsin the retinal ligand is covalently bound by a protonated Schiff  base
linkage, and the magnitude of the spectral shift is regulated by side-chain counterions.55,56
α-Crustacyanin belongs to the lipocalin superfamily, comprising over 20 diff erent proteins
which bind small lipophilic ligands.57,58 In contrast to rhodopsin, the carotenoids in α-crustacya-
nin are attached non-covalently. Furthermore, α-crustacyanin contains a β-barrel formed from
β-pleated sheets with apolar amino acid residues, instead of the trans-membrane seven-helix
structure in the retinal-binding proteins. 
Understanding the mechanism of the color shift and the interactions between the carot-
enoid and the protein will give information on how the proteins of the lipocalin superfamily
specifi cally bind their ligands. This information can be compared with the binding of retinal in
rhodopsins.
It is now known that α-crustacyanin is a 320 kDa water-soluble carotenoprotein complex which
consists of an octamer of dimers. Each dimer consists of two polypeptide subunits of about
20 kDa, containing two astaxanthins.48-60 The dimer is also known as β-crustacyanin, and has a
purple color, with λ
max
= 586 nm. The absorption spectra of α-crustacyanin, β-crustacyanin and
astaxanthin are shown in Figure 3. 
A model for the dimer was proposed by Zagalsky et al.61-63 and recently refi ned by X-ray stud-
ies, as shown in Figure 4.64 No X-ray analysis of α-crustacyanin is known as yet, but the study of 
β-crustacyanin gave useful information on the structure of the subunits and the binding site of 
the carotenoid.65
It was found that the subunits have a tertiary structure resembling other members of the
lipocalin superfamily. Both subunits of the dimer contain a β-barrel, consisting of two distinct
β-sheets. The β-barrel has a calyx shape, with the open ends of each calyx facing each other,
forming a cavity that contains the chromophore. The two bound astaxanthins interpenetrate
the interface between the subunits, each subunit containing half of each carotenoid.66
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Astaxanthin can be extracted from the purifi ed protein complex and the colorless apopro-
tein can be reconstituted with chemically modifi ed astaxanthins.67,68 Reconstitution studies
with modifi ed chromophores have established essential structural characteristics required for
binding.69 In general, only a minor variation in the overall shape and size of the chromophore
is tolerated for binding. It was found that the presence of both 20 and 20’-methyl groups is
essential for reconstitution. Also the two 4,4’-carbonyl groups are necessary for binding. Only
if both carbonyl groups are in conjugation with the polyene chain a blue protein complex can
be formed.
UV-Vis absorption spectra of astaxanthin (·····), β-crustacyanin (-----) and α-crustacyanin
(——). (after Britton et al.69).
Figure 4. X-ray model of β-crustacyanin with the chromophores (AXT1 and AXT2) located in the







In contrast, the hydroxyl groups at positions 3 and 3’ are not essential for binding. In particu-
lar, canthaxanthin (4) also binds to give a blue carotenoprotein.50
For over 50 years scientists have devoted their attention to understanding the fundamental
basis of the bathochromic shift, but the precise mechanism that could account for such a large
color shift is still a matter of debate. 
In a seminal paper, Buchwald and Jencks reported that α-crustacyanin can be irreversibly dis-
sociated in eight β-crustacyanin units.49,70 Every β-crustacyanin consists of two apoprotein units
and two bound astaxanthin units. The visible, optical rotary dispersion and circular dichroism
(CD) spectra of α- and β-crustacyanin show evidence for a splitting of the excitation which is in
line with exciton theory. Among the possible mechanisms for the perturbed optical properties
of astaxanthin in α-crustacyanin it was suggested that intermolecular interactions of the π-
electron systems and/or distortion such as twisted double bonds induced by the protein may
play a role.49
The subsequent resonance Raman spectroscopy of α-crustacyanin by Carey et al. indicated
that the astaxanthin chromophore shows no distortion due to twists in the double bonds of 
the conjugated system and is in agreement with free relaxed carotenes.49 On the basis of this
resonance Raman study the hypothesis of the exciton mechanism was discarded and it was
concluded that the bathochromic shift is caused by a charge polarization mechanism possibly
induced by charged groups and/or by hydrogen bonds in the binding site.49
Weesie et al. used the combination of selective isotope enrichment, 13C magic angle spinning
(MAS) solid-state NMR and semi-empirical quantum chemical modeling to analyze the ligand-
protein interactions, associated with the bathochromic shift of astaxanthin in α-crustacyanin. In
this work, 13C-enriched astaxanthins were prepared by total organic synthesis,71,72 reconstituted
into the protein and analyzed by 13C CP/MAS NMR. Although α-crustacyanin is a water-soluble
protein, it is too large to be analyzed by solution NMR techniques. Solution NMR spectra show
broad and diff use signals, due to relatively slow movement of the large protein in solution. 
The presence of 13C labels at specifi c positions in astaxanthin, increases the NMR signal of 
these C-atoms by a factor 90. This makes it possible to distinguish these signals from protein
background response, and to obtain the chemical shifts for the enriched 13C nuclei.
Spectra of α-crustacyanin were obtained after reconstitution with 13C
2
-labeled astaxanthins
with 13C enrichment at positions 4,4’, 12,12’, 13,13’, 14,14’, 15,15’ or 20,20’.73 The chemical shift
data were compared with the 13C NMR data of astaxanthin in solution. The 13C MAS NMR stud-
ies reveal substantial downfi eld shifts at C-atoms 12,12’ and 14,14’ when astaxanthin is bound
in α-crustacyanin. Small upfi eld shifts were observed at 13,13’ and 15,15’. The results show an
unequal perturbation of both halves of the chromophore after binding. However, the main
perturbation is of symmetrical origin, since the chemical shift diff erences show a symmetrical
pattern in both halves of the chromophore.74,75
These experiments provide a strong indication that, when excitonic interactions are excluded,
charge polarization is essential to explain the observed bathochromic shift. The NMR shifts and
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color shift were compared with calculated charge densities of several protein-ligand models.
The initial NMR results could be reconciled with a mechanism in which astaxanthin is consider-
ably charged and subject to electrostatic polarization originating from both keto groups. This
hypothesis was in line with computational studies76,77 and Stark spectroscopy.78
Specifi c 13C labeling of the chromophore gives information on the contribution of distinct
vibrations to the vibrational lines in the Raman spectrum and on the geometry of the electronic
ground state and excited states of the chromophore in α-crustacyanin. 76,77,79 Resonance Raman
spectroscopy is an important technique for probing the vibrational properties of carotenoids.
The frequency of the vibrational bands is a property of the electronic ground state of the sys-
tem, while the intensity of the bands is a property of the geometry of both the ground state and
the excited electronic states. Resonance Raman spectroscopy can be applied to dilute samples
and is therefore very suitable for the study of a chromophore in a biological system. By using
a laser excitation wavelength that corresponds to the electronic transition of the molecule in
the visible absorption region, the vibrational levels of the molecule are dramatically increased.
Some Raman lines can be enhanced by a factor of about 105.
The eff ect of 13C labeling in resonance Raman experiments is visible by a shift of the vibra-
tional bands. Since the vibration depends on the mass of the atoms, the substitution of 12C by
13C shifts the vibrational frequencies. In addition, coupled modes can be decoupled due to 13C
enrichment.
The resonance Raman studies of 13C-labeled astaxanthins and the corresponding 13C-labeled
crustacyanins show that upon binding to the protein the Raman spectrum of astaxanthin is
changed. Bands are shifted, intensity is redistributed and new lines appear. Since the position
of the bands is determined by the electronic ground state and the intensity of the bands by
both the electronic ground state and excited states of the chromophore, the spectra indicate
that the geometries of both the electronic ground state and the excited state of astaxanthin
change upon binding.76,77
In spite of the considerable progress made in structural and spectroscopic studies, a clear
converging picture on the dominant mechanism for the bathochromic shift in crustacyanin is
still missing. There are two main hypotheses that are still debated: (i) the “on-site” (intramolecu-
lar) mechanism involving protein induced conformational changes and/or charge-polarization
eff ects modifying the electronic ground state of the chromophore; (ii) the aggregation (intermo-
lecular) mechanism due to the interaction of the chromophores in the subunits of crustacyanin
inducing an exciton coupling of the transition dipole moments in the excited state.
In order to resolve the precise molecular basis of the coloration mechanism of α-crustacya-
nin we used 13C-labeled astaxanthins as chromophores for solid-state 13C NMR and resonance




α-crustacyanin, establishing the electronic charge distribution and vibrational contribution







astaxanthin chromophore. The position of the 13C enrichment is marked with (A) for [6,6’,7,7’]-
13C
4
astaxanthin and with (B) for [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
astaxanthin.
We complement the spectroscopic data with quantum mechanical calculations of the
electronic ground state and excitation energies of various astaxanthin models based on the
structural information available for β-crustacyanin. The theoretical investigation is crucial in
identifying the relative importance of diff erent mechanisms that can contribute to the total
bathochromic shift.
1.3 SYNTHESIS OF 13CLABELED CAROTENOIDS AND RETINOIDS
As demonstrated in the earlier study of the blue lobster carotenoprotein α-crustacyanin, the
use of 13C-labeled carotenoids is essential for the isotope-sensitive analysis of carotenoids in
biological systems. This requires the development of appropriate synthetic methods for the
preparation of these compounds.
The synthesis of many carotenoids is well known and published in the literature, but the
synthesis of 13C-labeled carotenoids and retinoids is subject to limitations.80 The 13C labels have
to be introduced using 13C-labeled compounds. Only relatively small uniformly or selectively
13C-labeled compounds are commercially available at reasonable price, e.g. acetone, methyl
iodide, acetic acid, acetonitrile and ethyl acetoacetate. These small synthons have to be used
to obtain 13C enrichment at the desired position(s) in the fi nal product. These compounds are
all derived from natural abundant 1.1% 13CO, which is separated from 12CO via several distilla-
tions until >99% 13CO is obtained. This is the reason that 13C-labeled compounds are relatively
expensive. For example, 13C
2
-acetonitrile costs about € 1000 /g, while the unlabeled acetonitrile
costs about € 0.20 /g. Therefore, large-scale synthesis, for which most synthetic schemes of 
carotenoids are developed, would be very expensive. To prevent loss of expensive 13C-labeled
material, a short synthetic route is essential, with high overall yield based on the 13C-labeled
starting compounds. Very effi  cient is the use of a convergent modular synthetic scheme, in











































Figure 5. Molecular structure and IUPAC numbering of synthetic all-E astaxanthin as a mixture of 
25% (3R,3’R), 25% (3S,3’S) and 50% (3R,3’S). 
A = 13C for [6,6’,7,7’]-13C
4
all-E astaxanthin




of the synthesis. A modular synthetic strategy was developed in our group for the synthesis
of uniformly 13C-labeled retinal,81 and a similar approach could be used for the synthesis of 
13C-labeled carotenoids.
1.4 OUTLINE OF THE THESIS
The introduction gives the background of the research and explains the research strategy.
First synthetic schemes will be developed for the preparation of 13C-enriched retinoids and
carotenoids. The synthesized 13C-labeled carotenoids are used for the analysis of retinoids and
carotenoids in their natural systems in a second step.
A modular scheme for the synthesis of 13C-labeled carotenoids is described in Chapter 2, and




astaxanthin is discussed in detail.
The application of 13C-labeled carotenoids for study of biological systems is described in
Chapter 3, where the binding of astaxanthin in the carotenoprotein α-crustacyanin is dis-
cussed. The 13C-labeled astaxanthin was reconstituted into the natural system, and analyzed
in a non-invasive way by SSNMR spectroscopy and resonance Raman spectroscopy. The results
of the SSNMR and Raman analysis are interpreted with the help of quantum chemical calcula-
tions, giving pronounced insight into the binding of astaxanthin in α-crustacyanin and the
accompanying color change.
In Chapter 4 the introduction of 13C labels in the central part of carotenoids is discussed. A
method was developed for the synthesis of 13C-labeled 2,7-dimethylocta-2,4,6-triene-1,8-dial,
the C
10
-dialdehyde that is used as the central part of carotenoids in synthetic schemes. Intro-
duction of 13C labels in the central part of carotenoids makes them suitable for in vivo studies
in the human body, via LC-MS or resonance Raman spectroscopy. This way useful information
about the health eff ects of carotenoids in the human body can be obtained. 
Synthetic schemes for the preparation of 13C-labeled retinal derivatives, 3,4-didehydroretinal,
3-hydroxyretinal and 4-hydroxyretinal, are described in Chapter 5. These retinal analogues are
the chromophores of the visual pigments of animals like amphibians and fresh-water fi sh, fl ies
and butterfl ies, and squid. The 13C-labeled compounds can be used to study the visual systems
of these animals. This also gives possibilities to study the eff ect of substituents on the end-ring
of retinal in bovine or human rhodopsin via 13C SSNMR. The 13C-labeled retinal derivatives can
be used for the synthesis of 13C-enriched carotenoids, via the McMurry dimerization. This gives
another route to a short and effi  cient synthesis of 13C-labeled carotenoids.
Finally, general conclusions and prospects are given in Chapter 6. Ideas for future research,
both for organic synthesis as well as for the application of 13C-labeled carotenoids in the study
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CHAPTER 2
SYNTHESIS OF 13CLABELED 
ASTAXANTHIN
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2.1 INTRODUCTION
The synthesis of 13C-labeled compounds has to be effi  cient, because enriched compounds
have to be made from a limited number of commercially available, small building blocks that
are expensive. Synthetic schemes for the preparation of 13C-labeled astaxanthin have been
developed by Jansen et al. and have been applied for the synthesis of several 13C
2
-labeled
astaxanthins. Via these schemes, astaxanthins with symmetrical 13C
2
 labels at the central posi-
tions 12-15, 20 and at the carbonyl at position 4 were made.1-4 The 13C
2
-labeled astaxanthins
were incorporated in the lobster carotenoprotein α-crustacyanin and analyzed with SSNMR
and resonance Raman spectroscopy. These studies indicated that a protonation at the carbonyl
groups of astaxanthin upon binding to the protein may be responsible for the blue color of 
α-crustacyanin.5,6 We prepared 13C-labeled astaxanthins with 13C labels at the positions close to
the C6-ring, where the eff ects of a protonation at the carbonyl group would yield a consider-
able NMR chemical shift. By incorporation of the 13C-labeled astaxanthins in α-crustacyanin
and subsequent SSNMR and resonance Raman analysis it can be determined if protonation of 
astaxanthin is the basis of the color shift that occurs upon binding to the protein.
Using the modular synthetic scheme that was developed for the synthesis of uniformly 13C-
labeled ([U-13C]) retinal by Creemers et al.7, multifold 13C-labeled astaxanthin can be prepared in





astaxanthin, as depicted in Figure 1, was optimized

















































1a [6,6',7,7']-13C4 all-E astaxanthin, # = 
13C
Figure 1. Structure, numbering and position of 13C labeling of synthetic all-E astaxanthin as a







This chapter will give detailed information on the recent improvements in the synthesis of 
13C-labeled astaxanthin, providing essential knowledge for reproduction of the synthetic steps.
Also the NMR characterization and the eff ect of the 13C labeling on the NMR spectra is discussed
in this chapter. It is concluded with a section providing experimental details and the NMR data
of the intermediates that are produced in the synthesis.
2.2 MODULAR SYNTHETIC STRATEGY








scheme, which is based on the
fi nal step in which a suitable C
15
-Wittig compound is linked to both sides of the central C
10
-












In Chapter 4 the strategy to introduce 13C labels in the central part of carotenoids is discussed,





compound is built from a C
10
-synthon and a C
5
-synthon. Jansen et al. have described a route
for the synthesis of astaxanthin with 13C labels in the C
10
-synthon of the C
15
-part.2,3 This method
could be improved by using the scheme developed for the synthesis of [U-13C]-retinal, by
Creemers et al.7 Introduction of 13C labels at positions 8,9,10,11 and 19 is eff ected via triethyl










































scheme for the synthesis of the C
15
-Wittig compound (22).
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2.3 SYNTHESIS OF THE C10SYNTHON
The synthesis of [6,6’,7,7’]-13C
4
astaxanthin had to be optimized for the introduction of 13C labels
in the C
10
-aldehyde 9. Scheme 3 shows the synthesis of 2,10,10-trimethyl-4,7-dioxaspiro[4,5]dex-
1-enecarbaldehyde 9a, with 13C labels at positions 6 and 7. 
The synthesis starts with the commercially available 6-methyl-5-hepten-2-one (2), which
can also be prepared with 13C labels at any position or combination of positions.1,7,9 The 13C
labels are introduced by a Horner-Wadsworth-Emmons (HWE) reaction of ketone 2 with 13C
2
diethyl cyanomethylphosphonate, which was made in situ from commercially available 13C
2
acetonitrile and diethyl chlorophosphate. After purifi cation on a silica-gel column, [1,2]-13C
2
3,7-dimethyl-2,6-octadienenitrile (3a) was obtained in 96% yield. It was found that purifi cation
on a silica column (20% diethyl ether/light petroleum (PE)) is essential, since low yields for the
next reaction were obtained, even when small amounts of side-products were still present.
Nitrile 3a was treated with sulfuric acid, to give [1,2]-13C
2
α-cyclonitrile (4a) in 83% yield. When
the reaction mixture is kept at 0˚C and workup is performed under non-basic conditions, more
than 95% of the product is the desired α-cyclonitrile. A small amount of the thermodynamically
more stable β-cyclonitrile, with the double bond between C-5 and C-6, is formed. α-Cyclonitrile
(4a) reacts with meta-chloroperbenzoic acid (mCPBA) to form epoxide 5a, while β-cyclonitrile
does not react. The epoxide 5a is converted to alcohol 6a with lithium diisopropylamide (LDA).
The allylic alcohol is oxidized to compound 7a with pyridinium chlorochromate (PCC). Workup
of this reaction is troubled by the PCC-tar formed during the reaction, and yields improve from








































Synthesis of the C
10
-synthon (9a) leading to astaxanthin with 13C labels at positions 6,6’ 







gel. The resulting β-cyclonitrile can be separated from ketone 7 after the PCC-oxidation by
silica-gel chromatography. Subsequently, the ketone is protected by ethylene glycol to form
acetal 8a in 98% yield. With diisobutylaluminium hydride (Dibal-H) the nitrile group of 8a is
reduced to an aldehyde, to give 9a in 86% yield. It is important to follow this reaction closely
with thin layer chromatography (TLC, 50% diethyl ether/PE), to verify if complete conversion to
9a is achieved. Traces of unreacted nitrile are diffi  cult to remove via column chromatography,
and their presence in the reaction mixture leads to signifi cant lower yields in the next step of 
the reaction scheme.
2.4 SYNTHESIS OF U13C C5PHOSPHONATE
The C
15
-Wittig salts that are used in the synthesis of astaxanthin were prepared by coupling of 
the C
10
-ring 9 to C
5
-phosphonate 17. The suitable Wittig salts for the synthesis of astaxanthin
with 13C labels at positions 8,9,10,11 and 19 were made using [U-13C]-C
5
 phosphonate. The syn-
thesis of [U-13C] 4-(diethylphosphono)-3-methyl-2-butenenitrile was developed by Creemers
et al.7 and the same scheme, with small modifi cations, could be used for the synthesis of 13C
5
triethyl 3-methyl-4-phosphonocrotonate (17b), shown in Scheme 4. Starting compounds for
this synthesis are the commercially available 13C
2




Acetic acid is quantitatively converted into ethyl bromoacetate (11b) with the Hell-Vollhardt-
Zelinsky reaction.8 Bromoacetate is converted into triethyl phosphonoacetate (12b) via an
Arbuzov reaction, in 90% yield after distillation. The commercially obtained [1,2,3,4]-13C
4
ethyl
acetoacetate (13b) was chlorinated at the α-position with sulfuryl chloride to obtain ethyl











































































 triethyl 3-methyl-4-phosphonocrotonate (17b) (* = 13C).
27Synthesis of 13C-Labeled Astaxanthin
2 days in tetrahydrofuran (THF) the compound was saponifi cated and decarboxylated, to give
13C
3 
chloroacetone (15b). In this step one 13C label is lost, but since 13C
4 
ethyl acetoacetate is less
expensive than [2,3,4]-13C
3
ethyl acetoacetate, this is acceptable. After workup, the relatively
unstable chloroacetone was kept in a THF-solution, dried with molecular sieves, and directly
used in the next reaction. After a HWE-coupling reaction, 13C
3
chloroacetone (15b) and 13C
2
triethyl phosphonoacetate (12b) gave 13C
5
ethyl 4-chloro-3-methylcrotonate (16b), as a mixture
of E/Z-isomers, in 72% yield (over 2 steps). Subsequent Arbuzov reaction with triethyl phosphite




triethyl 3-methyl-4-phosphonocrotonate (17b) in 89% yield.
2.5 SYNTHESIS OF C15WITTIG SALTS




astaxanthin are the same, which is an
advantage of this modular scheme for the synthesis of these compounds. By introducing the
13C labels in the desired synthon, the same route can be used for the synthesis of astaxanthins
with 13C labels at diff erent positions, and a limited number of reactions with the expensive 13C-













































Scheme 5a. Synthesis of C
15
































































Scheme 5b. Synthesis of C
15














-labeled astaxanthin, as shown
in Scheme 5. The 13C labels of 13C
4 
astaxanthin (1a) are marked with (#), the 13C labels of 13C
10
astaxanthin (1b) are marked with (*).
The C
10
-aldehyde 9 was coupled in HWE-coupling to C
5
-phosphonate 17, to give the C
15
-ester
18 in 85% yield. The ester was dissolved in PE and reduced to the corresponding alcohol 19
with 2.2 equivalent of Dibal-H. Reproducibility of this reaction is poor, and yields vary between
40% and 80%. This is partly caused by the reduction of the acetal to the corresponding ether
which occurs as a side-reaction.9 We tried to optimize this step by changing conditions such
as temperature, scale, amount of Dibal-H and reaction times. Best yields were obtained when
Dibal-H was added at -80˚C and the solution was allowed to slowly warm up. The reaction
was quenched just after all the starting material was converted, as shown by TLC (50% diethyl
ether/PE), usually at about -40˚C. The starting compound needs to be well purifi ed. In particu-
lar, it is of importance that no C
10
-nitrile 8 is present, since this compound is reduced to the
corresponding aldehyde 9, this way interfering with the reduction of the ester. The acetal group
of 19 was hydrolyzed to ketone 20 with a trace of acid in acetone in 93% yield. At this stage
the hydroxyl group at position 3 was introduced. With 2.2 equivalent of LDA the dianion of 20
was made, and reacted with (+)-(dichlorocamphorylsulforyl)oxaziridine to give diol 21 in 53%
yield. Higher yields for this reaction have been reported in the literature.9 Purifi cation of the
desired product 21 is diffi  cult, since this product and the reduced reagent, (+)-(8,8-di chloro-
camphoryl sulfonyl)imine, have similar retention times on silica-gel chromatography. When the
reaction is performed on larger scale (>1 g of 20), most of the side-product can be removed by
recrystallization of the imine in dichloromethane/diethyl ether, followed by a silica-gel column
purifi cation (50% diethyl ether/PE).
When the reaction mixture is allowed to warm to room temperature, a mixture of 3R and
3S isomers is obtained. Stereoselectivity can be obtained when the reaction is kept at low
temperature. The confi guration at the 3-position can be manipulated by choosing the desired
combination of (+)- or (-)-oxaziridine and base.10,11 The relatively expensive oxaziridine can be
recycled by oxidation of the formed imine back to the original oxaziridine with OXONE.12
Subsequently, the allylic hydroxyl group of 21 is converted to a bromide with hydrogen
bromide, and the resulting product reacts with triphenylphosphine (PPh
3
) to form the desired
C
15
-Wittig salt 22 with 13C labels at the desired positions, in 50% yield. 
2.6 SYNTHESIS OF ASTAXANTHIN
In the fi nal step, 2.2 equivalents of the C
15
-Wittig compound and 1 equivalent C
10
-dialdehyde 23
were suspended in 1,2-epoxybutane and refl uxed overnight, under dim red light. This double
Wittig reaction gives the desired [6,6’,7,7’]-13C
4 
astaxanthin 1a and [8,8’,9,9’,10,10’,11,11’,19,19’]-
13C
10
astaxanthin 1b in one step, as shown in Schemes 6a and 6b. Astaxanthin was precipitated in
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ethanol, collected by fi ltration and isomerized to the all-E confi guration by refl uxing overnight
in n-heptane. After cooling, the crystals of all-trans astaxanthin were collected by fi ltration, and
further purifi ed by crystallization in DCM/MeOH and DCM/n-hexane. This way, [6,6’,7,7’]-13C
4
all-E astaxanthin 1a and [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10 
all-E astaxanthin 1b were prepared,
with >99% 13C enrichment at the desired positions. Yields of the fi nal reaction are usually about
30%, although higher yields, up to 70%, have been reported in the literature for similar Wittig
reactions.13
The main reason for the lower yields that were obtained compared to the literature, is the
relatively small scale on which the reactions were performed.14-16 During the crystallization steps,
a considerable amount of product is lost when working at 100 mg-scale. The use of expensive
13C labels demands a small synthetic scale. For the reconstitution of astaxanthin to the lobster
protein α-crustacyanin, less than 1 mg is suffi  cient, so the aim was to develop a synthetic route
that would give suffi  cient amounts of the fi nal product for structural analysis. Working at too
























Scheme 6a. Double coupling of C
15
-Wittig compound 22a to the central C
10
-dialdehyde 23 to 
synthesize all-E [6,6’,7,7’]-13C
4





























Scheme 6b. Double coupling of C
15
-Wittig compound 22b to the central C
10
-dialdehyde 23 to 
synthesize all-E [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 astaxanthin 1b as mixture of 25% (3R,3’R), 50% 







The total yield of the synthesis of 13C
10










acetonitrile (10 steps, 66% average).
2.7 1H NMR SPECTROSCOPY
[6,6’,7,7’]-13C
4
 all-E astaxanthin (1a), [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 all-E astaxanthin (1b) and
natural abundance all-E astaxanthin (1) were characterized with 600 MHz 1H NMR, to determine
the structure and purity of the compounds, the position of the 13C labels and the label incorpora-
tion.
The NMR data are given in the experimental details at the end of the chapter, and will briefl y
be discussed here. Figure 2 shows the 600 MHz 1H NMR spectrum and the assignment of the
all-E astaxanthin NMR response. 
The spectral values are well in line with the published data for all-E astaxanthin of Englert et
al.17 The spectrum confi rms a high purity and the all-E structure; within experimental error, no
Z-isomers could be detected. The synthetic astaxanthin consists as a mixture of 25% (3R,3’R),
50% (3R,3’S) and 25% (3S,3’S). No diff erences between these stereoisomers are observed.

















Figure 2. 600 MHz 1H NMR spectrum and assignment of all-E astaxanthin in CDCl
3
.




















Figure 3. The vinylic region (7.0 - 6.0 ppm) and aliphatic region (2.2 – 1.0 ppm) of the 600 MHz 
1H NMR spectrum of [6,6’,7,7’]-13C
4
 all-E astaxanthin (A), [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 all-
E astaxanthin (B) and natural abundance all-E astaxanthin (C). In C the assignment of the













 all-E astaxanthin (1b) and natural abundance
all-E astaxanthin (1). The 1H NMR chemical shifts of 13C
4
 astaxanthin 1a and 13C
10
 astaxanthin 1b
are the same as for natural abundance all-E astaxanthin 1, confi rming the purity and all-E struc-
ture of 13C
4
 astaxanthin 1a and 13C
10
astaxanthin 1b. However, at specifi c positions additional
splitting of signals is observed in the 1H NMR spectra of the 13C-labeled astaxanthins, due to the
presence of 13C labels. Compared to the 1H NMR spectrum of all-E astaxanthin, the spectrum
of [6,6’,7,7’]-13C
4
astaxanthin (Figure 3A) shows a large additional splitting of the signal of H7/7’ 
(1J
C7H7
 = 151.8 Hz) and a smaller splitting of 4.7 Hz of H8/8’. According to Courtin et al.18 this




. Doublets are observed for H16/16’, H17/17’ (3J
C6H16/17
= 3.4/3.7 Hz) and H18/18’ (3J
C6H18






 = 6.0 Hz). The other signals are unperturbed compared to natural abundance all-E
astaxanthin. The observed 13C-1H couplings confi rm the selective 13C labeling at 6,6’ and 7,7’. No
peaks at the original position of H7/7’ can be observed, which shows the high 13C enrichment
of >99%.
The 1H NMR spectrum of [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 astaxanthin (Figure 3B) shows a
complex splitting pattern in the vinylic region due to 13C-1H couplings. The chemical shift values
and J-couplings could not be determined directly or via a simulation.
In the vinylic region of the spectrum, only H14/14’ and H15/15’ are unperturbed compared
to natural abundance all-E astaxanthin. The signals of H8/8’ (1J
C8H8
 =132 Hz), H10/10’ (1J
C10H10
=
138 Hz) and H11/11’ (1J
C11H11
 = 143 Hz) show a splitting caused by the large 1J
CH
-coupling. The
aliphatic region of the spectrum is the same as for natural astaxanthin, except for the signal of 
H19/19’. This resonance is observed as a broad doublet (1J
C19H19
= 126 Hz). The broad shape of 




-couplings occur. Also the signals of H7/7’ (J = 3 Hz)




-couplings with nearby 13C labels.
The observed J
CH
-splittings in the 1H NMR spectrum of [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 asta-
xanthin confi rms the selective 13C enrichment at the desired positions. The absence of a signal
at the original position of H19/H19’ confi rms that a high 13C enrichment is achieved.
In order to establish that all the changes in the spectrum 3B are due to the presence of the





 all-E astaxanthin (1b) was recorded.
In Figure 4 this spectrum is given (spectrum A), together with the 1H NMR (600 MHz, CDCl
3
)
spectrum (spectrum B) of natural abundance all-E astaxanthin (1).
Comparison of these spectra reveals that the spectra of all-E astaxanthin (1) and [8,8’,9,9’,10,
10’,11,11’,19,19’]-13C
10
 all-E astaxanthin (1b) are identical within experimental error, confi rming
that the additional splitting pattern in the spectrum of 1a is caused by the introduction of the
13C enrichment. The only signifi cant diff erence between the two spectra is the signal of the 3,3’ 
OH group, which is broadened and shifted in the spectrum of natural abundance astaxanthin
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due to a higher humidity in the sample. The assigment of the signals and splitting pattern of 
[6,6’,7,7’]-13C
4
 astaxanthin (1a) can easily be determined from the 1H NMR spectrum.
A
B
Figure 4. 13C noise-decoupled 1H (600 MHz, CDCl
3
) NMR spectrum of [8,8’,9,9’,10,10’,11,11’,19,19’]-
13C
10
 all-E astaxanthin (A) and 1H NMR (600 MHz, CDCl
3








2.8 13C NMR SPECTROSCOPY
1H noise-decoupled 13C NMR spectroscopy can be used to confi rm the position of the 13C labels
and to verify that no scrambling of the labels has taken place. Also the isomeric purity can easily
be determined, since the signals of the Z-isomers resonate at a higher fi eld. The 150 MHz 1H
noise-decoupled 13C NMR spectra of [6,6’,7,7’]-13C
4
all-E astaxanthin (1a), [8,8’,9,9’,10,10’,11,11’,
19,19’]-13C
10
 all-E astaxanthin (1b) and natural abundance all-E astaxanthin (1) and assignment
of the signals are shown in Figure 5. In the spectrum (5C) of natural abundance astaxanthin,
20 signals can be observed. The chemical shift values are in agreement with the 13C NMR data
reported by Englert et al. for all-E astaxanthin, confi rming the structure and purity of the syn-
thesized compound.19
The 13C NMR spectra of the 13C-labeled astaxanthins are dominated by the 13C-enriched posi-
tions. Since the level of 13C is increased by a factor of 90, the intensity of the NMR peaks are
enhanced 90-fold for these carbon atoms. The 13C chemical shifts are the same as for natural
abundance all-E astaxanthin, confi rming the structure and purity of the 13C-labeled astaxan-
thins.
The 13C NMR spectrum of 13C
4 
astaxanthin (1a, Figure 5B) shows two distinct doublets for the
13C-enriched carbons C6/6’ (1J
C6C7
= 55 Hz) and C7/7’ (1J
C6C7
= 55 Hz). The signals of the unlabeled
C atoms have a relatively low intensity, indicating that selective 13C enrichment of positions
6/6’ and 7/7’ was achieved, and no scrambling of the 13C labels has occurred. A closer look 
shows splitting of the signals of C1/1’ (1J
C1C6
= 38 Hz), C5/5’ (1J
C5C6
= 53 Hz) and C8/8’  (1J
C7C8
 =
73 Hz), which is in accordance with the 13C labeling at positions 6/6’ and 7/7’. The absence of 
signals at the original position of C6/6’ and C7/7’ confi rms that a high 13C-enrichment (>99%)
is achieved.
In the 13C NMR spectrum of [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10 
astaxanthin (1b, Figure 5B) the
signals of the 13C-enriched positions are clearly recognized by their increased intensities. An
enlargement of the signifi cant regions in the spectrum is shown in Figure 6. 
The increased intensity of the 13C-labeled positions is clearly observed in the 13C NMR
spectrum of [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
astaxanthin (1b). The signals of the unlabeled C
atoms have a relatively low intensity, indicating that selective >99% 13C enrichment of positions
8/8’,9/9’,10/10’,11/11’ and 19/19’ was achieved, and no scrambling of the 13C labels has occurred.
Furthermore, the chemical shift values are in agreement with the data for all-E astaxanthin,
confi rming the structure and purity of the synthesized compound.
Due to the introduction of multiple 13C labels, splitting of several signals is observed. The
signal of C19/19’ shows a large splitting caused by the presence of the 13C label at C9/9’, 1J
C9C19
= 39 Hz. Similar splitting of the signals of C8/8’ (1J
C8C9
= 52 Hz) and C11/11’ (1J
C10C11 
= 50 Hz) is
observed. The observed carbon-carbon couplings are in good agreement with selective 13C
labeling at positions 8,8’,9,9’,10,10’,11,11’ and 19,19’. The absence of signals at the original posi-
tion of these C atoms confi rms that a high 13C-enrichment (>99%) is achieved. 
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Figure 5. 150 MHz 13C NMR spectrum of [6,6’,7,7’]-13C
4
 all-E astaxanthin (A),
[8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10










The signals of C9/9’ and C10/10’ show a high order splitting pattern due to the presence
of 3 and 2 neighbouring 13C-enriched positions, from which the chemical shift values and J-
couplings could not be determined accurately. Also splitting of the signals of C7/7’ and C12/12’ 
is observed.
The signifi cant chemical shifts and coupling constants (J) for the 1H NMR and 13C NMR spectra
of [6,6’,7,7’]-13C
4
 astaxanthin 1a [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 astaxanthin 1b are given in
tables 1-4.
Table 1. 1H NMR data of [6,6’,7,7’]-13C
4
 astaxanthin (1a).
δ(ppm) H Multiplicity J(Hz) Integral
1.32/1.21 H-16/H-17 d/d 3J
C6H18
= 3.4/3.7 12































Enlargement of the signifi cant regions of the 150 MHz 13C NMR spectrum (CDCl
3
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Table 2. 1H NMR data of [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 astaxanthin (1b).
δ(ppm) H Multiplicity J(Hz) Integral
2.00 H-19 d 1J
C19H19
= 126 6












































Table 3. 13C NMR data of [6,6’,7,7’]-13C
4
astaxanthin (1a).
δ(ppm) C Multiplicity J(Hz)
36.8 C-1 d 1J
C1C6
= 38.2
123.3 C-7 d 1J
C6C7
= 55
126.8 C-5 d 1J
C5C6
= 52.5
142.3 C-8 d 1J
C7C8
= 73.1
162.2 C-6 d 1J
C6C7
= 55
Table 4. 13C NMR data of [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
astaxanthin (1b).
δ(ppm) C Multiplicity J(Hz)
12.5 C-19 d 1J
C9C19
 = 39
123.2 C-7 d 1J
C7C8
= 73
124.6 C-11 d 1J
C10C11
 = 50















139.8 C-12 d 1J
C11C12
 = n.d.a
142.3 C-8 d 1J
C8C9
= 52








In this chapter, the synthetic schemes that have been developed and optimized for the synthe-
sis of 13C
4
 astaxanthin and 13C
10 
astaxanthin are described. The schemes are based on a modular
strategy, which was developed to effi  ciently introduce 13C labels at the desired positions in the
carotenoids. The presented synthetic routes are based on known methods, with small modifi ca-
tions, and were successfully applied for the synthesis of [6,6’,7,7’]-13C
4
 all-E astaxanthin 1a and
[8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10 
all-E astaxanthin 1b. 
The 1H NMR and 13C NMR characterization of the 13C-labeled astaxanthins, and comparison
of the spectra with the data of natural abundance all-E astaxanthin, shows that the desired
compounds were obtained with good purity. The splitting pattern of the 1H NMR and 13C NMR
spectra and increased intensity of the 13C-labeled carbons in the 13C NMR spectra confi rmed
selective 13C enrichment at the desired postions, with a high isotope enrichment (>99%) was
achieved. The 13C NMR spectra of the 13C-labeled compounds show that no scrambling of the
13C labels had occurred.
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EXPERIMENTAL
General Remarks: Unless stated otherwise, dry reactions were carried out in a dry nitrogen atmosphere,
reaction vessels were fl ame-dried prior to use. Dry solvents were obtained by distillation (low-boiling petro-




, toluene with CaH
2
) and stored on sodium-wire. Dichloromethane (DCM) was
dried with CaH
2
, and stored on 4Å molecular sieves. THF was distilled from Na/benzophenone, or dried
with molecular sieves (4Å). Solutions of NaCl and NH
4





O is a homogeneous mixture of SiO
2 
(400 g) and water (120 mL). Ether refers to diethyl ether. PE
refers to distilled, low-boiling petroleum ether, bp. 40-60ºC. Dibal-H refers to a 1.0 M solution of diisobutyl
aluminium hydride in hexanes.
 Reactions were monitored using thin-layer chromatography (TLC), on Merck F
254
silica gel 60 aluminum






 in 100 mL water). Column chromatography was performed using Merck silica gel 60 (0.040-
0.063 nm, 230-400 mesh).




OD on a Bruker AM-600, Bruker AV-400 or a
Bruker WM-300 apparatus with tetramethylsilane (TMS; 1Hδ = 0.00 ppm), CDCl
3
 (13Cδ = 77.00 ppm) or CD
3
OD
(13Cδ = 49.00 ppm) as internal standard. Due to the presence of multiple 13C labels, several 1H and 13C NMR
spectra gave a complex splitting pattern, from which the chemical shift values and J-couplings could not
be determined accurately. In those cases, the observed estimated values are given here.
 All chemicals were purchased from Aldrich, Fluka or Acros Chimica.
3,7-Dimethyl-2,6-octadienenitrile (3)
At -20°C, n-BuLi (1.6 M, 60.9 mL, 97.4 mmol) was added to a solution of diisopropylamine (DIPA, 10.3 g,
101 mmol) in dry THF (100 mL). After 1 h the solution was cooled to -80°C, acetonitrile (2.0 g, 48.7 mmol)
was added and the mixture was stirred for another hour at -80°C. A solution of diethylchlorophosphate
(8.4 g, 48.7 mmol) in THF (20 mL) was slowly added, and after 30 min 6-methyl-5-heptene-2-one 2 (6.1 g,
40.6 mmol) in THF (10 mL) was added. The solution was allowed to warm to RT and stirred overnight. TLC
analysis (20% diethyl ether/PE, KMnO
4
-detection) showed complete conversion of the ketone. A solution of 
NH
4
Cl(sat) was added, the mixture was extracted three times with ether and the organic layer was washed
with NaCl(sat). The organic layers were dried with MgSO
4
, fi ltered and the solvents evaporated in vacuo. The
product was purifi ed on a silica-gel column (20% diethyl ether/PE) to give a 2-E/Z mixture of 3,7-dimethyl-
2,6-octadienenitrile 3 (5.06 g, 33.9 mmol, 84%).
1H NMR (CDCl
3
) δ (ppm) = 1.60 (s, 3 H, 7Z-CH
3
), 1.69 (s, 3 H, 7E-CH
3
), 2.05 (s, 3 H, 3-CH
3
), 2.19 (br. s, 4 H,
4-H/5-H), 5.03 (m, 1 H, 6-H), 5.10 (s, 1 H, 2-H).
13C NMR (CDCl
3






), 25.7 (C-5), 25.7 (7E-CH
3
), 36.1 (C-4Z),
38.4 (C-4E), 95.0 (C-2Z), 95.7 (C-2E), 116.8 (C-1E), 117.1 (C-1E), 122.0 (C-6), 133.0 (C-7), 164.9 (C-3). 
[1,2]-13C2 3,7-Dimethyl-2,6-octadienenitrile (3a)
Using a similar procedure as described above, 13C
2







LDA [made from n-BuLi (58.1 mL, 92.9 mmol) and DIPA (9.8 g, 96.8 mmol) in dry THF (10 mL)] at -80°C. Sub-
sequently, diethyl chlorophosphate (8.0 g, 46.5 mmol) and 6-methyl-5-heptene-2-one (4.9 g, 38.7 mmol)
were added and the solution was allowed to warm to RT overnight. After workup and silica-gel purifi cation,
(20% diethyl ether/PE) an E/Z-mixture of [1,2]-13C
2
3,7-dimethyl-2,6-octadienenitrile 3a (5.62 g, 37.2 mmol,
96%) was obtained. 
1H NMR (CDCl
3
) δ (ppm) = 1.61 (s, 3 H, 7Z-CH
3
), 1.69 (s, 3 H, 7E-CH
3
), 2.05 (d, J = 6.0 Hz, 3 H, 3-CH
3
), 2.18 (m,
4 H, 4-H/5-H), 5.04 (m, 1 H, 6-H), 5.10 (dd, J = 2.0 Hz/172 Hz, 1 H, 2-H).
13C NMR (CDCl
3






), 36.2 (C-4Z), 38.4 (C-4E), 95.1 (d, J =
78.9 Hz, C-2Z), 95.6 (d, J = 79.1 Hz, C-2E), 116.9 (d, J = 79.1 Hz, C-1E), 117.2 (d, J = 78.9 Hz, C-1Z), 122.1 (C-6),
133.1 (C-7), 164.9 (d, J = 74.4 Hz, C-3). 
2,6,6-Trimethyl-2-cyclohexenecarbonitrile (4)
A solution of 3,7-dimethyl-2,6-octadienenitrile 3 (5.06 g, 33.9 mmol) in nitromethane (20 mL) was slowly
added to sulfuric acid (5 mL) in nitromethane (50 mL) at 0°C. After stirring for 30 min at 0°C water (100 mL)
was added and the mixture extracted three times with diethyl ether. The combined organic layers were
washed twice with NaCl(sat) and neutralized with NaOAc(sat). After drying the organic layers with MgSO
4
,
the solution was concentrated in vacuo. Flash chromatography (silica gel, 10% diethyl ether/PE) gave a
mixture of α-cyclonitrile (~95%; 4.24 g, 28.4 mmol, 84% yield) and β-cyclonitrile (~5%).
1H NMR (CDCl
3
) δ (ppm) = 1.04 (s, 3 H, 6-CH
3
), 1.14 (s, 3 H, 6-CH
3
), 1.5-1.6 (m, 3 H, 5-H), 1.83 (s, 3 H, 2-CH
3
),
2.05 (m, 2 H, 4-H), 2.77 (br. s, 1 H, 1-H), 5.59 (br. s, 1 H, 3-H).
13C NMR (CDCl
3






), 31.8 (C-6), 32.6 (C-5), 43.7 (C-1),
119.6 (CN), 124.5 (C-3), 126.3 (C-2).
[1]-13C 2,6,6-Trimethyl-2-cyclohexene-13C-carbonitrile (4a)
In a similar way to that described above, [1,2]-13C
2
3,7-dimethyl-2,6-octadienenitrile 3a (5.62 g, 37.2 mmol)
in nitromethane (20 mL) was added to a mixture of sulfuric acid in nitromethane at 0°C. After workup,
[1]-13C 2,6,6-trimethyl-2-cyclohexene-13C-carbonitrile 4a (4.67 g, 30.9 mmol, 83%) was obtained.
1H NMR (CDCl
3
) δ (ppm) = 1.04 (d, J = 5.3 Hz, 3 H, 6-CH
3
), 1.14 (d, J = 4.7 Hz, 3 H, 6-CH
3
), 1.3-1.8 (m, 2 H, 5-H),
1.83 (d, J = 4.7 Hz, 3 H, 2-CH
3
), 2.05 (m, 2 H, 4-H), 2.77 (dd, J = 11.6 Hz/132.6 Hz, 1 H, 1-H), 5.59 (m, 1 H, 4-H).
13C NMR (CDCl
3






), 31.7 (d, J = 32.7 Hz, C-6), 32.5
(d, J = 2.1 Hz, C-5), 43.6 (d, J = 55.3 Hz, C-1), 119.4 (d, J = 55.3 Hz, CN), 124.4 (d, J = 2.4 Hz, C-3), 126.3 (d, J =
35.2 Hz, C-2).
2,3-Epoxy-2,6,6-trimethylcyclohexanecarbonitrile (5)
A solution of 4 (4.24 g, 28.4 mmol) in ethyl acetate (40 mL) was added to mCPBA (70% in water, 9.1 g,
36.9 mmol) in ethyl acetate (40 mL) at 0°C and the solution was stirred overnight at RT. The solution was
concentrated in vacuo, PE (150 mL) was added, and at 0°C TEA (4.6 g, 45.5 mmol) was added. After stirring
for 10 min the suspension was fi ltered through silica gel and washed with 25% ether/3% TEA/PE and con-
centrated. When necessary, the resulting product was fi ltered a second time through silica gel to remove all
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chlorobenzoic acid. This way, crude 2,3-epoxy-2,6,6-trimethylcyclohexanecarbonitrile 5 (4.04 g, 34.5 mmol,
86%) was obtained as a yellow liquid.
1H NMR (CDCl
3
) δ (ppm) = 1.05 (s, 3 H, 6-CH
3
), 1.09 (s, 3 H, 6-CH
3
), 1.20-1.35 (m, 2 H, 5-H), 1.55 (s, 3 H, 2-CH
3
),
1.99 (m, 2 H, 4-H), 2.75 (s, 1 H, 1-H), 3.05 (s, 1 H, 3-H).
13C NMR (CDCl
3
) δ (ppm) = 20.7/21.5 (2-CH
3
), 23.3 (C-4), 28.4 (C-6), 29.3/30.3 (6-CH
3
), 31.3 (C-5), 44.7 (C-1),
55.3 (C-2), 58.6 (C-3), 118.5 (CN).
[1]-13C 2,3-Epoxy-2,6,6-trimethylcyclohexane-13C-carbonitrile (5)
By using the same procedure as described above, 4a (4.67 g, 30.9 mmol) reacted with mCPBA (70%, 9.9 g,




) δ (ppm) = 1.05 (s, 3 H, 6-CH
3
), 1.09 (s, 3 H, 6-CH
3
), 1.2-1.4 (m, 2 H, 5-H), 1.55 (d, J = 3.1 Hz, 3 H,
2-CH
3
), 1.8-2.1 (m, 2 H, 4-H), 2.74 (dd, J = 11.0 Hz/134.2 Hz, 1 H, 1-H), 3.05 (br. s, 1 H, 3-H).
13C NMR (CDCl
3
) δ (ppm) = 44.7 (d, J = 57 Hz, C-1), 118.5 (d, J = 57 Hz, CN).
3-Hydroxy-2,6,6-trimethyl-1-cyclohexenecarbonitrile (6)
Lithium diisopropylamide (LDA) was prepared at -20°C by adding n-BuLi (16.8 mL, 26.9 mmol) to a solution
of DIPA (4.1 mL, 29.3 mmol) in dry THF. A solution of 2,3-epoxy-2,6,6-trimethylcyclohexanecarbonitrile 5
(4.04 g, 24.5 mmol) in dry THF (10 mL) was slowly added at -40°C, and the reaction mixture was allowed to
warm to RT overnight. The mixture was neutralized by adding NH
4
Cl(sat), and extracted three times with
diethyl ether. The combined organic layers were washed with NaCl(sat) and dried with MgSO
4
. After fi ltra-
tion and concentration in vacuo the crude product 3-hydroxy-2,6,6-trimethyl-1-cyclohexenecarbonitrile 6
(4.32 g, 24.5 mmol, 100%) was obtained.
1H NMR (CDCl
3
) δ = 1.14 (s, 3 H, 6-CH
3
), 1.20 (s, 3 H, 6-CH
3
), 1.4-2.0 (m, 4 H, 4-H/5-H), 2.10 (s, 3 H, 2-CH
3
), 4.05
(t, J = 6.0 Hz, 3-H).
13C NMR (CDCl
3




), 27.8 (C-4), 32.7 (C-5), 33.2 (C-6), 67.5 (C-3), 117.2 (CN), 119.4
(C-1), 152.5 (C-2).
[1]-13C 3-Hydroxy-2,6,6-trimethyl-1-cyclohexene-13C-carbonitrile (6a)
By using a similar procedure as described for the unlabeled product, 5a (4.67 g, 27.9 mmol) was deproton-
ated with 1.1 equiv. LDA to give crude [1]-13C 3-hydroxy-2,6,6-trimethyl-1-cyclohexene-13C-carbonitrile 6a
(4.67 g, 27.9 mmol, 100%) as a dark yellow liquid. 
1H NMR (CDCl
3
) δ = 1.14 (s, 3 H, 6-CH
3
), 1.19 (s, 3 H, 6-CH
3
), 1.3-2.0 (m, 4 H, 4-H/5-H), 2.09 (d, J = 5.5 Hz, 3 H,
2-CH
3
), 4.05 (dt, J = 4 Hz, 1 H, 3-H).
13C NMR (CDCl
3
) δ = 116.9 (d, J = 75.3 Hz, CN), 119.9 (d, J = 75.3 Hz, C-1).
3-Oxo-2,6,6-trimethyl-1-cyclohexenecarbonitrile (7)
A solution of 3-hydroxy-2,6,6-trimethyl-1-cyclohexenecarbonitrile 6 (4.32 g, 24.5 mmol) in DCM (20 mL) was







was stirred overnight at RT, fi ltered through silica gel, washed with diethyl ether and concentrated in vacuo.
The brown-black suspension was fi ltered a second time through silica gel, until a clear yellow solution was
obtained. The solvents were removed in vacuo and the resulting crude product was purifi ed on a silica-gel
column (20-40% diethyl ether/PE gradient elution) to give 3-oxo-2,6,6-trimethyl-1-cyclohexenecarbonitrile
7 (2.63 g,16.1 mmol, 62% over 3 steps).
1H NMR (CDCl
3
) δ = 1.34 (s, 6 H, 6-CH
3
), 1.95 (t, J = 6.9 Hz, 2 H, 5-H), 2.06 (s, 3 H, 2-CH
3








), 33.8 (C-4), 34.4 (C-6), 35.7 (C-5), 115.6 (CN), 135.3 (C-1), 144.2
(C-2), 196.2 (C-3).
[1]-13C 3-Oxo-2,6,6-trimethyl-1-cyclohexene-13C-carbonitrile (7a)
By using the procedure described above, crude [1]-13C 3-hydroxy-2,6,6-trimethyl-1-cyclohexene-13C-car-
bonitrile 6a (4.67 g, 27.9 mmol) was oxidized with PCC/Al (20 wt%, 39.1 g, 36.3 mmol). After workup and
purifi cation, [1]-13C 3-oxo-2,6,6-trimethyl-1-cyclohexene-13C-carbonitrile 7a (3.35 g, 20.3 mmol, 73%) was
obtained as a pale yellow liquid.
1H NMR (CDCl
3
) δ = 1.34 (d, J = 4.8 Hz, 6 H, 6-CH
3
), 1.96 (dt, J = 5.9 Hz/6.9 Hz, 2 H, 2-H), 2.05 (d, J = 6.2 Hz, 3 H,
2-CH
3
), 2.56 (t, J = 6.9 Hz, 2 H, 3-H).
13C NMR (CDCl
3




), 33.8 (C-4), 34.3 (d, J = 41.5 Hz, C-6), 35.6 (C-5), 115.5 (d, J =
74.4 Hz, CN), 134.9 (d, J = 74.4 Hz, C-1), 144.1 (d, J = 70.2 Hz, C-2), 196.2 (C-4).
2,10,10-Trimethyl-4,7-dioxaspiro[4,5]dec-1-enecarbonitrile (8)
A catalytic amount of p-toluenesulfonic acid was added to a mixture of 3-oxo-2,6,6-trimethyl-1-cyclohex-
enecarbonitrile 7 (2.63 g, 16.1 mmol), trimethyl orthoformate (3.5 mL) and ethylene glycol (2.7 mL). After
stirring for 2 h, TLC (25% diethyl ether/PE) showed complete conversion of the starting material and the
reaction was quenched by adding NaHCO
3
(sat). The mixture was extracted three times with diethyl ether,
the combined organic layers were washed with NaCl(sat) and dried with MgSO
4
. After removal of the solids
by fi ltration and concentration in vacuo, the crude product was dissolved in acetone (75 mL) and 10 drops






were added. The solids were
removed by fi ltration and the solvents were removed in vacuo. After fl ash-column chromatography (silica
gel, 25% diethyl ether/2% TEA/PE) 2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-enecarbonitrile 8 (3.27 g,
15.8 mmol, 98%) was obtained.
1H NMR (CDCl
3
) δ = 1.18 (s, 6 H, 10-CH
3
), 1.60-1.85 (m, 4 H, 8-H/9-H), 1.97 (s, 3 H, 2-CH
3
), 4.02 (s, 4 H, 5-H/6-H).
13C NMR (CDCl
3




), 29.3 (C-8), 33.3 (C-10), 33.8 (C-9), 65.2 (C-5/C-6), 105.0 (C-4),
116.4 (CN), 122.5 (C-1), 149.7 (C-2).
[1]-13C 2,10,10-Trimethyl-4,7-dioxaspiro[4,5]dec-1-ene-13C-carbonitrile (8a)
By using a similar procedure as described for the unlabeled compound, [1]-13C 3-oxo-2,6,6-trimethyl-
1-cyclohexene-13C-carbonitrile 7a (3.35 g, 20.3 mmol) was converted into the corresponding acetal 8a
(4.16 g, 19.9 mmol, 98%).
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1H NMR (CDCl
3
) δ = 1.18 (d, J = 4.4 Hz, 6 H, 10-CH
3
), 1.66-1.80 (m, 4 H, 8-H/9-H), 1.96 (d, J = 5.0 Hz, 3 H, 2-CH
3
),
4.02 (br. s, 4 H, 5-H/6-H).
13C NMR (CDCl
3




), 29.4 (C-8), 33.4 (d, J = 46.3 Hz, C-10), 34.0 (C-9), 65.3 (C-5/C-6),
105.2 (C-4), 116.5 (d, J = 74.6 Hz, CN), 122.7 (d, J = 74.6, C-1), 149.7 (d, J = 73.8 Hz, C-2).
2,10,10-Trimethyl-4,7-dioxaspiro[4,5]dec-1-enecarbaldehyde (9)
At -60°C, Dibal-H (20.5 mL, 20.5 mmol) was added to a solution of 2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-
1-enecarbonitrile 8 (3.27 g, 15.8 mmol) in dry PE. The solution was allowed to warm to RT during 1 h











 were added, and the solids were
removed by fi ltration. The crude product was concentrated in vacuo, and purifi ed on a fl ash-column (silica
gel, 50% diethyl ether/1% TEA/PE) to give 2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-enecarbaldehyde 9
(2.97 g, 14.1 mmol, 89%).
1H NMR (CDCl
3
) δ = 1.21 (s, 6 H, 10-CH
3
), 1.58 (m, 2 H, 9-H), 1.79 (m, 2 H, 8-H), 2.01 (s, 3 H, 2-CH
3
), 4.07 (s, 4 H,
5-H/6-H), 10.16 (s, 1 H, HC=O).
13C NMR (CDCl
3




), 29.3 (C-8), 33.3 (C-10), 36.5 (C-9), 65.4 (C-5/C-6), 107.1 (C-4),
143.7 (C-1), 149.5 (C-2), 193.8 (C=O).
[1]-13C 2,10,10-Trimethyl-4,7-dioxaspiro[4,5]dec-1-ene-13C-carbaldehyde (9a)
Reduction of [1]-13C 2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-ene-13C-carbonitrile 8a (4.16 g, 19.9 mmol)
with Dibal-H (25.9 mL, 25.9 mmol) to the corresponding aldehyde was carried out using the same procedure
as described above, to obtain [1]-13C-2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-ene-13C-carbaldehyde 9a
(3.64 g,17.1 mmol, 86%).
1H NMR (CDCl
3
) δ = 1.20 (d, J = 3.8 Hz, 6 H, 10-CH
3
), 1.53-1.59 (m, 2 H, 9-H), 1.76-1.80 (m, 2 H, 8-H), 2.01 (d, J
= 4.3 Hz, 3 H, 2-CH
3
), 4.06 (br. s, 4 H, 5-H/6-H), 10.16 (dd, J = 11.0 Hz/173.4 Hz, 1 H, HC=O).
13C NMR (CDCl
3




), 29.2 (C-8), 33.2 (d, J = 39.4, C-10), 36.5 (C-9), 65.3 (C-5/C-6),
106.9 (C-4), 144.7 (d, J = 50.9 Hz, C-1), 149.4 (d, J = 68.9 Hz, C-2), 193.4 (d, J = 50.9 Hz, C=O).
Bromoacetic acid
Trifl uoroacetic acid anhydride (TFAA; 21 mL, 147 mmol) was slowly added to acetic acid 10 (3.0 g, 50 mmol)
at 0°C. Bromine (8.0 g, 2.6 mL, 50 mmol) was added and the brown mixture was stirred at RT for 22 h, in the
course of which the mixture became colorless. Water (2.7 mL, 150 mmol) was added at 0°C and the mixture
stirred for 30 min. Trifl uoroacetic acid (TFA) was removed by destillation, and the resulting bromoacetic acid
was collected as a white solid. The distillate was found to contain a small additional amount of bromoacetic
acid, which was collected by removing TFA under a nitrogen fl ow, to obtain white, solid bromoacetic acid
(6.71 g, 48.3 mmol, 97%).
1H NMR (CDCl
3
) δ (ppm) = 3.92 (s, 2 H, 2-H).
13C NMR (CDCl
3










By using the same procedure as described above, 13C
2
acetic acid 10b (3.0 g, 48.3 mmol) was converted to
13C
2
bromoacetic acid (6.80 g, 48.2 mmol, 99%).
1H NMR (CDCl
3
) δ (ppm) = 3.92 (dd, J = 4.7 Hz/153 Hz, 2 H, 2-H), 10.37 (s, 1 H, OH).
13C NMR (CDCl
3
) δ (ppm) = 25.2 (d, J = 52.6 Hz, C-2), 173.1 (d, J = 52.6 Hz, C-1).
Ethyl bromoacetate (11)
Oxalyl chloride (4.6 mL, 6.7 g, 53 mmol) was added to bromoacetic acid (6.71 g, 48.3 mmol) and the mixture
was stirred for 30 h. After cooling to 0°C ethanol (3.4 mL, 58 mmol) was slowly added. The reaction was
quenched after 30 min by adding brine. The mixture was extracted three times with diethyl ether, washed
with NaHCO
3




, fi ltered and the solvent was evaporated in vacuo, to
yield ethyl bromoacetate 11 (7.41 g, 44.4 mmol, 92%).
1H NMR (CDCl
3





















[1,2]-13C2 Ethyl bromoacetate (11b)
By using the same procedure as described before, 13C
2
bromoacetic acid (6.8 g, 48.2 mmol) reacted with
ethanol to give [1,2]-13C
2
ethyl bromoacetate 11b (7.50 g, 44.4 mmol, 92%)
1H NMR (CDCl
3




), 3.87 (dd, J = 4.3 Hz/153.4 Hz, 2 H, 2-H), 4.23 (dq,















), 166.9 (d, J = 65.1 Hz,
C-1).
Triethyl phosphonoacetate (12)
Triethyl phosphite (8.4 mL, 8.1 g, 48.8 mmol) was added to ethyl bromoacetate 11 (7.51 g, 44.4 mmol) and
the mixture was refl uxed at 180°C for 5 h, while ethyl bromide was removed occasionally by suction. After

































[1,2]-13C2 Triethyl phosphonoacetate (12a)
In a similar way to that described above, [1,2]-13C
2 
ethyl bromoacetate 11b (7.5 g, 44.4 mmol) reacted with
triethyl phosphite to give [1,2]-13C
2
triethyl phosphonoacetate 12b (9.03 g, 40 mmol, 90%).
1H NMR (CDCl
3
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13C NMR (CDCl
3

















), 165.5 (d, J = 58.8 Hz, C-1).





; 3.7 mL, 6.2 g, 46.0 mmol) was added to ethyl acetoacetate 13 (5.9 mL, 6.0 g,
46.0 mmol) at 0°C and the mixture was stirred overnight at RT. Traces of sulfuryl chloride were removed in
vacuo, to give 2-chloro ethyl acetoacetate 14 (7.5 g, 45.6 mmol, 99%).
1H NMR (CDCl
3









4.78 (s, 1 H, 2-H).
13C NMR (CDCl
3








), 164.7 (C-1), 196.3 (C-3).
[1,2,3,4]-13C4 Ethyl 2-chloro acetoacetate (14b)
[1,2,3,4]-13C
4 
Ethyl acetoacetate 13b (6.0 g, 44.8 mmol) reacted with sulfuryl chloride (6.2 g, 23.0 mmol),
using the same procedure as described above, to give [1,2,3,4]-13C
4 








), 2.39 (ddd, J = 1.3 Hz/6.3 Hz/130.8 Hz, 3 H, 1-H),




), 4.78 (ddd, J = 5.6 Hz/5.6 Hz/154.4 Hz, 1 H, 2-H).
13C NMR (CDCl
3




), 26.1 (dd,J = 15.5 Hz/44.9 Hz, C-4), 61.2 (ddd, J = 15.5 Hz/38.4 Hz/




), 164.7 (d, J = 62.4 Hz, C-1), 196.3 (dd, J = 38.4 Hz/44.9 Hz, C-3).
Chloroacetone (15)
Ethyl 2-chloro acetoacetate 14 (3.6 g, 21.9 mmol) was dissolved in THF (75 mL) and H
2




(2.3 mL) were added. The solution was refl uxed for 2 days and the reaction was quenched with brine. The
mixture was extracted three times with diethyl ether, the combined organic phases were washed with a
saturated NaCl solution and dried with MgSO
4
. The solid was removed by fi ltration and the diethyl ether
was removed using a rotary evaporater. Chloroacetone 15 was stored in THF and mol. sieves were added to




Ethyl 2-chloro acetoacetate 14b (3.7 g, 22.0 mmol) was converted into [1,2,3]-13C
3
chloroac-
etone 15b using the same procedure as described above. The product was stored in THF with mol. sieves
and used in the next reaction without further purifi cation. 
Ethyl 3-methyl-4-chlorocrotonate (16)
Triethyl phosphonacetate 12 (8 g, 35.8 mmol) was dissolved in dry THF in a 500 mL three-necked round-
bottomed fl ask under a nitrogen atmosphere. The solution was cooled to -80 °C and n-BuLi (19.2 mL,
30.7 mmol) was added using a syringe. The anion was formed while the mixture was stirred for 30 min at
-80 °C, after which chloroacetone 15 in THF was added using a dropping funnel. The mixture was allowed
to warm to RT and stirred at for 2 h. A saturated NH
4







three times with diethyl ether. The combined organic layers were washed with brine and dried with MgSO
4
.
This was removed by fi ltration and the solution was concentrated in vacuo. The resulting brown oil was
purifi ed by fl ash chromatography (10% diethyl ether/PE) to obtain ethyl 3-methyl-4-chlorocrotonate 16
(2.56 g, 15.3 mmol, 72% over 2 steps) as a mixture of E/Z isomers.
1H NMR (CDCl
3




), 2.03 (s, 3 H, 3-CH
3
Z), 2.24 (s, 3 H, 3-CH
3
E), 4.05 (s,




), 4.68 (s, 2 H, 4Z-H), 5.79 (s, 1 H, 2Z-H), 5.96 (s, 1 H, 2E-H).
13C NMR (CDCl
3













), 118.8 (C-2E), 119.5 (C-2Z), 151.8 (C-3E), 152.1 (C-3Z), 165.8 (C-1).
[1,2,3,4,3-methyl]-13C5 Ethyl 3-methyl-4-chlorocrotonate (16b)
By using the same procedure as described above, [1,2]-13C
2
triethyl phosphonoacetate 12b (9.7 g, 42.8 mmol)
reacted with [1,2,3]-13C
3
 chloroacetone 15b to give [1,2,3,4,3-methyl]-13C
5
 ethyl 3-methyl-4-chlorocrotonate
16b (3.23 g, 19.3 mmol, 88% over 2 steps). Excess triethyl phosphonoacetate was collected by washing
the fl ash-column with diethyl ether and subsequent distillation under reduced pressure, to recover pure
[1,2]-13C
2
triethyl phosphonoacetate 12b (2.71 g, 12.0 mmol).
1H NMR (CDCl
3




), 2.03 (dddd, J = 4.3 Hz/4.3 Hz/4.9 Hz/128.0 Hz,
3 H, 3-CH
3
Z), 2.24 (dddd, J = 4.1 Hz/4.1 Hz/4.7 Hz/128.9 Hz, 3 H, 3-CH
3
E), 4.05 (dddd, J = 3.6 Hz/3.6 Hz/4.3 Hz/




), 4.68 (dddd, J = 4.0 Hz/4.0 Hz/4.2 Hz/153.4 Hz,








), 16.6 (d, J = 41.7 Hz, 3-CH
3
Z), 22.6 (d, J = 43.1 Hz, 3-CH
3
E), 42.0 (d,




), 118.8 (m, C-2E), 119.5 (m, C-2Z), 151.8 (m,
C-3E), 152.1 (m, C-3Z), 165.8 (dd, J = 3.5 Hz/8.8 Hz, C-1).
Triethyl 3-methyl-4-phosphonocrotonate (17)
Triethyl phosphite (2.9 mL, 2.8 g, 16.8 mmol) was added to ethyl 3-methyl-4-chlorocrotonate 16 (2.56 g,
15.3 mmol) and the mixture was refl uxed for 5 h at 180°C, while the formed chloroethane was occasionally
removed by applying suction. Distillation under reduced pressure gave triethyl 3-methyl-4-phosphonocro-
tonate 17 (mixture of E/Z isomers; 3.70 g, 14.0 mmol, 92%) as a colorless oil.
1H NMR (CDCl
3




), 2.06 (m, 3 H, 3-CH
3
Z), 2.31 (m, 3 H, 3-CH
3
E), 2.70 (d, J =




), 5.80 (s, 1 H, 2-H).
13C NMR (CDCl
3












E), 31.2 (d, J = 33.6 Hz,








), 118.5 (d, J = 11.7 Hz, C-2Z), 119.6 (d, J
= 11.7 Hz, C-2E), 149.2 (d, J = 11.7 Hz, C-3), 165.6 (C-1E), 165.6 (C-1Z).
[1,2,3,4,3-methyl]-13C5 Triethyl 3-methyl-4-phosphonocrotonate (17b)
The 13C
5
phosphonate ester 17b was prepared by refl uxing [1,2,3,4,3-methyl]-13C
5
 ethyl 3-methyl-4-chloro-
crotonate 16b (3.23 g, 19.3 mmol) and triethyl phosphite (3.7 mL, 3.5 g, 21.2 mmol) for 5 h. After distillation
the desired product 17b (4.61 g, 17.1 mmol, 89%) was obtained.
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1H NMR (CDCl
3




), 2.06 (dm, J= 127.9 Hz, 3 H, 3-CH
3
Z), 2.31 (dm, J= 129.9 Hz,
3 H, 3-CH
3
E), 2.70 (dddd, J = 4.9 Hz/4.9 Hz/23.3 Hz/128.0 Hz, 2 H, 4E-H), 3.48 (dddd, J = 5.4 Hz/5.4 Hz/24.7 Hz/




), 5.80 (ddd, J = 5.6 Hz/5.6 Hz/158.9 Hz, 1 H, 2-H).
13C NMR (CDCl
3








), 19.8 (d, J = 41.8 Hz, 3-CH
3
Z), 25.9 (d, J = 41.7 Hz,
3-CH
3









), 118.5 (m, C-2Z), 119.6 (m, C-2E), 149.2 (m, C-3), 165.8 (d, J = 76.1 Hz, C-1Z), 165.8 (d, J = 76.1 Hz,
C-1E).
Ethyl 2E,4E-3-methyl-5-(2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-en-1-yl)-2,4-pentadienoate (24)
In a 250 mL three-necked round-bottomed fl ask diisopropylamine (2.11 mL, 1.53 g, 15.1 mmol) was dis-
solved in dry THF (100 mL). The solution was cooled to -20°C and n-BuLi (8.75 mL, 14 mmol) was added.
After 30 min at -20°C triethyl 3-methyl-4-phosphonocrotonate 17 (3.4 mL, 3.7 g, 14.0 mmol) in THF (10 mL)
was slowly added using a dropping funnel. After 30 min the mixture was allowed to warm to 0°C and
2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-enecarbaldehyde 9 in THF (20 mL) was added. The reaction was
stirred overnight at RT and followed on TLC (50% diethyl ether/PE).
 When TLC showed complete conversion of the aldehyde, the mixture was poured in a saturated NaCl-
solution and extracted three times with diethyl ether. The combined organic layers were washed with satu-
rated NaCl and dried with MgSO
4
. After fi ltration and evaporation of the solvent the mixture was purifi ed on
a fl ash column (2% triethylamine/10% diethyl ether/PE). This resulted in a yellow oil of product 18 (2.97 g,
9.3 mmol, 86%), which became solid during storage at -20°C. 
1H NMR (CDCl
3
) δ (ppm) = 1.03 (s, 6 H, 1-CH
3




), 1.57-1.83 (m, 4 H, 2-H/3-H),
1.66 (s, 3 H, 5-CH
3
), 2.32 (s, 3 H, 9-CH
3








), 5.75 (s, 1 H,
10-H), 6.12 (d, J = 16.1 Hz, 8-H), 6.48 (d, J = 16.1 Hz, 7-H).
13C NMR (CDCl
3



















O), 107.7 (C-4), 119.1 (C-10), 129.5 (C-5), 132.4 (C-7), 137.5 (C-8), 144.5
(C-6), 151.8 (C-9), 166.9 (C-11).
Ethyl 2E,4E-3-methyl-5-([1,2]-13C2 2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-en-1-yl)-2,4-penta-
dienoate (18a)
Using the same procedure as described before, 13C
2
aldehyde 9a (3.64 g, 17.1 mmol) reacted with phos-
phonate 17 (5.4 mL, 5.9 g, 22.2 mmol) to give ethyl 2E,4E-3-methyl-5-([1,2]-13C
2
2,10,10-trimethyl-4,7-
dioxaspiro[4,5]dec-1-en-1-yl)-2,4-pentadienoate 18a (4.60 g, 14.3 mmol, 83%).
1H NMR (CDCl
3
) δ (ppm) = 1.03 (d, J = 3.7 Hz, 6 H, 1-CH
3




), 1.57-1.83 (m, 4 H,
2-H/3-H), 1.66 (d, J = 5.2 Hz, 3 H, 5-CH
3
), 2.32 (s, 3 H, 9-CH
3









), 5.75 (s, 1 H, 10-H), 6.11 (dd, J = 4.6 Hz/16.1 Hz, 1 H, 8-H), 6.48 (dd, J = 16.1 Hz/150.3 Hz, 1 H, 7-H).
13C NMR (CDCl
3










), 30.0 (C-3), 34.7 (C-1),








O), 107.7 (C-4), 119.1 (C-10), 129.5 (d, J = 73.9 Hz, C-5), 132.4 (d, J =









A similar procedure as described before was used to react 2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-ene-
carbaldehyde 9 (2.54 g, 12.1 mmol) with [1,2,3,4,3-methyl]-13C
5 
triethyl 3-methyl-4-phosphonocrotonate
17b (4.24 g, 15.7 mmol) to give [1,2,3,4,3-methyl]-13C
5
 ethyl 2E,4E-3-methyl-5-(2,10,10-trimethyl-4,7-
dioxaspiro[4,5]dec-1-en-1-yl)-2,4-pentadienoate 18b (3.48 g, 10.7 mmol, 88%).
1H NMR (CDCl
3
) δ (ppm) = 1.03 (s, 6 H, 1-CH
3




), 1.57-1.83 (m, 4 H, 2-H/3-H),
1.66 (s, 3 H, 5-CH
3
), 2.34 (ddd, J = 4.7 Hz/4.7 Hz/128.8 Hz, 3 H, 9-CH
3




O), 4.17 (dq, J =




), 5.75 (dt, J = 7.6 Hz/159.7 Hz, 1 H, 10-H), 6.12 (dddd, J = 3.6 Hz/3.6 Hz/16.1 Hz/
155 Hz, 1 H, 8-H), 6.48 (dd, J = 5.7 Hz/16.1 Hz, 1 H, 7-H).
13C NMR (CDCl
3



















O), 107.7 (C-4), 119.1 (dd, J = 74.7 Hz/77.6 Hz,
C-10), 129.5 (C-5), 132.4 (d, J = 51.4 Hz, C-7), 137.5 (dd, J = 7 Hz/52.7 Hz, C-8), 144.5 (C-6), 151.8 (ddd, J =
41.0 Hz/52.7 Hz/74.7 Hz, C-9), 166.9 (dd, J = 8 Hz/77.6 Hz, C-11).
2E,4E-3-Methyl-5-(2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-en-yl)-2,4-pentadienol (19)
A 250 mL three-necked round-bottomed fl ask was equipped with a septum inlet, outlet and a pentane-
thermometer. Under a nitrogen fl ow, the ester 18 (2.97 g, 9.3 mmol) was dissolved in dry PE and the solution
was cooled to -80°C, after which Dibal-H (20.5 mL, 20.5 mmol) was slowly added using a syringe. The reac-
tion was allowed to warm to -40°C in 1 h. When TLC (50% diethyl ether/PE) showed complete conversion







were added and the solids were removed by fi ltration and washed with diethyl
ether. After concentration the product was purifi ed by column chromatography (silica gel, gradient 50-98%
diethyl ether/PE + 2% TEA), resulting in the alcohol 19 (1.37 g, 4.92 mmol, 53%).
1H NMR (CDCl
3
) δ (ppm) = 1.03 (s, 6 H, 1-CH
3
), 1.61 (m, 2 H, 2-H), 1.67 (s, 3 H, 5-CH
3
), 1.80 (m, 2 H, 3-H), 1.83
(s, 3 H, 9-CH
3

























18a (4.6 g, 14.3 mmol) was reduced with Dibal-H (31.5 mL, 31.5 mmol) to give 2E,4E-3-methyl-5-([1,2]-13C
2
2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-en-yl)-2,4-pentadienol 19a (2.12 g, 7.56 mmol, 53%).
1H NMR (CDCl
3
) δ (ppm) = 1.03 (s, 6 H, 1-CH
3
), 1.55-1.90 (m, 4 H, 2-H/3-H), 1.66 (d, J = 5.1 Hz, 3 H, 5-CH
3
), 1.83
(s, 3 H, 9-CH
3




O), 4.29 (d, J = 6.9 Hz, 2 H, 11-H), 5.63 (t, J = 6.9 Hz, 1 H, 10-H), 6.06 (dd, J
= 16.2 Hz/153.0 Hz, 1 H, 7-H), 6.07 (ddd, J = 3.0 Hz/4.5 Hz/16.2 Hz, 1 H, 8-H).
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13C NMR (CDCl
3
) δ (ppm) = 11.4 (9-CH
3
), 13.0 (d, J = 88.9 Hz), 27.8 (1-CH
3
), 30.2 (C-3), 34.6 (d, J = 50.6 Hz), 36.0




O), 108.1 (C-4), 125.8 (d, J = 54.3 Hz, C-7), 128.0 (d, J = n.d., C-5), 130.0 (C-10),
135.0 (C-9), 138.3 (d, J = 71.7 Hz, C-8), 145.3 (d, J = 54.3 Hz, C-6).
[1,2,3,4,3-methyl]-13C5 2E,4E-3-Methyl-5-(2,10,10-trimethyl-4,7-dioxaspiro[4,5]dec-1-en-yl)-2,4-pen-
ta dienol (19b)
By using the same procedure as described before, [1,2,3,4,3-methyl]-13C
5
 ethyl 2E,4E-3-methyl-5-(2,10,10-
trimethyl-4,7-dioxaspiro[4,5]dec-1-en-1-yl)-2,4-pentadienoate 18b (3.48 g, 10.7 mmol) was reduced with
Dibal-H (23.5 mL, 23.5 mmol) to obtain the corresponding 13C
5
alcohol 19b (1.17 g, 4.13 mmol, 39%).
1H NMR (CDCl
3
) δ (ppm) = 1.02 (s, 6 H, 1-CH
3
), 1.61 (m, 2 H, 2-H), 1.66 (s, 3 H, 5-CH
3
), 1.80 (m, 2 H, 3-H), 1.84
(ddd, J = 4.7 Hz/4.7 Hz/126.4 Hz, 3 H, 9-CH
3




O), 4.29 (ddd, J = 6.0 Hz/6.5 Hz/142.6 Hz,
1 H, 11-H), 5.63 (ddd, J = 7.6 Hz/7.6 Hz/154.5 Hz, 1 H, 10-H), 6.07 (dddd, J = 4.7 Hz/4.7 Hz/15.0 Hz/153.5 Hz,
1 H, 8-H), 6.07 (ddd, J = 4.7 Hz/4.7 Hz/15.0 Hz, 1 H, 7-H).
13C NMR (CDCl
3






), 30.1 (C-3), 34.7 (C-1), 36.1




O), 108.1 (C-4), 126.0 (d, J = 71.0 Hz, C-7), 128.0 (C-5), 129.6
(dd, J = 47.7 Hz/71.0 Hz, C-10), 135.1 (ddd, J = 42.2 Hz/56.2 Hz/71.0 Hz, C-9), 138.3 (d, J = 56.2 Hz, C-8), 145.2
(C-6).
2E,4E-3-Methyl-5-(-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-pentadienol (20)
A few drops of HCl (1 M) were added to a solution of 2E,4E-3-methyl-5-(2,10,10-trimethyl-4,7-
dioxaspiro[4,5]dec-1-en-yl)-2,4-pentadienol 19 (1.37 g, 4.92 mmol) in acetone (125 mL), until the solution






 were added. The mixture was stirred for 10 minutes,
and the solids were removed by fi ltration and washed with diethyl ether. The solvents were removed in
vacuo, and the product was purifi ed by fl ash-chromatography (50% diethyl ether/PE). The solution was
concentrated in vacuo to obtain the desired product 20 (1.04 g, 44 mmol, 90%).
1H NMR (CDCl
3
) δ (ppm) = 1.17 (s, 6 H, 1-CH
3
), 1.82 (s, 3 H, 5-CH
3
), 1.86 (t, J = 6.9 Hz, 2 H, 2-H), 1.87 (s, 3 H,
9-CH
3










), 33.8 (C-3), 35.3 (C-1), 36.8 (C-2), 58.6
(C-11), 123.6 (C-7), 129.2 (C-9), 133.0 (C-5), 134.2 (C-10), 140.0 (C-8), 161.5 (C-6), 199.4 (C-4).
[5]-13C 2E,4E-3-Methyl-5-([1]-13C-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-pentadienol (20a)
Hydrolysis of the 13C
2 
acetal 19a (2.12 g, 7.6 mmol) gave the corresponding 13C
2 




) δ (ppm) = 1.17 (d, J = 3.8 Hz, 6 H, 1-CH
3
), 1.83 (d, J = 4.9 Hz, 3 H, 5-CH
3
), 1.86 (t, J = 6.7 Hz,
2 H, 2-H), 1.87 (s, 3 H, 9-CH
3
), 2.50 (t, J = 6.7 Hz, 2 H, 3-H), 4.34 (d, J = 6.7 Hz, 2 H, 11-H), 5.75 (t, J = 6.7 Hz, 1 H,















), 34.1 (C-3), 35.6 (d, J = 39.3 Hz, C-1), 37.2
(C-2), 59.1 (C-11), 124.3 (d, J = 53.7 Hz, C-7), 129.6 (d, J = 67.3 Hz, C-5), 132.6 (C-10), 135.1 (C-9), 140.0 (d, J =
70.7 Hz, C-8), 161.4 (d, J = 53.7 Hz, C-6), 199.4 (C-4).
[1,2,3,4,3-methyl]-13C5 2E,4E-3-Methyl-5-(2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-pentadienol
(20b)
By using the same procedure as described before, [1,2,3,4,3-methyl]-13C
5
 2E,4E-3-methyl-5-(2,10,10-tri-




(0.92 g, 3.8 mmol, 93%).
1H NMR (CDCl
3
) δ (ppm) = 1.17 (s, 6 H, 1-CH
3
), 1.82 (s, 3 H, 5-CH
3
), 1.85 (t, J = 6.9 Hz, 2 H, 2-H), 1.87 (dq, J =
4.6 Hz/126.6 Hz, 3 H, 9-CH
3
), 2.50 (t, J = 6.9 Hz, 2 H, 3-H), 4.34 (dd, J = 6.7 Hz/142.0 Hz, 2 H, 11-H), 5.76 (dt, J










), 34.1 (C-3), 35.5 (C-1), 37.1
(C-2), 59.0 (C-11), 124.3 (d, J = 45.1 Hz, C-7), 132.7 (dd, J = 47.4 Hz/71.5 Hz, C-10), 133.0 (C-5), 135.0 (ddd, J =
42.2 Hz/52.7 Hz/71.5 Hz, C-9), 140.0 (d, J = 52.7 Hz, C-8), 161.5 (C-6), 199.5 (C-4).
2E,4E-3-Methyl-5-(4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-pentadienol (21)
Diisopropylamine (1.98 g, 19.5 mmol, 2.75 mL) was dissolved in dry, freshly distilled THF. The solution was
cooled to -20°C and n-BuLi (11.1 mL, 17.8 mmol) was added via a syringe. After 10 min the LDA-solution
was cooled to -80°C and 2E,4E-3-methyl-5-(2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-pentadienol 20
(1.04 g, 4.4 mmol) in 20 mL dry THF was added. After 30 min a solution of (+)-(8,8-dichlorocamphoryl-
sulfonyl)oxaziridine (5.3 g, 17.8 mmol) in THF was slowly added. The reaction was allowed to warm up to
RT and followed by TLC (diethyl ether). When all starting material had reacted, the reaction was quenched






 solutions. The mixture was extracted three times with diethyl ether
and the combined organic layers were washed with saturated NaCl and dried with MgSO
4
. The solids were
removed by fi ltration. Concentration in vacuo gave a mixture of (+)-(8,8-dichlorocamphorylsulfonyl)imine
and 2E,4E-3-methyl-5-(4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-pentadienol. After silica-gel
column chromatography (50-100% diethyl ether/PE) the diol 21 (0.56 g, 2.2 mmol, 50%) was obtained.
1H NMR (CDCl
3
) δ (ppm) = 1.18 (s, 3 H, 1-CH
3
), 1.30 (s, 3 H, 1-CH
3
), 1.81 (t, J = 13.8 Hz, 1 H, 2-H
ax
), 1.87 (s, 3 H, 9-
CH
3
), 1.89 (s, 3 H, 5-CH
3
), 2.16 (dd, J = 5.5 Hz/12.6 Hz, 1 H, 2-H
eq
), 3.71 (s, 1 H, OH), 4.33 (dd, J = 5.5 Hz/13.8 Hz,
1 H, 3-H), 4.35 (d, J = 6.6 Hz, 2 H, 11-H), 5.78 (t, J = 6.6 Hz, 1 H, 10-H), 6.16 (d, J = 16.3 Hz, 1 H, 7-H), 6.28 (d, J
= 16.3 Hz, 1 H, 8-H).
13C NMR (CDCl
3






), 36.4 (C-1), 45.3 (C-2), 59.1 (C-11), 69.2
(C-3), 123.4 (C-7), 126.7 (C-5), 133.6 (C-10), 134.6 (C-9), 141.0 (C-8), 162.2 (C-6), 200.4 (C-4).
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[5]-13C 2E,4E-3-Methyl-5-([1]-13C 4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-penta -
dienol (21a)
The same procedure as described above was used to synthesize [5]-13C 2E,4E-3-methyl-5-([1]-13C 4-
hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-pentadienol 21a (0.90 g, 3.6 mmol, 53%) from the
corresponding 13C
2
 alcohol 20a (1.7 g, 7.2 mmol).
1H NMR (CDCl
3
) δ (ppm) = 1.18 (d, J = 3.9 Hz, 3 H, 1-CH
3
), 1.30 (d, J = 3.6 Hz, 3 H, 1-CH
3
), 1.81 (t, J = 13.2 Hz,
1 H, 2-H
ax
), 1.86 (s, 3 H, 9-CH
3
), 1.88 (d, J = 4.9 Hz, 3 H, 5-CH
3
), 2.16 (dd, J = 5.6 Hz/12.0 Hz, 1 H, 2-H
eq
), 3.87 (s,
1 H, OH), 4.32 (dd, J = 5.7 Hz/13.8 Hz, 1 H, 3-H), 4.34 (d, J = 6.6 Hz, 2 H, 11-H), 5.78 (t, J = 6.6 Hz, 1 H, 10-H),
6.17 (dd, J = 16.3 Hz/155.2 Hz, 1 H, 7-H), 6.28 (ddd, J = 3.0 Hz/4.9 Hz/16.3 Hz, 1 H, 8-H).
13C NMR (CDCl
3






), 36.5 (d, J = 39.0 Hz, C-1), 45.0 (C-2), 58.9
(C-11), 69.2 (C-3), 123.4 (d, J = 54.0 Hz, C-7), 131.6 (d, J = 53.1 Hz, C-5), 133.5 (d, J = 8.0 Hz, C-10), 134.6 (d, J =
5.7 Hz, C-9), 141.0 (d, J = 71.3 Hz, C-8), 162.2 (d, J = 54.0 Hz, C-6), 200.4 (C-4).
[1,2,3,4,3-methyl]-13C5 2E,4E-3-Methyl-5-(4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-
pen ta di e nol (21b)
Using the same procedure as described above, [1,2,3,4,3-methyl]-13C
5
 2E,4E-3-methyl-5-(2,6,6-trimethyl-3-
oxo-1-cyclohexen-1-yl)-2,4-pentadienol 20b (0.9 g, 3.8 mmol) was converted into [1,2,3,4,3-methyl]-13C
5




) δ (ppm) = 1.18 (s, 3 H, 1-CH
3
), 1.30 (s, 3 H, 1-CH
3
), 1.81 (t, J = 13.2 Hz, 1 H, 2-H
ax
), 1.87 (dd, J =
4.5 Hz/126.6 Hz, 3 H, 9-CH
3
), 1.89 (s, 3 H, 5-CH
3
), 2.16 (dd, J = 5.5 Hz/12.6 Hz, 1 H, 2-H
eq
), 3.71 (s, 1 H, OH), 4.32
(dd, J = 5.5 Hz/13.9 Hz, 1 H, 3-H), 4.35 (dd, J = 7.5 Hz/142.3 Hz, 2 H, 11-H), 5.77 (dt, J = 7.5 Hz/152.4 Hz, 1 H,
10-H), 6.17 (dd, J = 4.9 Hz/16.5 Hz, 1 H, 7-H), 6.27 (dd, J = 16.5 Hz/155.4 Hz, 1 H, 8-H).
13C NMR (CDCl
3






), 36.7 (C-1), 45.3 (C-2), 59.3
(d, J = 47.3 Hz, C-11), 69.2 (C-3), 123.8 (d, J = 71.3 Hz, C-7), 131.4 (C-5), 133.1 (dd, J = 47.3 Hz/71.5 Hz, C-10),




A solution of diol 21 (0.56 g, 2.2 mmol) in DCM (50 mL) was cooled to 0°C and HBr (47%, 0.53 mL, 4.5 mmol)
was slowly added. The mixture was stirred for 30 min and followed by TLC (diethyl ether). If necessary, two
more equivalents of HBr were added until TLC showed complete conversion of the starting material. A satu-
rated NaCl solution was added and the mixture was extracted three times with ethyl acetate. The combined
organic layers were dried with MgSO
4
and the solids were removed by fi ltration. 1,2-Epoxybutane was added
until the solution was at pH 7. The solution was concentrated to a volume of circa 20 mL and ethyl acetate
(30 mL) and 1,2-epoxybutane (0.5 mL) were added. Subsequently, the solution was concentrated again to a
volume of 20 mL. This solution was slowly added to a solution of triphenylphosphine (0.59 g, 2.2 mmol) in







24 h, during which a white preciptate was formed. TLC analysis (diethyl ether) showed complete conversion
of the starting material. The white solid product was collected by fi ltration, washed with diethyl ether, and
dried in vacuo to give the phosphonium salt 22 (0.65 g, 1.13 mmol, 50%).
1H NMR (CDCl
3
) δ (ppm) = 1.12/1.26 (2s, 6 H, 1-CH
3
), 1.47 (d, J = 3.7 Hz, 3 H, 9-CH
3
), 1.77 (t, J = 12.9 Hz, 1 H,
2-H
ax
), 1.81 (s, 3 H, 5-CH
3
), 2.24 (dd, J = 5.6 Hz/7.1 Hz, 1 H, 2-H
eq
), 3.67 (s, 1 H, OH), 4.29 (dd, J = 5.6 Hz/13.9 Hz,
1 H, 3-H), 4.90 (m, 2 H, 11-H), 5.58 (dd, J = 7.5 Hz/7.5 Hz, 1 H, 10-H), 6.06 (d, J = 16.2 Hz, 1 H, 7-H), 6.17 (d, J =
16.2 Hz, 1 H, 8-H), 7.64-7.92 (m, 15 H, phenyl).
13C NMR (CDCl
3
) δ (ppm) = 12.5 (C-19), 13.4 (C-18), 24.8 (d, J = 45.5 Hz, C-11), 25.5/30.1 (C-16/17), 36.3 (C-1),
44.9 (C-2), 68.8 (C-3), 117.3 (d, J = 85.6 Hz, C-10), 125.1 (C-7), 126.9 (C-5), 130.1/133.4/134.9 (C-phenyl), 138.8
(C-8), 142.3 (C-9), 161.0 (C-6), 200.0 (C-1).
[5]-13C (2E,4E-3-Methyl-5-([1]-13C (4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-penta-
dien-1-yl)-phosphonium bromide (22a)
[5]-13C 2E,4E-3-Methyl-5-([1]-13C 4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-pentadienol 21a
(0.90 g, 3.6 mmol) reacted with HBr and triphenylphosphine using the same procedure as described above,
to yield pure [5]-13C (2E,4E-3-methyl-5-([1]-13C (4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-
pentadien-1-yl)-phosphonium bromide 22a (0.88 g, 1.5 mmol, 43%).
1H NMR (CDCl
3
) δ (ppm) = 1.13/1.27 (2d, J = 3.8 Hz, 6 H, 1-CH
3
), 1.48 (d, J = 3.7 Hz, 3 H, 9-CH
3
), 1.77 (t, J =
13.3 Hz, 1 H, 2-H
ax
), 1.81 (d, J = 4.9 Hz, 3 H, 5-CH
3
), 2.14 (dd, J = 5.9 Hz/12.9 Hz, 1 H, 2-H
eq
), 3.75 (s, 1 H, OH), 4.31
(dd, J = 5.6 Hz/13.9 Hz, 1 H, 3-H), 4.88/4.94 (dd, J = 7.0 Hz/7.3 Hz, 2 H, 11-H), 5.61 (dt, J = 7.0 Hz/7.3 Hz, 1 H,
10-H), 6.09 (dd, J = 16.3 Hz/139.2 Hz, 1 H, 7-H), 6.19 (d, J = 16.3 Hz, 1 H, 8-H), 7.70-7.94 (m, 15 H, phenyl).
13C NMR (CDCl
3
) δ (ppm) = 12.1 (9-CH
3
), 13.0 (d, J = 5.2 Hz, 5-CH
3
), 24.4 (d, J = 50.2 Hz, C-11), 25.2 (1-CH
3
),
35.8 (d, J = 39.4 Hz, C-1), 44.5 (C-2), 68.4 (C-3), 117.1 (d, J = 85.5 Hz, C-10), 124.8 (dd, J = 53.7 Hz, J = 4.7 Hz,
C-7), 128.1 (d, J = 53.6 Hz, C-5), 129.7 (d, J = 12.5 Hz, C-phenyl), 133.1 (d, J = 9.8 Hz, C-phenyl), 134.5 (d, J
= 2.9 Hz, C-phenyl), 138.4 (dd, J = 6.1 Hz/71.8 Hz, C-8), 141.8 (dd, J = 5.5 Hz/13.6 Hz, C-9), 160.5 (dd, J =
1.9 Hz/55.5 Hz, C-6), 199.6 (C-4).
[1,2,3,4,3-methyl]-13C5 (2E,4E-3-Methyl-5-(4-hydroxy-2,6,6-trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-
pentadien-1-yl)-phosphonium bromide (22b)
By using the same procedure as described before, 13C
5
Wittig salt 22b (0.63 g, 1.1 mmol, 53%) was synthe-
sized, starting from the corresponding 13C
5 
diol 21b (0.52 g, (2.04 mmol).
1H NMR (CDCl
3
) δ (ppm) = 1.11/1.26 (2s, 6 H, 1-CH
3
), 1.48 (dd, J = 3.7 Hz/127.3 Hz, 3 H, 9-CH
3
), 1.77 (t, J =
13.3 Hz, 1 H, 2-H
ax
), 1.81 (s, 3 H, 5-CH
3
), 2.13 (dd, J = 5.6 Hz/12.7 Hz, 1 H, 2-H
eq
), 4.29 (dd, J = 5.6 Hz/13.8 Hz,
2 H, 3-H), 3.65 (s, 1 H, OH), 4.91/4.99 (ddd, J = 7.0 Hz/7.0 Hz/134.8 Hz, 2 H, 11-H), 5.56 (ddt, J = 7.0 Hz/7.0 Hz/








), 25.1 (dd, J = 46.6 Hz/46.6 Hz, C-11), 25.6
(1-CH
3
), 36.4 (C-1), 45.1 (C-2), 69.0 (C-3), 117.5 (ddd, J = 46.6 Hz/73.4 Hz/84.3 Hz, C-10), 126.8 (C-5), 130.2 (d, J
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= 12.7 Hz, C-phenyl), 133.7 (d, J = 9.5 Hz, C-phenyl), 135.0 (d, J = 3.2 Hz, C-phenyl), 139.0 (d, J = 53.0 Hz, C-8),
142.3 (dddd, J = 11.8 Hz/43.5 Hz/53.0 Hz/73.4 Hz, C-9), 161.2 (C-6), 200.1 (C-4).
Astaxanthin (1)
In dim red light, 2,7-dimethylocta-2,4,6-triene-1,8-dial 23 (78 mg, 0.48 mmol) and (2E,4E-3-methyl-5-(2,6,6-
trimethyl-3-oxo-1-cyclohexen-1-yl)-2,4-pentadien-1-yl)-phosphonium bromide 22 (0.65 g, 1.1 mmol) were
dissolved in 1,2-epoxybutane (15 mL) and refl uxed overnight in a nitrogen atmosphere. When TLC (50%
diethyl ether/PE) showed complete conversion of the starting material, the mixture was allowed to cool to
RT and absolute ethanol (30 mL) was added. Via distillation 1,2-epoxybutane was removed, and after cool-
ing the solution back to RT, astaxanthin precipitated as small, dark crystals. The precipitate was collected by
fi ltration, washed with cold ethanol and removed from the fi lter with dichloromethane. n-Heptane (30 mL)
was added, and dichloromethane was removed via distillation. The solution in n-heptane was refl uxed over-
night in a nitrogen atmosphere, and then cooled to 0ºC. The formed crystals of all-trans astaxanthin were
collected by fi ltration, and recrystallized with dichloromethane/methanol and dichloromethane/n-hexane,
to yield pure all-trans astaxanthin 1 (80 mg, 0.13 mmol, 28%).
1H NMR (CDCl
3
) δ (ppm) = 1.21/1.32 (s, 12 H, 16-H/17-H), 1.81 (t, J = 13.3 Hz, 2 H, 2-H
ax
), 1.94 (s, 6 H, 18-H),
1.99 (s, 6 H, 20-H), 2.00 (s, 6 H, 19-H), 2.16 (dd, J = 5.6 Hz/12.6 Hz, 2 H, 2-H
eq
), 3.68 (br. s, 2 H, OH), 4.32 (dd, J =
5.6 Hz/13.8 Hz, 2 H, 3-H), 6.21 (d, J = 16.1 Hz, 2 H, 7-H), 6.29 (d, J = 11.3 Hz, 2 H, 10-H), 6.31 (d, J = 7.4 Hz, 2 H,
14-H), 6.43 (d, J = 16.1 Hz, 2 H, 8-H), 6.47 (d, J = 14.8 Hz, 2 H, 12-H), 6.66 (dd, J = 11.3 Hz/14.8 Hz, 2 H, 11-H),
6.67 (d, J = 7.4 Hz, 2 H, 15-H).
13C NMR (CDCl
3
) δ (ppm) = 12.5 (C-19), 12.8 (C-20), 14.0 (C-18), 26.2/30.7 (C-16/C-17), 36.8 (C-1), 45.4 (C-2),
69.2 (C-3), 123.2 (C-7), 124.6 (C-11), 126.8 (C-5), 130.6 (C-15), 133.8 (C-14), 134.6 (C-9), 135.2 (C-10), 136.8
(C-13), 139.8 (C-12), 142.3 (C-8), 162.2 (C-6), 200.4 (C-4).
 [6,6’,7,7’]-13C4 Astaxanthin (1a)
The same procedure as used for the synthesis of natural abundance astaxanthin was carried out for the syn-
thesis of 13C
4
 astaxanthin 1a; 13C
2
Wittig salt 22a (0.88 g, 1.5 mmol) and C
10
dialdehyde 23 (0.11 g, 0.68 mmol)
gave, after isomerization and purifi cation, pure all-trans 13C
4
astaxanthin 1a (0.14 g, 0.23 mmol, 34%).
1H NMR (CDCl
3
) δ (ppm) = 1.21/1.32 (2d, J = 3.4 Hz/3.7 Hz, 12 H, 16-H/17-H), 1.81 (t, J = 13.2 Hz, 2 H, 2-H
ax
),
1.94 (d, J = 4.8 Hz, 6 H, 18-H), 1.99 (s, 6 H, 20-H), 2.00 (s, 6 H, 19-H), 2.16 (ddd, J = 6.0 Hz/6.8 Hz/12.8 Hz, 2 H,
2-H
eq
), 3.68 (s, 2 H, OH), 4.32 (dd, J = 5.6 Hz/13.8 Hz, 2 H, 3-H), 6.21 (dd, J = 15.8 Hz/152 Hz, 2 H, 7-H), 6.29 (d,
J = 11.5 Hz, 2 H, 10-H), 6.31 (d, J = 7.9 Hz, 2 H, 14-H), 6.43 (dd, J = 4.7 Hz/15.8 Hz, 2 H, 8-H), 6.45 (d, J = 14.4 Hz,
2 H, 12-H), 6.64 (dd, J = 11.5 Hz/14.4 Hz, 2 H, 11-H), 6.67 (d, J = 7.9 Hz, 2 H, 15-H).
13C NMR (CDCl
3
) δ (ppm) = 12.6 (C-19), 12.8 (C-20), 14.0 (C-18), 26.1/30.7 (C-16/C-17), 36.8 (d, J = 38.2 Hz,
C-1), 45.4 (C-2), 69.2 (C-3), 123.3 (d, J = 55 Hz, C-7), 124.6 (C-11), 126.8 (d, J = 52.5 Hz, C-5), 130.7 (C-15), 133.8








[8,8’,9,9’,10,10’,11,11’,19,19’]- 13C10 Astaxanthin (1b)
The same procedure as described above for the synthesis of natural abundance astaxanthin was used




Wittig salt 22b (0.60 g, 1.0 mmol) and C
10
dialdehyde 23 (74 mg,
0.45 mmol) were dissolved in 1,2-epoxybutane (15 mL) and refl uxed overnight. After crystallization,
isomerization in n-heptane, and subsequent recrystallization in DCM/methanol and DCM/n-hexane, purple
crystals of pure all-trans 13C
10
 astaxanthin 1b (50 mg, 0.08 mmol, 18%) were obtained.
1H NMR (CDCl
3
) δ (ppm) = 1.21/1.32 (s, 12 H, 16-H/17-H), 1.81 (t, J = 13.3 Hz, 2 H, 2-H
ax
), 1.94 (s, 6 H, 18-H), 1.99
(s, 6 H, 20-H), 2.00 (d, J = 126 Hz, 6 H, 19-H), 2.16 (dd, J = 5.6 Hz/12.6 Hz, 2 H, 2-H
eq
), 3.68 (br. s, 2 H, OH), 4.32
(dd, J = 5.6 Hz/13.8 Hz, 2 H, 3-H), 6.21 (dd, J = 4.0 Hz/16.1 Hz, 2 H, 7-H), 6.29 (ddd, J = 11.0 Hz/11.2 Hz/138 Hz,
2 H, 10-H), 6.31 (d, J = 7.5 Hz, 2 H, 14-H), 6.43 (dd, J = 16.1 Hz/132 Hz, 2 H, 8-H), 6.45 (dd, J = 7.0 Hz/14.7 Hz,
2 H, 12-H), 6.66 (ddd, J = 11.2 Hz/14.7 Hz/143 Hz, 2 H, 11-H), 6.67 (d, J = 7.5 Hz, 2 H, 15-H).
13C NMR (CDCl
3
) δ (ppm) = 12.5 (d, J = 39 Hz, C-19), 12.8 (C-20), 14.0 (C-18), 26.2/30.7 (C-16/C-17), 36.8 (C-1),
45.4 (C-2), 69.2 (C-3), 123.0 (d, J = 73 Hz, C-7), 124.6 (d, J = 50 Hz, C-11), 126.8 (C-5), 130.6 (C-15), 133.8 (C-14),
134.6 (ddd, J = 39 Hz/52 Hz/n.d.,C-9), 135.2 (dd, J = 50 Hz/n.d., C-10), 136.7 (C-13), 139.8 (d, J = n.d., C-12),
142.3 (d, J = 52 Hz, C-8), 162.2 (C-6), 200.4 (C-4).
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CHAPTER 3
SPECTROSCOPY AND QUANTUM CHEMICAL 
MODELING REVEAL A PREDOMINANT
CONTRIBUTION OF EXCITONIC INTERACTIONS TO
THE BATHOCHROMIC SHIFT IN αCRUSTACYANIN, THE
BLUE CAROTENOPROTEIN IN THE CARAPACE OF THE 
LOBSTER HOMARUS GAMMARUS
Published in J. Am. Chem. Soc. 127, 2005, 1438-1445.
To resolve the molecular basis of the coloration mechanism of α-crustacyanin, 13C-labeled
astaxanthins were used as chromophores for solid-state 13C NMR and resonance Raman spec-
troscopy of [6,6’,7,7’]-13C
4
 α-crustacyanin and [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
α-crustacyanin.
The experimental data were complemented with time-dependent density functional theory
calculations on several models based on the structural information available for β-crustacyanin.
The data rule out major changes and strong polarization eff ects in the ground-state electron
density of astaxanthin upon binding to the protein. Conformational changes in the chromo-
phore and hydrogen-bond interactions between the astaxanthin and the protein can account
for only about one-third of the total bathochromic shift in α-crustacyanin. The exciton coupling
due to the proximity of two astaxanthin chromophores is found to be large, suggesting that
aggregation eff ects in the protein represent the primary source of the color change.
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3.1 INTRODUCTION
Carotenoids are the most widespread class of pigments in both plants and animals. They are
responsible for many natural yellow, orange, or red colors. In addition, when carotenoids are
associated with proteins, these colors can be modifi ed to green, purple, or blue by the formation
of carotenoid-protein complexes. A well-known example of this phenomenon is provided by
the lobster Homarus gammarus, which is deep blue (λ
max
 = 632 nm, aq PO
4
buff er). Heat causes
the lobster to change color from blue to red. The high temperature denatures the protein under
liberation of the “red” astaxanthin (λ
max
= 472 nm in n-hexane, λ
max
= 478 nm in acetone). The
bathochromic shift of the astaxanthin chromophore in α-crustacyanin has intrigued scientists
for many years.
In a seminal paper, Buchwald and Jencks reported that α-crustacyanin can be irreversibly
dissociated in eight β-crustacyanin units.1 β-Crustacyanin consists of two apoprotein units
and two bound astaxanthin units. They also reported the visible, optical rotary dispersion and
circular dichroism (CD) spectra of α- and β-crustacyanin. In both systems, the main CD band
exhibits a change of sign at the absorption maximum with a negative and a positive peak at
wavelengths above and below the absorption maximum, respectively. Renström et al. found
that the CD spectra are not infl uenced by the intrinsic chirality of the astaxanthin in α-crusta-
cyanin.2 The negative chirality demonstrated by the CD spectra indicates an exciton coupling of 
the astaxanthins similar to that predicted by exciton theory.3 Among the possible mechanisms
for the perturbed optical properties of astaxanthin in α-crustacyanin, it was also suggested that
distortion, such as twisted double bonds induced by the protein, may play a role.1
The subsequent resonance Raman (RR) spectroscopy of α-crustacyanin by Carey et al. indi-
cated that the astaxanthin chromophore shows no distortion due to twists in the double bonds
of the conjugated system and is in agreement with free relaxed carotenes.4 On the basis of this
resonance Raman study, the hypothesis of the exciton mechanism was discarded and it was
concluded that the bathochromic shift is caused by a charge polarization mechanism possibly
induced by charged groups and/or by hydrogen bonds in the binding site.4
More recently, to obtain structural information with atomic resolution, a solid-state 13C NMR
and resonance Raman spectroscopic study was performed on α-crustacyanin regenerated with
astaxanthins that are symmetrically 13C
2
-enriched in the central part.5-7 The 13C NMR data show
substantial downfi eld shifts of 4.2 and 7.1 ppm for the 14,14’ position and 5.4 and 7.5 ppm for
the 12,12’ carbon positions in α-crustacyanin.5,6 Under the assumption that there is no exciton
coupling and together with semiempirical theoretical calculations that fi tted the electronic
absorption properties, this work led to the hypothesis that there is a strong electrostatic
polarization originating from the keto groups, most likely a double protonation.7 The resonance
Raman spectra from the same 13C isotopomers of α-crustacyanin showed that the pattern of 








Recently, the X-ray structure of β-crustacyanin at 3.2 Å resolution has been published.9 The X-
ray study shows that in β-crustacyanin two astaxanthins are present in parallel planes that cross
at a distance of 7 Å just a little outside the centers of the chromophores, as shown in Figure 1.
The vectors of the central axis are oriented at 120°. The conformation around the 6-7 and 6'-7'
bonds is planar s-trans, in contrast to free astaxanthin, which has a s-cis conformation. The oxy-
gen at the 4’-keto group is close to His-90 and His-92 for astaxanthin 1 and 2, respectively. The
two other keto groups have interactions with Asp, two Tyr residues, a Ser, and a bound water
molecule. Although the increased conjugation due to the end ring’s coplanarization should
lead to a bathochromic shift with respect to free astaxanthin, it has been stated that this eff ect
is not suffi  cient to explain the color of β-crustacyanin.9
Despite considerable progress made in structural and spectroscopic studies, a clear converg-
ing picture on the dominant mechanism for the bathochromic shift in crustacyanin is still
missing. There are two main hypotheses that are still debated: (i) the “on-site” (intramolecular)
mechanism involving protein-induced conformational changes and/or charge-polarization
eff ects modifying the electronic ground state of the chromophore; and (ii) the aggregation
(intermolecular) mechanism due to the interaction of the chromophores in the subunits of 
crustacyanin inducing an exciton coupling of the transition dipole moments in the excited
state.
To resolve the precise molecular basis of the coloration mechanism of α-crustacyanin
13C-labeled astaxanthins were used as chromophores for solid-state 13C NMR and resonance
Raman spectroscopy of [6,6’,7,7’]-13C
4 







Figure 1. Top view and side view of two astaxanthin molecules in β-crustacyanin. α is the angle
between the long axes of the astaxanthin molecules; R̂ is the unit vector connecting the center of 
mass of the two molecules, and μ shows the orientation of the transition dipole moment along the
axis. The atomic coordinates have been extracted from the Protein Data Bank fi le (PDB code 1GKA).
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α-crustacyanin (1b), establishing the electronic charge distribution and vibrational contribu-
tion of the remaining sp2 carbon atoms. Figure 2 shows the structure and numbering of the
all-E astaxanthin (3,3’-didehydro-β,β-carotene-4,4’-dione) chromophore. The position of the 13C
enrichment is marked with (A) for [6,6’,7,7’]-13C
4














































Figure 2. Molecular structure and IUPAC numbering of synthetic all-E astaxanthin (3,3’-didehydro-
β,β-carotene-4,4’-dione) as a mixture of 25% (3R,3’R), 25% (3S,3’S) and 50% (3R,3’S).
A is the 13C for [6,6’,7,7’]-13C
4
-all-E astaxanthin (2a)
B is the 13C for [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
-all-E astaxanthin (2b)
The spectroscopic data were complemented with quantum mechanical calculations of the
electronic ground state and excitation energies of various astaxanthin models based on the
structural information available for β-crustacyanin. The theoretical investigation is crucial to
identifying the relative importance of diff erent mechanisms that may contribute to the total
bathochromic shift.
3.2 MATERIALS AND METHODS
3.2.1 Synthesis of 13C-Labeled Astaxanthins
The synthetic strategy for preparing astaxanthin with 99% 13C enrichment at any position or
combination of positions is described in Chapter 2. For 13C enrichment of the 6,6’,7,7’-position,
the commercially available 13C
2
-acetonitrile was used. The 13C incorporation at the 8,8’,9,9’,
10,10’,11,11’,19,19’ positions was eff ected by 13C
5
-triethyl-3-methyl-4-phosphonocrotonate,
which was prepared analogous to the corresponding nitrile derivative which was used earlier
for the synthesis of uniformly 13C-enriched retinal.10,11
A quantity of 140 mg (0.23 mmol) of all-E [6,6’,7,7’]-13C
4
astaxanthin (2a) (25% (3R,3’R), 25%
(3S,3’S) and 50% (3R,3’S)) was obtained in 10 steps starting from 1.3 g (30.7 mmol) 13C
2
-acetoni-
trile. Similarly, 50 mg (0.08 mmol) of all-E [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 astaxanthin (2b) (25%
(3R,3’R), 25% (3S,3’S) and 50% (3R,3’S)) was obtained. Solution 1H and 13C NMR spectra were
recorded of 2a and 2b and compared with the spectra of unlabeled astaxanthin, to observe
the eff ect of the specifi c 13C enrichment on the NMR spectra, and to verify the position and








astaxanthin 2a and [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 astaxanthin 2b and >99% 13C enrichment
at the desired positions. The NMR characterization is discussed in Chapter 2.
3.2.2 Isolation and Reconstitution of α-Crustacyanin
The blue protein α-crustacyanin was extracted from lobster carapace and subsequently purifi ed
by anion-exchange and gel-fi ltration chromatography according to the procedure described by
Zagalsky.12 The purity of α-crustacyanin was determined by the ratio of absorbance at 632 nm




> 3.5 were used for reconstitution. The total amount of 
α-crustacyanin was determined from the absorbance at 632 nm. A molar extinction coeffi  cient,
ε = 1.25 × 105 M-1 cm-1, was used. 
The reconstitution procedure was based on the method described by Zagalsky.12 Briefl y,
astaxanthin was removed from the carotenoprotein with acetone/ether extraction. To the
resulting colorless apoprotein was quickly added the labeled carotenoid (2a or 2b) in acetone,
the mixture was stirred, and phosphate-buff er was added. The color of the complex quickly
turned blue-purple. The mixture was dialyzed overnight against 5 L phosphate buff er, pH 7.0,
and the reconstituted complex was purifi ed on a short gel-fi ltration column; the purity was




ratio with UV-vis spectroscopy. This method yielded [6,6’,7,7’]-13C
4
α-crustacyanin (1a) and [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
α-crustacyanin (1b).
3.2.3 Solution NMR Spectroscopy
1H NMR spectra, 1H-13C-decoupled NMR spectra, and 13C NMR spectra of astaxanthin in CDCl
3
were recorded on a Bruker AM-600 spectrometer using tetramethylsilane (1H δ = 0 ppm) or
CDCl
3
(13C δ = 77.00 pm) as internal standard.
3.2.4 Solid-State NMR Spectroscopy
Approximately 10 mg of α-crustacyanin reconstituted with 13C-labeled astaxanthin was used
for each SSNMR sample. The solutions were fi rst concentrated with a 100 kDa Macrosep
centrifugal concentrator to a volume of 2 mL. Subsequently, 10 kDa Eppendorf centrifugal
concentrators were used to reduce the volume to 200 μL. The resulting very dense blue solu-
tions were transferred to a 4 mm MAS rotor with a homemade centrifugal swing-out device.
NMR spectra were recorded at 188 MHz 13C frequency using a Bruker DSX-750 spectrometer
equipped with a double-resonance MAS probe. The samples were cooled to 223 K, and the
MAS spin rate was 12 kHz for all experiments. The CP/MAS spectra were recorded using 2.0 ms
ramped cross-polarization and two-pulse phase modulation decoupling during acquisition.13,14
Radio frequency-driven (RFDR) dipolar recoupling correlation spectra were acquired using a
pathway-selective phase-cycling method.15 The 2D heteronuclear correlation (HETCOR) spectra
were recorded with phase-modulated Lee-Goldburg decoupling during the t
1
-period.16,17
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3.2.5 Resonance Raman Spectroscopy
A home-built confocal Raman microspectrometer was used to measure Raman spectra of the
carotenoids (dissolved in CHCl
3
) and carotenoproteins (dissolved in aqueous phosphate buf-
fer). A Kr ion laser (Coherent Innova 90-K) with an emission wavelength of 647.1 nm was used to
excite the Raman scattering. The laser power on the sample was 5 mW. A dichroic beam splitter
(660 DCLP, Chroma Technology Corp.) was used in order to separate the Raman scattered light
from the laser light, which was further suppressed by a holographic notch fi lter (Kaiser Optical
Systems Inc.) with an optical density of 4.0 at the excitation wavelength.
The measurement time per spectrum was 50 s. The spectrograph stage (Jobin-Yvon HR460)
was equipped with a blazed holographic grating with 1200 l/mm. This resulted in a dispersion
of 0.8 cm/pixel on a CCD camera (Roper Scientifi c, Inc.). This camera contains a liquid-nitrogen-
cooled, back-illuminated chip with 1100 × 330 pixels and a pixel size of 24 × 24 μm2. The setup
is connected to a computer that controls the instrument settings, the data read-out, and the
data storage.
3.2.6 Computational Methods and Details
The geometry optimization of astaxanthin and of the various models considered here was
performed with the semiempirical AM1 method. The calculation of excitation energies and
transition dipole moments to the optically allowed 1B
u
excited state was performed using time-
dependent density functional theory (TDDFT).18 The BLYP generalized gradient approximations
was used for the exchange and correlation functional.19 The calculations were done with a
triple-ζ Slater-type orbital (STO) basis set with a single set of polarization functions using the
Amsterdam Density Functional (ADF) package.20
TDDFT allows calculating properties, such as excitation energies, through the linear density
response of the system to the external time-dependent fi eld. It is known that TDDFT shows a
systematic underestimation of the excitation to the optically allowed 1B
u
state in linear polyenes
by about 0.5-0.7 eV.21 However, the general trend of decreasing excitation energy with chain
length is correctly reproduced. Since here the bathochromic shift of the absorption energy is
of interest rather than the absolute values, TDDFT represents a good compromise between
accuracy and computational effi  ciency for our models. Indeed, the use of more accurate multi-
confi guration self-consistent fi eld (MCSCF) calculations would be computationally prohibitive
for the large molecules studied here.
The aggregation eff ects are estimated using a simple dipole-dipole approximation of the
interaction between the two astaxanthins in the geometry of the β-crustacyanin dimer. Within








Here, µ is the transition dipole moment; R̂ is the unit vector connecting the two molecules,
and R is the distance between the two molecules. The transition dipole moment is obtained
from the TDDFT calculation, and the orientation factor is estimated using the β-crustacyanin
structure. The dielectric constant in the vacuum was used, though inside the protein it may
generally be larger.
3.3 RESULTS
3.3.1 Solid-State NMR Spectroscopy of α-Crustacyanin
13C CP/MAS NMR data were collected from natural abundance α-crustacyanin, [6,6’,7,7’]-13C
4
α-crustacyanin (1a) and [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
α-crustacyanin (1b) (Figure 3). The
natural abundance spectrum of α-crustacyanin shows the characteristic features of a protein
spectrum. Between 0 and 40 ppm, the signals of the aliphatic side chains of the amino acids are
observed. Around 50 ppm, the resonances from C
α
atoms are found, while around 120 ppm, the
responses of the aromatic amino acid residues are recognized. The sharp signal at 170 ppm is
assigned to the carbonyl-carbon of the peptide bonds.
In the spectra of Figure 3, the signals marked with (*) are not detected for the natural abun-
dance sample and arise from the 13C labels of the chromophore. The signal at 120 ppm in Figure
3A is assigned to the 13C label at C7/C7’ of the chromophore since the shift is comparable with
δ(C7) = 123.3 ppm observed for astaxanthin in CDCl
3
.22 The signal from the 13C label at C6/C6’ of 
the chromophore at 162 ppm is also close to δ(C6) = 162.4 ppm for the C6 of free astaxanthin in
CDCl
3
. The NMR response appears symmetric as no diff erence between C6 and C6’ and between
C7 and C7’ was observed within the resolution of the NMR spectra.
In the spectrum of 1b, the strongest signal is at 11 ppm, which is assigned to C19/C19’ (Figure
3B). This shift is close to the shift of C19/C19’ in solution (δ(C19) = 12.6 ppm in CDCl
3
).22 The sig-
nals between 120 and 150 ppm from C8 – C11 can be assigned using 2D homonuclear (13C-13C)
and 2D heteronuclear (1H-13C) dipolar correlation techniques. Figure 4 shows the contour region
of the 2D RFDR and 2D HETCOR NMR spectra of [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
α-crustacyanin.
Starting from the signal of C19/C19’, we assigned the label clusters. The signal of C11/C11’ was
found at 123 ppm, similar to the value in solution (δ(C11) = 124.1 ppm in CDCl
3
).22 A correlation
between C11 and C10 was found, and the C10/C10’chemical shift was determined at 144 ppm.
This value is about 9 ppm higher compared to the value in solution (δ(C10) = 135.1 ppm in
CDCl
3
).22 From C10, correlations to C8 and C9 were found at 142, 134, and 131 ppm. The signals
at 134 and 131 ppm show no correlation in the HETCOR spectrum and are assigned to C9 and
C9’. These values are comparable to the chemical shift of C9 for astaxanthin in solution (δ(C9) =
134.7 ppm in CDCl
3
).22 Finally, the signal at 142 ppm was assigned to C8/C8’. Again, this signal is
comparable to the value for astaxanthin in solution (δ(C8) = 142.2 ppm in CDCl
3
).22  Table 1 gives
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From the NMR data, C8/C8’, C10/C10’, C11/C11’, and C19/C19’ could not be discriminated, which
shows that for these carbon sites, the interactions of the chromophore with the protein on
Figure 3. 13C CP/MAS NMR spectra of α-crustacyanin: A, reconstituted with [6,6’,7,7’]-13C
4
astaxanthin (1a); B, reconstituted with [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10 
astaxanthin (1b), and the
natural abundance spectrum (C). The signals arising from the 13C enrichment are indicated with 
(*). The spinning sidebands are marked with (s). The signal arising from the carbonyl carbons of the
protein is marked with (CO). The spectra are recorded at 188 MHz 13C frequency and 223 K with a







both halves of the astaxanthin are similar. Only for C9/C9’, C12/C12’, and C14/14’ are slightly
diff erent chemical shifts observed, confi rming that the binding of the chromophore is not fully
symmetrical.6 The slight asymmetry is probably caused by a diff erence in protein environment,
although it is not clear why these specifi c signals can be resolved as distinct signals, whereas
the signals of other pairs overlap. 
It was found that only minor changes in the ground-state electron density of the C atoms 8-11
of astaxanthin occur upon binding. In particular, small shifts to higher fi eld are found for C7/C7’ 
(-3 ppm) and C9/C9’(-1/-4 ppm), and a relatively large downfi eld shift is detected for C10/C10’ 
(+9 ppm). The small eff ect for the C8 eff ectively rules out the hypothesis of a polarization origi-
nating from the keto groups of the chromophore. NMR studies on protonated canthaxanthin
show that a strong electrostatic eff ect, like a single or double protonation, should give increas-
ingly larger changes in the chemical shift values of the even-numbered atoms closer to the
ring,23 in contrast with the observed data for astaxanthin in α-crustacyanin.
Figure 4. Contour region of the 2D homonuclear (13C-13C) and 2D heteronuclear (1H-13C) dipolar 
correlation spectra of [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 α-crustacyanin (1b). The 13C-13C correlations
and 13C-1H correlations are shown.
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3.3.2 Resonance Raman Characterization of 13C-Labeled Astaxanthin
The resonance Raman spectra of astaxanthin, [6,6’,7,7’]-13C
4
astaxanthin (2a), and [8,8’,9,9’,10,
10’,11,11’,19,19’]-13C
10
astaxanthin (2b) are shown in Figure 5. The spectra of β,β-carotene and
[12,12’,13,13’,14,14’,15,15’,20,20’]-13C
10
β,β-carotene are added for comparison.





), and 1005 cm-1 (ν
3
), in agreement with data for all-E astaxanthin published
before by other groups.24,25 The intense line around 1520 cm-1 has been assigned to the C=C
stretch vibrations of the central part of the polyene chain. The line of astaxanthin at 1158 cm-1
has been assigned previously to a combination of the unmethylated C-C stretch and the C-H
in-plane bending vibrations. The ν
3





signals and is assigned to the CH
3
in-plane rocking vibrations.
The Raman spectra of 13C
4
astaxanthin (2a, see Figure 5A) and 13C
10 
astaxanthin (2b, see Figure
5B) were compared with the spectrum of natural abundance astaxanthin (Figure 5C) to study
the eff ect of the 13C labeling. The spectrum of [6,6’,7,7’]-13C
4 
astaxanthin (2a) is almost identical
to the spectrum of unlabeled astaxanthin, with the main lines at 1516, 1156, and 1005 cm-1.
The 13C labels are at the end of the central polyene chain and have little or no eff ect on the RR
spectrum.
The bands of [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
 astaxanthin (2b, see Figure 5B) are shifted
compared to those of unlabeled astaxanthin. Although the shape and relative intensities of the
lines are similar, a signifi cant shift to lower frequencies is observed for the main lines. The ν
1
-line
is shifted to 1509 cm-1 (-11 cm-1), the ν
2
-line is shifted to 1147 cm-1 (-11 cm-1), and the ν
3
-line is



















8/8’ 142.2 142 0
9/9’ 134.7 133.8 130.5 -0.9 -4.2
10/10’ 135.1 144 9
11/11’ 124.1 123 -1
12/12’ 139.7 145.1 147.2 5.4 7.5
13/13’ 136.7 135.2 -1.5
14/14’ 133.8 138.0 140.9 4.2 7.1
15/15’ 130.7 129.5 -1.2
19/19’ 12.6 11.1 -1.5
20/20’ 12.8 11.1 -1.7
aData from Englert et al.22







shifted by -7 cm-1 from 1005 to 998 cm-1. Moreover, the 13C isotope substitution leads to a more
complex band pattern near the ν
2
-line, where a band is observed at 1115 cm-1, and the weak 
band of astaxanthin around 1200 cm-1 is split into bands at 1185 and 1205 cm-1. 
The RR spectrum of β,β-carotene (see Figure 5D) is very similar to the spectrum of astaxanthin,
though the end-groups are diff erent.8 The spectrum of 13C
10
β,β-carotene (Figure 5E), with 13C
labels in the central part of the polyene chain, is clearly diff erent from the spectrum of unla-




-line (-9 cm-1), and ν
3
-line (-11 cm-1). The
13C isotope substitution in β,β-carotene also leads to more complex spectral features around
the ν
2
-band, and a Raman band at 1125 cm-1 can be observed as a shoulder. In addition, the
intensity of the broad line at 1586 cm-1 is increased, and small changes in the fi ngerprint region
are observed. This confi rms that 13C labeling in the central parts of carotenoids signifi cantly





















Resonance Raman spectra: (A) [6,6’,7,7’]-13C
4
astaxanthin (2a); (B) [8,8’,9,9’,10,10’,11, 
11’,19,19’]-13C
10
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3.3.3 Resonance Raman Characterization of α-Crustacyanin
The resonance Raman spectra of α-crustacyanin, 13C
4
α-crustacyanin (1a), and 13C
10 
α-crusta-
cyanin (1b) are shown in Figure 6. The spectrum of α-crustacyanin (see Figure 6C) is distinctly
diff erent from the spectra of astaxanthin. The ν
1
-line is shifted from 1520 to 1492 cm-1, a shift
which is correlated with the change in absorption maximum from 472 to 632 nm, qualitatively




.26,27 In the fi ngerprint region between
1250 and 1400 cm-1, new Raman bands appear that are absent in free astaxanthin. The vibra-





























Figure 6. Resonance Raman spectra: (A) α-crustacyanin reconstituted with [6,6’,7,7’]-13C
4
astaxanthin (1a); (B) α-crustacyanin reconstituted with [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10








The spectrum of 13C
4 
α-crustacyanin (Figure 6A) is similar to the spectrum of natural abun-
dance α-crustacyanin. Only minor shifts of the ν
1
-line (1490 cm-1), the ν
2
-line (1151 cm-1), and the
ν
3
-line (1003 cm-1) are observed, compared to those of the natural abundance α-crustacyanin.
However, the spectrum of 13C
10
α-crustacyanin (see Figure 6B) shows distinct diff erences
compared to that of natural abundance α-crustacyanin. The ν
1
-line shows a downshift of 
11 cm-1, from 1492 cm-1 in natural abundance astaxanthin to 1481 cm-1 in 1b. The ν
2
-line in α-
crustacyanin is shifted –6 cm-1 to 1149 cm-1 and is broadened. The broadening is related to a
protein-induced splitting in otherwise degenerate vibrational modes. The 13C isotope labeling
in α-crustacyanin demonstrates a complete lifting of the degeneracy as an intense band arises
next to the ν
2
band at 1122 cm-1. The ν
3
-line shifts from 1005 to 997 cm-1 due to 13C labels in 1b.
For comparison, the spectrum of β-crustacyanin was also recorded, as shown in Figure 6D.




-line are the same as those for α-crustacyanin, although the
broadening of the ν
2
-line is smaller for β-crustacyanin than for α-crustacyanin. The ν
1
-line is
shifted to 1498 cm-1, which is in line with the λ
max
(586 nm) of β-crustacyanin being smaller than
for α-crustacyanin (632 nm).26 This indicates that the interactions of the chromophore with the
protein are similar in α- and β-crustacyanin.
3.3.4 Models and Quantum Chemical Calculations
To analyze the relative importance of the possible mechanisms contributing to the total
bathochromic shift, the following models were considered: (I) free astaxanthin, (II) 6-s-trans
astaxanthin with the end rings coplanar to the polyene chain, and (III) 6-s-trans astaxanthin,
including a hydrogen-bonded histidine analogue (methylimidazole) and a water molecule
according to the X-ray data on β-crustacyanin.9 Comparison of model I and model II gives a
measure of the shift induced by the increased conjugation due to the ring coplanarization.
Model III shows the importance of the polarization eff ects due to the hydrogen bonding with
the keto oxygens.
 Table 2 reports the fi rst excitation energy with a considerable oscillator strength obtained
with TDDFT for the three carotenoid models described above. This excitation corresponds to
the allowed 1B
u
-like excited state and can be described to a large extent as a HOMO to LUMO
transition (contributing to more than 80% of the excitation) in all cases. To compare the shift in
nanometers with the experimental values, the values in the second column are shifted by 0.7
eV. With this off set, the excitation energy of the free astaxanthin model corresponds closely to
the experimental value for astaxanthin. As discussed above, the underestimation of the excita-
tion energy within TDDFT is in line with previous theoretical investigations for long polyenes.
Nevertheless, the shift due to a change in conformation or to the presence of hydrogen bonds
is reliable.
In the free s-cis astaxanthin model optimized within the semiempirical AM1 approach, the end
rings form a dihedral angle of ~ 46˚ with the polyene chain. This is in close agreement with the
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43˚ angle observed in X-ray studies of canthaxanthin.28 According to the X-ray structure of β-
crustacyanin,9 the astaxanthin chromophores bound to the protein are in an all-E conformation
with the end rings essentially coplanar to the polyene chain. Thus, the main conformational
change from free astaxanthin to the chromophore in β-crustacyanin consists of the coplanariza-
tion of the end rings, inducing a more extended conjugated chain. Comparing models I and II,
it is found that this protein-induced conformational change produces a shift of 0.12 eV (∆λ
max
= 24 nm). The next step is the inclusion of polarization eff ects induced by hydrogen-bonding
interaction. The X-ray structure of β-crustacyanin9 has revealed an asymmetric environment of 
the chromophore with a histidine and a water molecule hydrogen bonded to the keto oxygens.
In model III, these interactions are included explicitly and a further shift in the excitation energy
is obtained, though relatively small, giving a total shift of 0.19 eV (∆λ
max 
= 39 nm) compared to
the s-cis-astaxanthin model.
The Mulliken partial atomic charge diff erences between models I and III have also been
calculated. It was found that the hydrogen bonds induce a small positive charge on the chro-
mophore, which is consistent with the small positive charge diff erence estimated on the basis
of 13C chemical shift data for α-crustacyanin, thus further supporting the conclusion that keto
groups are not protonated and no strong polarization occurs upon binding.
An analysis of the HOMO and LUMO orbitals for models I and III shows that a charge dis-
placement from the center of the chromophore toward the rings occurs upon excitation in
the model including the hydrogen bonding with the protein environment, while little charge
displacement is observed for the free chromophore. Subsequently, the importance of aggre-
gation eff ects for the bathochromic shift mechanism was considered. A fi rst-order estimate
of the exciton splitting induced by the proximity of the chromophores in the protein can be
obtained using the dipole-dipole approximation. The X-ray structural information available for
β-crustacyanin was used to evaluate the geometrical factor, and the transition dipole moment
within the TDDFT for model III was computed. The two bound astaxanthins in β-crustacyanin
approach each other within 7 Å at a position close to the C11-C12 bond. As can be seen in Figure
Table 2. Excitation Energies for Carotenoid Models I, II, and III Obtained with TDDFTa
model ∆E (eV) ∆E (eV) + 0.7 eV shift
I (s-cis astaxanthin) 1.89 2.59 (478 nm)
II (s-trans astaxanthin) 1.77 2.47 (502 nm)
III (s-trans astaxanthin + water + His) 1.70 2.40 (517 nm)
III + exciton splitting 1.91 (650 nm)
a In the second column, the TDDFT results are shifted for a comparison with the experimental data (see
text). In parentheses, the corresponding λ
max 
in nanometers is given. The excitation energy in the last row 







1, the long axes of the molecules form an angle of about 120˚. The computed transition dipole
moment is very intense (~ 19 D) and oriented parallel to the long axis of the molecule pointing
toward the ring hydrogen bonded to the His residue. By using this information together with
the orientation factor in the dipole-dipole approximation, an exciton splitting of 0.49 eV was
obtained. By adding the exciton splitting to the previously computed on-site shift for model III,
a λ
max
= 650 nm is obtained (see Table 2). Even considering the limitation of the simple dipole-
dipole approximation used here, it can be conclude that the aggregation eff ects appear to give
the largest contribution in determining the total bathochromic shift.
3.4 DISCUSSION
In principle, two hypotheses could serve as a basis for understanding the bathochromic shift.
The fi rst hypothesis is exciton coupling of the transition dipole moments in the excited state,
and the second hypothesis is interactions of the protein with the astaxanthin chromophore
in the ground state via a polarization mechanism. The exciton coupling hypothesis was fi rst
suggested on the basis of the observed circular dichroism spectra of α- and β-crustacyanin.1,29,30
However, the importance of this eff ect has been underestimated since it was expected that a
strong coupling should give rise also to large changes in the shape of the absorption bands
which were not observed.1 The resonance Raman spectra of Salares et al.4 showed a lowering
in the ν
C=C 
frequency indicative of electron delocalization in the electronic ground state. On the
basis of these Raman spectra, the polarization hypothesis was strongly supported and it has
since become favored as the primary basis of the bathochromic shift. Moreover, it was pointed
out that the argument that a large red shift in the absorption maximum should be accompanied
by a change in absorption profi le was not necessarily true.4
In view of the results from the SSNMR, Raman spectroscopy and quantum chemical calcula-
tions, these two hypotheses for the bathochromic shift can now be evaluated in more detail.
First, it should be noted that the SSNMR and Raman spectroscopy analyses are performed
on α-crustacyanin, whereas the computational analysis is carried out on models based on
the known structure of β-crustacyanin. It is assumed that the eff ects that are responsible for
the bathochromic shift in both carotenoproteins are qualitatively comparable and that the
chromophore-protein interactions are similar in α- and β-crustacyanin. This is based on the
knowledge that α-crustacyanin is an aggregate of eight β-crustacyanin units and supported by
the similar shape of the UV-vis, optical rotary dispersion, Raman spectra, and same sign pattern
in CD spectra of α- and β-crustacyanin.1,30
The SSNMR experiments show that no strong polarization eff ect in the ground state takes
place upon binding of astaxanthin in the protein. Now the earlier hypothesis that a large charge
eff ect, such as protonation, near the keto groups of the chromophore is responsible for the
bathochromic shift can defi nitely be discarded. Indeed, a strong electrostatic eff ect, such as
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the one induced by protonation, should give much larger changes in the chemical shifts of 
the atoms close to the ring.23 The rather small NMR chemical shift diff erences (see Table 1) are
indicative of small changes in the ground-state electronic distribution due to the rotation of 
the end rings and to polarization eff ects due possibly to hydrogen bonding with the protein.
These conclusions are consistent with the X-ray analysis of the binding site of β-crustacyanin.
Although the resolution of the X-ray data is not suffi  cient to determine protonation states, no
charged amino acids were observed in the proximity of the astaxanthin ring.9 The SSNMR data
show that the absence of strong polarization eff ects due to charged residues is true also in
α-crustacyanin.
A comparison of the resonance Raman spectra of astaxanthin and α-crustacyanin, show that
the ν
1
-line, which is assigned to the C=C stretch vibration, is shifted to a lower wavenumber,
consistent with previous Raman studies. The observed downshift of the ν
1
-line can be corre-
lated to the rotation around the C6-C7 bond of the chromophore from 6-s-cis to 6-s-trans. This
conformational change extends the conjugated polyene, leading to a larger delocalization of 
the π-electron system. However, the observed shift does not quantitatively fi t the empirical




.26 This indicates that
in addition to the extension of the conjugated system, other factors must contribute to the
bathochromic shift.
Also a striking change was observed in the spectral region near the ν
2
-line of the caroteno-
protein with 13C labels in the chromophore at the [8,8’,9,9’,10,10’,11,11’,19,19’] (1b) positions
where an intense band is present at 1122 cm-1, while in free 13C-labeled carotenoids, a weak 
band appears. The enhanced intensity of this band is a direct indication that the electronic
excited state delocalizes upon binding to the protein, adding Raman oscillator strength to this
mode.
Quantum chemical calculations on molecular models obtained from the X-ray data of 
β-crustacyanin show that the transition from 6-s-cis-astaxanthin to 6-s-trans- is accompanied
by a considerable change in λ
max
 to 502 nm. This is by far not suffi  cient to account for the full
bathochromic shift that occurs upon binding.31 Also, the eff ect of hydrogen bonding due to
the presence of a water molecule and a histidine close to the astaxanthin carbonyl gives rise
to a small bathochromic shift, the combined eff ects shifting λ
max
to 517 nm. Therefore, on the
basis of the TDDFT calculations, it can be concluded that the total protein-induced on-site
eff ects on the bathochromic shift are not very large and can account for only about 30% of 
the total observed bathochromic shift in α-crustacyanin and 40% of the bathochromic shift in
β-crustacyanin.
The charge displacement from the center of the chromophore toward the end rings upon
excitation shown by the analysis of the HOMO and LUMO orbitals is in line with the large
eff ect observed on the Raman ν
2
-line. This charge displacement is also consistent with Stark 
experiments showing an enhancement in the excited-state dipole moment for α-crustacyanin







The study described in this chapter strongly supports the hypothesis of exciton coupling as
the main source of the bathochromic shift. Indeed, when the dipole-dipole interactions between
the astaxanthin molecules in β-crustacyanin are taken into account, a large exciton splitting is
found. The exciton splitting and the angle of about 120˚ between the dipole moments are con-
sistent with the negative chirality observed in CD spectra of α- and β-crustacyanin.1-3,29 When
the exciton coupling is added to the on-site eff ects due to the more extended conjugation and
hydrogen-bonding polarization, a λ
max 
≈ 650 nm is obtained. The calculated total shift is even
larger than the observed bathochromic shift. In fact, the estimate of the exciton splitting is
based on the structural information on the dimer in β-crustacyanin, where λ
max 
= 586 nm. It is
very likely that the simple approximation of the dipole-dipole interaction in the excited state
used here overestimates the exciton splitting. Further refi nement in the modeling is needed
to obtain a more quantitative estimate of the exciton splitting. Nevertheless, it can clearly be
concluded that aggregation eff ects give the largest contribution to the observed color shift. 
The bathochromic shift of α-crustacyanin is larger than that of β-crustacyanin (λ
max
= 632 nm
and 586 nm, respectively). The X-ray analysis of β-crustacyanin suggests that subunit-subunit
interaction can take place in the aggregation of eight dimers in α-crustacyanin.9 This interac-
tion could induce a larger exciton splitting in α-crustacyanin, though a proper description of 
this eff ect needs further investigation.
3.5 CONCLUSION
The coloration mechanism of astaxanthin in α-crustacyanin was explored by using solid-state
NMR and resonance Raman spectroscopy complemented by quantum chemical calculations
based on time-dependent DFT. Solid-state NMR spectra of the 13C-enriched α-crustacyanin
show that only minor changes in the ground-state electron density of astaxanthin occur upon
binding, thus ruling out the hypothesis of a strong polarization. From the comparison of Raman
spectra for 13C-labeled astaxanthin and α-crustacyanin, can be concluded that delocalization
of the electronic excited state of the polyene chain close to the ring occurs upon binding.
Time-dependent DFT calculations show that the protein-induced conformational changes and
polarization eff ects contribute to about 30% of the total bathochromic shift in α-crustacyanin.
The exciton coupling due to the proximity of the astaxanthin chromophores, estimated using
the β-crustacyanin dimer structure, is found to be large and can account for the additional
absorption shift.
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CHAPTER 4
SYNTHETIC SCHEME FOR THE PREPARATION OF 
13CLABELED 2,7DIMETHYLOCTA2,4,6TRIENE1,8
DIAL, THE CENTRAL PART OF CAROTENOIDS
Published in Eur. J. Org. Chem. 2002, 4217-4221.
Starting from acetic acid and methyl iodide an effi  cient modular synthetic scheme has been 
developed for the synthesis of 13C-labeled 2,7-dimethylocta-2,4,6-triene-1,8-dial, which is
a  suitable building block in the synthesis of carotenoids with tenfold 13C-enrichment in the 
central part.





For a better understanding of the relation between diet and health knowledge of the metabolic
pathways of nutrients is required.1 Such studies in the fi eld of metabolomics are rapidly get-
ting more scientifi c attention in the past few years. Essential tools in metabolomics are mass
spectrometry and NMR spectroscopy, which are suitable techniques for the analysis of metabo-
lites.2-4 13C and 2H labeled isotopomers of nutrients are very useful as internal standards for the
quantifi cation of metabolites using mass spectrometry.5 The combination of NMR analysis with
stable 13C and 15N isotope labeling is a powerful tool for metabolomic analysis, enhancing the
NMR sensitivity for the nutrients of interest via isotope labeling.6
Fundamental information about the concentration level of various carotenoids in the
human body and its organs down to the cellular level is essential to study the health eff ects of 
carotenoids.7-20 Recently a method was published to quantify, without perturbation, the nutri-
tional status of β-carotene at the physiological level in individuals, by addition of 13C-labeled
β-carotene to their food.21,22 Using mass spectrometry the levels of the isotopically 13C-labeled
β-carotene and its metabolites were monitored. Also resonance Raman spectroscopy can be
used to obtain information on the presence and quantity of carotenoids in living human tis-
sue, like skin and retina.23-26 When 13C-labeled carotenoids are added to the food of individuals,
resonance Raman spectroscopy can be used to distinguish between diff erent carotenoids and
determine their presence and amount in humans in vivo in a non-invasive way.27,28
Extending the use of mass spectrometry, NMR spectroscopy and resonance Raman spectro-
scopy methods to other carotenoids that are present in our diet is now of utmost importance to
study the presence, quantity, bioconversion and bioavailability of carotenoids in individuals. To
perform such analyses, labeled carotenoids will be indispensable, which requires development
of effi  cient synthetic strategies applicable to a range of carotenoids. It is well known that almost
all carotenoids can be prepared using 2,7-dimethylocta-2,4,6-triene-1,8-dial (C
10
-dialdehyde)
and the appropriate end groups.29-35 The synthesis of 13C-labeled C
10
-dialdehyde described in
the literature has the severe drawback that it is inconvenient for multifold 13C labeling, and
multiple schemes are necessary to introduce 13C labels at diff erent positions.36-39





 level. Using a modular total organic synthetic strategy we can now specifi cally intro-
duce 13C labels at any position or combination of positions. By varying the end groups, we can








A scheme was developed in which the sp2-atoms of C
10
-dialdehyde are derived from acetic acid
and the methyl groups from methyl iodide. Both starting materials are commercially available
in 99% 13C-enriched form at a reasonable price. Earlier we have described the high-yield conver-
sion of 13C
2
acetic acid into 13C
4
diethyl fumarate (1)40 and 13C
2
acetic acid and 13C methyl iodide
into [1-(ethoxycarbonyl)ethyl]triphenylphosphonium iodide (3).37-43 Scheme 1 indicates that (1)
can be reduced with Dibal-H into but-2-ene-1,4-diol (2). This diol can be converted in a double
MnO
2
oxidation and double Wittig coupling, in a one-pot reaction, to diethyl 2,7-dimethylocta-
2,4,6-trien-1,8-oate (4) in excellent yield. 
Treatment with Dibal-H followed by oxidation with MnO
2
 gives the required all-trans 2,7-
dimethylocta-2,4,6-triene-1,8-dial (5).37,38 The fi nal product (5) proved to be identical in all
analytical aspects to the authentic material. 
The Wittig reaction was fi rst tried with two equivalents of phosphorane 3, which gave 61% of 
the desired product (4) and 19% of the ethyl 2-methyl-6-oxo-2,4-hexadienoate (8; see Scheme
2). After optimization, best results for this reaction were obtained with 2.4 equivalents of the
phosphorane. This is a drawback when labeled materials are used, but the good yield [91%
based on (2)], short route and easy workup and purifi cation make this reaction very useful. 
The overall yield for the synthesis, based on methyl iodide and acetic acid, is 61% for 13C
labels at positions 1-2 and 7-10, and 45% for central positions 3-6.
4.3 DISCUSSION 
Scheme 1 involves the double oxidation and double Wittig coupling of but-2-ene-1,4-diol
(2), to give C
10
-diester 4 in a one-pot reaction. But-2-ene-1,4-diol (2) is oxidized with MnO
2
,
in the presence of phosphorane 3. Following the reaction closely by TLC, it was found that
ethyl 2-methyl-6-oxo-2,4-hexadienoate (8) is formed as an intermediate, which reacts with the
































Scheme 1. Synthesis of 2,7-dimethyl-octa-2,4,6-triene-1,8-dial (5).
81Synthesis of 13C-labeled C
10
-dialdehyde
Probably the reaction proceeds by oxidation of one hydroxyl group of 2 to an aldehyde,
which reacts with the phosphorane 3 to give ethyl 6-hydroxy-2-methyl-2,4-hexadienoate.
Subsequently, the second hydroxyl group is oxidized to an aldehyde, which reacts in a second
Wittig coupling with 3 to give the desired product 4
Before we developed the method described above, a protection and deprotection scheme
was developed to synthesize the C
10






















Scheme 2. Alternative synthesis of diethyl 2,7-dimethylocta-2,4,6-trien-1,8-oate (4).
The diol (2) reacts with one equivalent acetic anhydride to give a mixture consisting of 50%
monoacetate, 25% unchanged diol and 25% diacetate.44 These product can easily be separated
by washing the organic solution containing the mixture with water, which removes the diol. The
diester can be separated by silica-gel column chromatography. The diester is reconverted to the
diol with KOH, and, together with the unchanged diol from the acetylation reaction, acetylated
again as described above. The monoacetate 6 is oxidized with pyridinium chlorochromate on
basic alumina (PCC/Al) to give 4-acetoxy crotonaldehyde, which is allowed to react under Wittig
conditions with 3 to give ethyl 6-acetoxy-2-methylhexa-2,4-dienoate (7).
Selective conversion of the 6-acetoxy function in 7 to the alcohol without saponifi cation




in ethanol to give ethyl 6-hydroxy-2-
methyl-2,4-hexadienoate. Subsequent oxidation of the alcohol gives ethyl 2-methyl-6-oxo-
2,4-hexadienoate (8), which is coupled via another Wittig reaction with (3) to give diethyl
2,7-dimethylocta-2,4,6-trien-1,8-oate (4). This compound is converted into the C
10
-dialdehyde
5 as described above.
In this scheme both Wittig couplings are carried out with one equivalent of the phosphorane
3, which makes this scheme useful for effi  cient introduction of 13C labels at positions 1,2 and 9
of the fi nal C
10
-dialdehyde 5.
As alternative for the base-labile acetate group for protection of but-2-ene-1,4-diol, the acid
sensitive tetrahydropyran(THP)-ether can be used, giving a statistical mixture of unchanged
diol, mono- and di-ether (1:2:1).45 After oxidation and subsequent Wittig reaction with the
C
3
-phosphorane 3 the THP-ether can be removed with a trace of acid (p-toluenesulfonic acid)







Scheme 2. This alternative route can be preferred when basic conditions in one of the synthetic
steps are undesired.
Another scheme to reduce the number of steps is converting 3 into ethyl pyruvate accord-
ing to literature,40,46 and couple this to either 1,4-bis(diethoxyphosphoryl)-2-butene 10 or
1,4-bis(triphenylphosphonium)-2-butene dibromide 11, which are both made in two steps
from but-2-ene-1,4-diol (2). Both the Wittig coupling and the phosphonate coupling of ethyl
pyruvate 12 only gave degradation products and starting material, even though several diff er-
ent conditions were tried. This is shown in Scheme 3.
4.4 CONCLUSION
The synthetic scheme described in this chapter allows the quick and easy preparation of 
isotopically 13C-labeled 2,7-dimethylocta-2,4,6-triene-1,8-dial. The key step in this synthesis is
the double MnO
2





-diester 4 in a one-pot reaction. All carotenoids can now be prepared with selective





































Scheme 3. Scheme for the synthesis of C
10
-diester 4 via a double Wittig coupling.





Under a nitrogen atmosphere, a solution of diethyl fumarate (1; 2.0 g, 11.6 mmol) in dry PE was cooled to
-60ºC, and di-isobutyl aluminium hydride (Dibal-H; 4.4 equiv., 51 mL 1 M-solution in hexanes, 51 mmol)
was added with a syringe. The solution was allowed to warm up to -20ºC in 1 hour, after which TLC (diethyl




O (83.9 g) was added, and






were added, and the solids were removed
by fi ltration and washed thoroughly with diethyl ether. The solution was concentrated in vacuo, to give
but-2-ene-1,4-diol (2; 0.82 g, 9.3 mmol, 80%).
1H NMR (300 MHz, CD
3
OD) δ (ppm) = 4.11 (d, J = 3.8 Hz, 4 H, 1-H/4-H), 4.91 (s, 2 H, OH), 5.87 (t, J = 3.8 Hz,
2 H, 2-H/3-H). 
13C NMR (75 MHz, CD
3
OD) δ (ppm) = 63.0 (C-1/C-4), 131.1 (C-2/C-3).
4-Acetoxy-2-buten-1-ol (6)
Acetic anhydride (2.55 g, 25 mmol) was slowly added to a solution of but-2-ene-1,4-diol (2; 2.20 g, 25 mmol)
and pyridine (2.37 g, 30 mmol) in dry toluene. The mixture was stirred at room temperature (RT) for 1 hour
after which TLC analysis (diethyl ether) showed a mixture of starting compound, monoacetate and diace-
tate. H
2
O was added, and the mixture was extracted three times with diethyl ether. The combined organic
layers were dried with MgSO
4
and concentrated in vacuo. After purifi cation on a silica column (50% diethyl
ether/PE) the monoacetate (6; 1.36 g, 10.5 mmol, 42%) was collected. Unchanged diol was collected by
extracting the water layer thoroughly with dichloromethane; the organic layers were combined, dried
with MgSO
4
and solvents were removed in vacuo. Diacetate, collected after column chromatography, was
treated with KOH to obtain another batch of diol.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 2.06 (s, 3 H, CH
3
acetoxy), 4.24 (d, J = 6.2 Hz, 2 H, 4-H), 4.57 (br. s, 1 H,
OH), 4.66 (d, J = 6.5 Hz, 2 H, 1-H), 5.62 (dt, J = 6.2 Hz/12.3 Hz, 1 H, 3-H), 5.80 (dt, J = 6.5 Hz/12.3 Hz, 1 H, 2-H).
13C NMR (75 MHz, CDCl
3
) δ (ppm) = 20.7 (CH
3
 acetoxy), 57.9 (C-4), 59.9 (C-1), 125.0 (C-2), 133.1 (C-3), 171.1
(C=O acetoxy).
Ethyl 6-acetoxy-2-methylhexa-2,4-dienoate (7)
At 0ºC, 4-acetoxy-2-buten-1-ol (6; 1.36 g, 10.5 mmol) was added to a suspension of pyridinium chlorochro-
mate on basic alumina (PCC/Al 20 wt%; 14.8 g, 13.7 mmol) in DCM. The mixture was stirred at RT until TLC
analysis (diethyl ether) showed complete conversion of the starting compound. PCC/Al was removed by
fl ash chromatography, the solids were washed with diethyl ether, and the organic solvents were removed
in vacuo, to give 4-acetoxy-crotonaldehyde (1.0 g, 7.8 mmol, 74%).
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 2.14 (s, 3 H, CH
3 
acetoxy), 4.87 (d, J = 4.4 Hz, 2 H, 4-H), 6.28 (dd, J 
=7.9 Hz/15.9 Hz, 1 H, 2-H), 6.88 (dt, J = 4.3 Hz/15.9 Hz, 1 H, 3-H), 9.59 (d, J = 7.9 Hz, 1 H, 1-H).
13C NMR (75 MHz, CDCl
3
) δ (ppm) = 20.2 (CH
3








4-Acetoxy-crotonaldehyde (1.0 g, 7.8 mmol) was dissolved in 5 mL DCM and C
3
-phosphorane 3 (2.83 g,
7.8 mmol) in DCM was added. The solution was stirred for 30 min at RT and followed by TLC-analysis (15%
diethyl ether/PE). When TLC showed complete conversion of the aldehyde, the solvent was removed in
vacuo. The product was purifi ed on a fl ash-column (10% diethyl ether/PE), to yield ethyl 6-acetoxy-2-methyl-
hexa-2,4-dienoate (7; 1.66 g, 7.8 mmol, 100%).
1H NMR (300 MHz, CDCl
3




), 1.96 (s, 3 H, 2-CH
3
), 2.10 (s, 3 H, CH
3




), 4.69 (d, J = 6.0 Hz, 2 H, 6-H), 6.09 (dt, J = 6.0 Hz/15.2 Hz, 1 H, 5-H),
6.59 (dd, J = 11.4 Hz/15.2 Hz, 1 H, 4-H), 7.17 (d, J = 11.4 Hz, 1 H, 3-H).
13C NMR (75 MHz, CDCl
3



















(2g) was addes to a solution of 7 (1.66 g, 7.8 mmol) in ethanol. After 2 hours at RT, TLC (diethyl ether)
showed complete conversion of the starting material. The solution was concentrated to a volume of 20 mL,
and NaCl-solution (50 mL, sat) was added. The water layer was extracted three times with diethyl ether, and
the combined organic layers were dried with MgSO
4
, which was removed by fi ltration. After evaporation of 
the solvent, the desired ethyl 6-hydroxy-2-methyl-2,4-hexadienoate (1.28 g, 7.5 mmol, 96%) was obtained.
No further purifi cation was necessary.
1H NMR (300 MHz, CDCl
3




), 1.94 (s, 3 H, 2-CH
3





), 4.28 (d, J = 5.1 Hz, 2 H, 6-H), 6.17 (dt, J = 5.1 Hz/15.2 Hz, 1 H, 5-H), 6.59 (dd, J = 11.4 Hz/15.2 Hz,
1 H, 4-H), 7.18 (d, J = 11.4 Hz, 1 H, 3-H).
13C NMR (75 MHz, CDCl
3










), 62.7 (C-6), 125.2 (C-4),
127.1 (C-2), 137.3 (C-5), 139.7 (C-3), 168.5 (C-1).
Ethyl 6-hydroxy-2-methylhexa-2,4-dienoate (1.28 g, 7.5 mmol) was added at 0ºC to a solution of PCC/Al
(20 wt%; 10.5 g, 9.8 mmol) in dry DCM. The mixture was stirred for 16 hours, until TLC analysis (50% diethyl
ether/PE) showed complete conversion of the starting material. PCC was removed by fi ltration through
silica and washed with diethyl ether. The organic solvents were removed in vacuo to yield ethyl 6-oxo-2-
methyl-2,4-hexadienoate (8; 1.0 g, 6.0 mmol, 80%).
1H NMR (300 MHz, CDCl
3




), 2.13 (s, 3 H, 2-CH
3





), 6.39 (dd, J = 7.9 Hz/14.4 Hz, 1 H, 5-H), 7.33 (d, J = 12.0 Hz, 1 H, 3-H), 7.48 (dd, J=12.0 Hz/14.4 Hz,
1 H, 4-H), 9.61 (d, J = 7.9 Hz, 1 H, 6-H).
13C NMR (75 MHz, CDCl
3










), 133.8 (C-2), 135.8 (C-5),
136.9 (C-3), 144.8 (C-4), 166.8 (C-1), 192.9 (C-6).





But-2-ene-1,4-diol (2; 0.56 g, 6.3 mmol) in DCM (10 mL) was added to a suspension of activated MnO
2
(10 g)
in DCM (25 mL) at 0ºC. C
3
-phosphorane 3 (5.5 g, 15.2 mmol) in DCM (15 mL) was added and the mixture
was followed by TLC (50% diethyl ether/PE). The mixture was stirred overnight and MnO
2
was removed by
fi ltration through Hyfl oTM. The fi ltrate was concentrated in vacuo and triphenylphosphonium oxide was
removed by fl ash chromatography through silica gel (50% diethyl ether/PE). After a second purifi cation
on a short silica-gel column diethyl 2,7-dimethylocta-2,4,6-triene-1,8-oate (4; 1.5 g, 5.8 mmol, 92%) was
obtained.
Method B:
Ethyl 2-methyl-6-oxo-2,4-hexadienoate (8; 1.0 g, 6.0 mmol) was dissolved in DCM (10 mL), and C
3
-phos-
phorane 3 (2.2 g, 6.0 mmol) in DCM was added. The reaction was stirred at RT for 5 hours, until TLC (diethyl
ether) showed completion of the reaction. The solvent was evaporated in vacuo and the triphenylphos-
phine oxide formed was removed on a short fl ash column (50 % ether/PE) to yield the C
10
-diester (4; 1.5 g,
5.9 mmol, 99%) as a pure, white solid.
1H NMR (300 MHz, CDCl
3








), 4.23 (q, J




), 6.81 (dd, J = 3.1 Hz/7.8 Hz, 2 H, 3-H/6-H), 7.29 (m, 2 H, 4-H/ 5-H). 
13C NMR (75 MHz, CDCl
3













7), 133.2 (C-4/C-5), 136.8 (C-3/C-6), 167.5 (C-1/C-8). 
2,7-Dimethylocta-2,4,6-triene-1,8-dial (5)
A solution of 4 (1.5 g, 5.8 mmol) in dry PE was cooled to -80ºC, and 4.4 equiv. Dibal-H (25.9 mL of a 1 M
solution in hexanes, 25.9 mmol) was added with a syringe. The yellow-orange mixture was allowed to warm




O (45.4 g) was added,






 were added, and the solids were removed
by fi ltration and washed with DCM. The product was concentrated in vacuo, and the resulting diol was
oxidized, without further purifi cation.
 2,7-Dimethylocta-2,4,6-triene-1,8-diol was dissolved in acetone (10 mL), and MnO
2
 (10 g) was added
at 0ºC. The reaction was stirred overnight, and followed by TLC (diethyl ether). When the reaction was
complete, the Mn salts were removed by fi ltration through Hyfl oTM, washed with DCM and the product was
concentrated in vacuo. After purifi cation on a silica-gel column, pure all-trans-C
10
-dialdehyde (5; 0.77 g,
4.7 mmol, 80%) was obtained.
1H NMR (300 MHz, CDCl
3




), 7.06 (m, 4 H, 3-H/4-H/5-H/6-H), 9.55 (s, 2 H,
1-H/8-H).
13C NMR (75 MHz, CDCl
3
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CHAPTER 5
SYNTHETIC SCHEME FOR THE PREPARATION
OF 13CLABELED 3,4DIDEHYDRORETINAL, 
3HYDROXYRETINAL AND 4HYDROXYRETINAL 
UP TO UNIFORM 13CENRICHMENT
Published in Eur. J. Org. Chem. 2003, 863-868.
A modular synthetic scheme has been developed for the synthesis of 13C-labeled naturally
occuring visual pigment chromophores; 3,4-didehydroretinal, 3-hydroxyretinal, and 4-
hydroxyretinal. These compounds can now be made with >99% 13C enrichment at any position






scheme for the synthesis of retinals was
used, and by making variations in the C
10
part, the desired retinal derivatives can now be pre-
pared with selective or uniform 13C enrichment.
The McMurry-dimerization of retinal-derivatives was explored, to develop an effi  cient
method for the synthesis of 13C-labeled carotenoids. Pure zeaxanthin was obtained from 3-
hydroxyretinal and 3,4,3’,4’-tetradehydro-β,β-carotene from 3,4-didehydroretinal, indicating
the potential of this method.
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5.1 INTRODUCTION
Light is essential for living organisms as it provides the energy for life through photosynthesis
as well as the means to effi  ciently interact with the outside world through visual sensation. In
the eyes of animals - vertebrates, mollusks and anthropoids - light from the environment is
converted into neural information by pigmented membrane proteins called rhodopsins, that
start the visual process. Rhodopsin is the photosensitive protein of the rod photoreceptor in
the vertebrate retina that mediates dim-light vision. Rhodopsin serves as a paradigm for the
superfamily of seven-transmembrane-helix G-protein-coupled receptors (GPCRs).1 The GPCRs
mediate a broad array of important physiological and pharmacological signal-transduction
processes that involve signalling by neurotransmitters, hormones, and neuropeptides.2 Conse-
quently, GPCRs are major pharmaceutical targets for pharmacological intervention in human
(and veterinary) pathology. 
In the majority of the known visual pigments 11Z-retinal is covalently bound in the interior of 
the protein via a protonated Schiff -base linkage with a lysine residue to form the retinylidene
chromophore.3 Absorption of a photon leads to the ultrafast isomerization of the C11=C12
bond of the retinylidene ligand from the 11Z to the all-E confi guration in only ~200 fs, the
fastest photochemical reaction known.4,5
The chromophores of the visual pigments of important groups of animals are derived from
systems closely related to retinal. These chromophores include, for example, 3,4-didehydroreti-
nal (also known as vitamin A
2
-aldehyde), in amphibians and fresh-water fi sh,6,7 (R)-3-hydroxyreti-
nal in fl ies and butterfl ies,8-10 and (R)-4-hydroxyretinal in squid.11-13 These retinal derivatives are
shown in Figure 1.
Recently the fi rst ultra high-fi eld 1H and 13C solid state NMR study of bovine rhodopsin with
uniformly 13C-enriched retinal was published.14 Besides detailed chemical shift information
of each carbon and hydrogen atom of the chromophore, unique information about the non-
bonding interactions between hydrogen atoms of the methyl groups of the six-membered





















Figure 1. (all-E) retinal (1) with IUPAC numbering, (all-E)-3,4-didehydroretinal (2), (3R, all-E)-3-














-18.15 The chromophore occurs in one conformation only
with a non-planar 6s-cis conformation with negative helicity and a non-planar 12s-trans con-
formation with positive helicity.14 Surprisingly, in the case of isorhodopsin the interaction of the
aromatic side chains of the active site of the protein with the six-membered ring, is substantially
diff erent from that of rhodopsin.16 A similar solid-state 1H and 13C NMR study of rhodopsins and
isorhodopsins regenerated with the uniformly 13C-enriched 3,4-didehydro-, (R)-3-hydroxy- and
(R)-4-hydroxyretinals will give access to as yet unavailable information about the factors that






-18 groups with the
aromatic amino-acids in the active site of visual pigments and about the eff ects of modifi ca-
tions in the ring on the binding to the active site.
In addition to the results obtained via uniformly 13C-labeled rhodopsin, also very precise
distance information between atoms C8 and C18, C10 and C20, and C11 and C20 in the chro-
mophore has been obtained via rotational-resonance solid-state 13C NMR measurements of 
13C
2
-labeled rhodopsins. This distance information is an order of magnitude more accurate than
distances obtained via X-ray crystallography.17-19 Also, information on the torsion around the
10-11 single bond in the chromophore has been obtained via double-quantum solid-state 13C
NMR, using 13C-labeled retinal.20,21 In addition, the full vibrational analysis of the chromophore
of rhodopsin, isorhodopsin and bathorhodopsin was based on a set of 13C isotopomers.22,23
To obtain the 1H and 13C NMR solid-state NMR data, distance measurements and vibrational
analysis of 3,4-didehydro-, (R)-3-hydroxy- and (R)-4-hydroxyrhodopsin and isorhodopsin with
13C-enriched chromophores, the corresponding 13C isotopomers of these chemically modifi ed
retinoids have to be prepared.
The basis for these syntheses is the chemistry that is explored for the preparation of uniformly
13C-labeled retinal via a modular total organic synthetic strategy that allows the preparation of 
any 13C isotopomer up to the uniformly labeled form.24 The central modules in this synthesis
are [13C
10
]-α-cyclocitronitrile (5, Scheme 1) and [13C
5
]-4-(diethylphosphono)-3-methyl-2-butene-
















Scheme 1. Synthesis of racemic 4-hydroxy-β-cyclocitral (9), safranal (10) and racemic 3-hydroxy-
β-cyclocitral (11).
93Synthesis of 13C-labeled retinal-derivatives
cyclocitral (9), safranal (10) and racemic 3-hydroxycyclocitral (11) is discussed. The cyclocitral
derivatives serve as C
10
-building blocks for the synthesis of the corresponding retinal derivatives
3,4-didehydroretinal (2), (R)-3-hydroxyretinal (3) and (R)-4-hydroxyretinal (4) (see Figure 1). The
resolution of 3 and 4 into the optically pure forms has been reported in the literature.8,25-28
These C
10
-cyclocitral derivatives fi t perfectly in the synthetic scheme for the synthesis of 13C-
labeled retinals, and by making variations in the C
10
-part, retinal derivatives with 13C enrichment
at the desired positions can easily be obtained.
This chapter ends with the McMurry-dimerization of functionalized retinals. This reaction is
commonly used for the synthesis of β-carotene from retinal. The exploration of the McMurry-
dimerization of 3,4-didehydroretinal, 3-hydroxyretinal and 4-hydroxyretinal to the correspond-
ing carotenoids is described here.
5.2 RESULTS AND DISCUSSION
In this chapter the synthetic scheme for the synthesis of 13C-enriched 3,4-didehydroretinal
(2), (RS)-3-hydroxyretinal (3) and (RS)-4-hydroxyretinal (4) (see Figure 1) is worked out at the
natural abundance level. The scheme (see Scheme 1) starts with the easily accesible α-cyclo-
nitrile (5),24 which is converted into racemic 4-hydroxy-β-cyclocitral (6) by treatment with
meta-chloroperbenzoic acid (mCPBA) and subsequent opening of the formed epoxide with
base.29 Acid-catalyzed dehydration of 6 gives safronitrile (7) in high yield.30 It was found that
subsequent epoxidation with mCPBA gives 3,4-epoxy-β-cyclocitronitrile (8) in good yield. It
is interesting that the C5=C6 double bond, conjugated with the nitrile group, is suffi  ciently
deactivated that only the C3=C4 double bond of safronitrile (7) reacts. The β-cyclocitronitriles
6,7 and 8 are converted in high yield into the corresponding aldehydes by reduction with
Dibal-H. Safronitrile (7) is treated with 1.3 equivalents of Dibal-H to give safranal (10). For the
reduction of 4-hydroxy-β-cyclonitrile (6), an additional equivalent of Dibal-H is required to
give 4-hydroxy-β-cyclocitral (9). Similar reduction of 3,4-epoxy-β-cyclocitronitrile (8) with 2.3
equivalents of Dibal-H converts the nitrile to an aldehyde in one step, and the epoxide opens
in the same step to give the hydroxyl group selectively at the 3-position, yielding a racemic
mixture of 3-hydroxy-β-cyclocitral (11). 
The β-cyclocitral derivatives 9, 10, and 11 can easily be converted into the corresponding
retinals 2, 3, and 4 by a Horner-Wadsworth-Emmons (HWE) coupling with phosphonate 12 and
subsequent Dibal-H reduction to obtain the intermediate β-ionylidene acetaldehydes. Repeti-
tion of the phosphonate coupling reaction and reduction gives the retinal derivatives 2, 3, and
4 as depicted in Scheme 2.
This sequence worked without problems for safranal (10). However, the presence of the
hydroxyl groups in 9 and 11 interferes with the HWE-coupling reaction. For this reason, the







Using another equivalent NaH to deprotonate the phosphonate 12, these alkoxides reacted in
the HWE-coupling reactions without diffi  culties.
The retinals were obtained as a mixture of 13Z and all-E isomers, with the all-E isomers as
the predominant products (60/40).31 The all-E retinals can be isolated by purifi cation of the
mixture of isomers via column chromatography or HPLC, according to literature.8,26,32,33 The fi nal
products were characterized using 1H and 13C NMR spectroscopy; the analytical data proved to
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Scheme 2. Synthesis of C
20
-retinal derivatives.










scheme, where the fi nal step is the
double Wittig-coupling of the C
15
-Wittig salt to the central C
10
-dialdehyde. However, it is known






being the actual reducing agent. Via this so-called McMurry dimerization, all-E
β-carotene can be obtained in good yield (50% after recrystallization) from retinal.36-40
Starting from the above described retinal-derivates, the McMurry-dimerization was used
to prepare the corresponding C
40












Scheme 3. Synthesis of C
40
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synthetic scheme for carotenoids
when 13C labels are desired in the central polyene-chain. As described above for the synthesis of 
retinal derivatives 9, 10, and 11, the carbons of the central polyene chain are introduced at the
end of the synthetic scheme, by two consecutive HWE-coupling reactions to C
5
-phosphonate
12 (see Scheme 2). This C
5
-phosphonate can easily be made with 13C enrichment at any position






 synthetic scheme, the desired C
40
-




McMurry reaction by carrying out only a limited
number of reactions after the 13C labels are introduced, which improves the yield compared to
the relatively expensive 13C labeled starting compounds. 
The retinal-derivatives 9, 10, and 11 were subjected to a McMurry-dimerization for synthesis
of the corresponding C
40
-carotenoids 3,4,3’,4’-tetradehydro-β,β-carotene (13) (also known as
dehydrocarotene III), zeaxanthin (14) and isozeaxanthin (15), as shown in Scheme 4.41
The results of the coupling reactions varied for the diff erent retinal derivatives. As expected,
3,4-didehydroretinal reacted without diffi  culties to give the corresponding all-E dehydrocaro-
tene III (13), in good yield (50% after recrystallization), similar to the synthesis of all-E β,β-caro-
tene from retinal.
In the literature is described that McMurry-dimerization of aldehydes can be performed in
the presence of a free hydroxyl-function.42,43 However, the dimerization of 3-hydroxyretinal is
very sensitive to oxygen, good quality reagents have to be used, and good practical skills are
required. When the reaction was carried out carefully, pure all-E zeaxanthin (14) was obtained
after recrystallization. The reaction should be optimized to increase the yield, which was now
only 10%. However, these results indicate that the developed reaction scheme leads to the
desired products and is promising as an effi  cient method for the introduction of 13C labels in
the polyene chain of carotenoids.
Reductive coupling of 4-hydroxyretinal (11) did not give the desired product (15), but only
degradation of the starting material. Therefore, a suitable protection group for the hydroxyl
function was needed. First, it was tried to convert the hydroxyl group to a THP-ether. However,










Scheme 4. McMurry dimerization of 3,4-didehydroretinal (2), 3-hydroxyretinal (3) and 4-
hydroxyretinal (4) to obtain the corresponding C
40







giving 3,4-didehydroretinal (9) instead of the desired THP-ether of 11. It was expected that
the allylic alcohol-group would be acid-sensitive, since a similar acid-catalyzed dehydration
is used to obtain 3,4-didehydrocyclocitral (10). This latter reaction requires heating overnight
with removal of water to obtain the desired product. Due to the longer polyene chain in 11, the
allylic alcohol is more easily dehydrated. To circumvent this problem a base-catalyzed protec-
tion group was introduced, a t-butyldimethylsilyl (TBDMS) ether. Unfortunately, this reaction
only gave degradation of the starting compound.
If in the future the above-mentioned problems with the McMurry-dimerization of 4-hydroxyreti-
nal can be overcome, this can lead to an improved synthetic scheme for the synthesis of (13C
labeled) carotenoids like isozeaxanthin. Isozeaxanthin can be converted to cantaxanthin
according to literature,44-46 which in turn can be converted to astaxanthin.47-49
A suitable synthetic method would lead to a new and effi  cient scheme for the synthesis of 
these carotenoids, that play an important role in food and feed industry, with 13C enrichment
at the desired positions.
5.4 CONCLUSION
Based on our modular strategy to prepare 13C isotopomers of all-E retinal, we have described the
chemical modifi cation of the α-cyclocitral module to prepare 3,4-didehydro-, 3-hydroxy- and
4-hydroxyretinal. The McMurry-dimerization of retinal-derivatives to obtain the correspond-
ing carotenoids was explored, to develop an effi  cient method for the synthesis of 13C-labeled
carotenoids. Using this method, pure zeaxanthin was obtained from 3-hydroxyretinal and
3,4,3’,4’-tetradehydro-β,β-carotene from 3,4-didehydroretinal, indicating the potential of this
scheme. The synthesis of other carotenoids via this method requires further investigation.
97Synthesis of 13C-labeled retinal-derivatives
EXPERIMENTAL
3-Hydroxy-2,6,6-trimethylcyclohex-1-enecarbonitrile (6)
A solution of α-cyclocitronitrile 5 (5.76 g, 38.6 mmol) in ethyl acetate (30 mL) was slowly added to a solu-
tion of 70% mCPBA (11.4 g, 46.3 mmol) in ethyl acetate (30 mL) at 0°C. The reaction mixture was stirred
overnight at room temperature. The solvent was removed in vacuo and PE (100 mL) was added. The solu-
tion was cooled to 0°C and triethylamine (TEA, 10 mL) was slowly added. After stirring for 10 min a white
precipitate was formed, which was removed by fi ltration through silica gel. The silica was washed (25%
diethyl ether/3% TEA/PE) and the fi ltrate was concentrated in vacuo, to obtain 2,3-epoxy-2,6,6-trimethyl-2-
cyclohexanecarbonitrile (5.46 g, 33.0 mmol, 88%) as a mixture of isomers.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.05 (s, 3 H, 1-CH
3
), 1.09 (s, 3 H, 1-CH
3
), 1.2-1.3 (m, 2 H, 2-H), 1.55 (s, 3 H,
5-CH
3
), 2.00 (m, 2 H, 3-H), 2.75 (s, 1 H, 6-H), 3.05 (br. s, 1 H, 4-H).
13C NMR (75 MHz, CDCl
3
) δ (ppm) = 20.7/21.5 (5-CH
3
), 23.3 (C-3), 28.4 (C-1), 29.3/30.3 (1-CH
3
), 31.3 (C-2), 44.7
(C-6), 55.3 (C-5), 58.6 (C-4), 118.5 (CN).
Lithium diisopropylamide (LDA) was prepared at -20°C by adding n-BuLi (1.6 M solution in hexane, 24.8 mL,
39.6 mmol) to a solution of diisopropylamine (DIPA, 6.0 mL, 43.0 mmol) in dry THF. A solution of 2,3-epoxy-
2,6,6-trimethyl-2-cyclohexanecarbonitrile (5.46 g, 33.0 mmol) in dry THF (10 mL) was slowly added at -40°C,
and the reaction mixture was allowed to warm to RT overnight. The mixture was neutralized by adding
NH
4
Cl (sat), and the mixture was extracted three times with diethyl ether. The combined organic layers
were washed with NaCl (sat) and dried with MgSO
4
. After fi ltration and concentration in vacuo of the crude
product 3-hydroxy-2,6,6-trimethylcyclohex-1-enecarbonitrile 6 (5.05 g, 30.6 mmol, 93%) was obtained. 
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.15 (s, 3 H, 1-CH
3
), 1.20 (s, 3 H, 1-CH
3
), 1.3-2.0 (m, 4 H, 2-H/3-H), 2.10 (s,
3 H, 5-CH
3
), 2.45 (br. s, 1 H, OH), 4.06 (t, J = 6.0 Hz, 1 H, 3-H).
13C NMR (75 MHz, CDCl
3




), 28.2 (C-3), 33.0 (C-2), 33.7 (C-1), 68.2 (C-4),
117.1 (CN), 119.7 (C-6), 152.5 (C-5).
2,6,6-Trimethylcyclohexa-1,3-dienecarbonitrile (7)
4-Hydroxy-β-cyclocitronitrile 6 (5.0 g, 30.5 mmol) was dissolved in toluene and p-toluenesulfonic acid
(pTsOH, 2.0 g) was added. The mixture was refl uxed overnight and the water formed during the reaction
was trapped with a Dean-Stark apparatus. Workup was carried out by adding diethyl ether (100 mL) and
NaHCO
3
(75 mL, sat). The organic layer was collected and washed again with NaHCO
3
(sat) and NaCl (sat),
dried with MgSO
4
and concentrated in vacuo to give 2,6,6-trimethylcyclohexa-1,3-dienecarbonitrile 7
(3.46 g, 23.5 mmol, 77%).
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.15 (s, 6 H, 1-CH
3
), 2.05 (s, 3 H, 5-CH
3
), 2.19 (dd, J = 1.9 Hz/4.4 Hz, 2 H,
2-H), 5.92 (dt, J = 1.9 Hz/9.5 Hz, 1 H, 4-H), 6.06 (dt, J = 4.4 Hz/9.6 Hz, 1 H, 3-H).
13C NMR (75 MHz, CDCl
3




), 31.2 (C-1), 37.3 (C-2), 113.6 (CN), 117.5 (C-6),








2,6,6-Trimethylcyclohexa-1,3-dienecarbonitrile 7 (2.09 g, 14.2 mmol) was dissolved in ethyl acetate (30 mL)
and mCPBA (4.2 g, 17 mmol) in ethyl acetate (30 mL) was added at RT and the mixture was refl uxed over-
night. The solvent was removed by evaporation in vacuo, and PE (150 mL) was added. The suspension was
cooled to 0°C and TEA (9 mL) was added. After stirring for 15 min the white precipitate of m-chlorobenzoic
acid was removed by fi ltration through silica gel. The silica was washed (25% ether/3% TEA/PE) and the
fi ltrate concentrated in vacuo, to yield 3,4-epoxy-2,6,6-trimethylcyclohex-1-enecarbonitrile 8 (2.04 g,
12.1 mmol, 85%) as a mixture of isomers.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.19/1.21 (2s, 6 H, 1-CH
3
), 1.63/1.71 (m, 1 H, 2-H), 2.12/2.21 (d, J = 2.4 Hz,
1 H, 2-H), 2.25 (s, 3 H, 5-CH
3
), 3.23/3.25 (m, 1 H, 3-H), 3.59 (m, 1 H, 4-H).
13C NMR (75 MHz, CDCl
3




), 32.9 (C-6), 35.2 (C-2), 49.6 (C-3), 55.2 (C-4),
116.3 (CN), 119.6 (C-1), 147.5 (C-5). 
3-Hydroxy-2,6,6-trimethylcyclohex-1-enecarbaldehyde (9)
A solution of 3-hydroxy-2,6,6-trimethylcyclohex-1-enecarbonitrile 6 (1.0 g, 6.1 mmol) in dry toluene was
cooled to -60°C and Dibal-H (14 mL, 14.0 mmol) was added. The solution was allowed to warm to RT and











were added, and after
stirring for 15 min the solids were removed by fi ltration, washed with diethyl ether and the fi ltrate was
concentrated in vacuo to yield, after fl ash column chromatography (60% diethyl ether/PE) 3-hydroxy-2,6,6-
trimethylcyclohex-1-enecarbaldehyde 9 (0.74 g, 4.4 mmol, 73%).
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.16/1.21 (2s, 6 H, 1-CH
3
), 1.3-2.0 (m, 4 H, 2-H/3-H), 2.20 (s, 3 H, 5-CH
3
),
3.72 (br. s, 1 H, OH), 4.07 (t, J = 6.2 Hz, 1 H, 4-H), 10.11 (s, 1 H, CHO).
13C NMR ( 75 MHz, CDCl
3




), 27.6 (C-3), 33.1 (C-1), 35.7 (C-2), 70.2 (C-4),
140.8 (C-6), 154.4 (C-5), 193.5 (CHO).
2,6,6-Trimethylcyclohexa-1,3-dienecarbaldehyde (10)
2,6,6-Trimethylcyclohexa-1,3-dienecarbonitrile 7 (2.0 g, 13.6 mmol) was dissolved in dry PE (75 mL) and
Dibal-H (17.7 mL, 17.7 mmol) was added at -60°C. The solution was allowed to warm to RT and stirred




O (30.9 g) was added and the suspension was






were added, the solids were removed by fi ltration and the fi ltrate
was concentrated in vacuo. Flash-column purifi cation (10% diethyl ether/PE) yielded aldehyde 10 (2.04 g,
12.1 mmol, 92%).
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.19 (s, 6 H, 1-CH
3
), 2.15 (dd, J = 1.9 Hz/4.5 Hz, 2 H, 2-H), 2.17 (s, 3 H,
5-CH
3
), 5.91 (dt, J = 1.9 Hz/9.5 Hz, 2 H, 4-H), 6.15 (dt, J = 4.5 Hz/9.5 Hz, 1 H, 3-H), 10.14 (s, 1 H, CHO).
13C NMR (75 MHz, CDCl
3




), 32.6 (C-1), 40.9 (C-2), 129.8 (C-4), 134.4 (C-3),
137.4 (C-6), 146.8 (C-5), 191.7 (CHO).
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4-Hydroxy-2,6,6-trimethylcyclohex-1-enecarbaldehyde (11)
Dibal-H (36.3 mL, 36.3 mmol) was added to a solution of 3,4-epoxy-2,6,6-trimethyl-cyclohex-1-enecarbo-
nitrile 8 (2.04 g, 12.1 mmol) in dry PE at -60°C. The solution was allowed to warm to RT in 1 h and stirred




O (63.6 g) was added and the suspension was stirred






 were added. The solids were removed by fi ltration and the
solvent removed by evaporation in vacuo. After fl ash-chromatography (60% diethyl ether/PE) 3-hydroxy-β-
cyclocitral 11 (1.60 g, 9.53 mmol, 79%) was obtained.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.23/1.25 (2s, 6 H, 1-CH
3
), 1.47 (dt, J = 2.6 Hz/8.9 Hz, 1 H, 2-H
ax
), 1.71 (d, J
= 2.7 Hz, 1 H, 2-H
eq
), 2.13 (s, 3 H, 5-CH
3
), 2.25 (dd, J = 9.2 Hz/18.4 Hz, 4-H
eq
), 2.53 (dd, J = 2.2 Hz/2.9 Hz, 4-H
ax
),
3.3 (br. s, 1 H, OH), 3.98 (m, 1 H, 3-H), 10.10 (s, 1 H, CHO).
13C NMR (75 MHz, CDCl
3




), 35.5 (C-1), 44.2 (C-4), 49.0 (C-2), 63.4 (C-3),
139.6 (C-6), 153.4 (C-5), 191.6 (CHO).
3,4-Didehydroretinal (2)
3-Methyl-5-(2,6,6-trimethylcyclohexa-1,3-dienyl)-penta-2,4-dienal
A suspension of NaH (60% in mineral oil, 0.43 g, 10.7 mmol) was washed three times with dry PE and trans-
ferred into a fl ame-dried fl ask. The suspension was once more washed with dry PE, PE was removed with a
N
2
-fl ow and dry THF (75 mL) was added. At 0°C, 4-(diethylphosphono)-3-methyl-2-butenenitrile 12 (2.14 g,
9.9 mmol) in THF was added and during 30 min of stirring at RT the phosphonate anion was formed. The
solution was cooled to 0°C and 2,6,6-trimethyl-cyclohexa-1,3-dienecarbaldehyde 10 (1.23 g, 8.21 mmol)
in THF was added. After stirring overnight at RT, the reaction was quenched by adding NH
4
Cl (sat) and the
mixture was extracted three times with diethyl ether. The combined organic layers were washed with NaCl
(sat), dried with MgSO
4
and concentrated in vacuo. After purifi cation on a silica-gel column (20% diethyl
ether/PE) pure 3-methyl-5-(2,6,6-trimethylcyclohexa-1,3-dienyl)-penta-2,4-dienitrile (1.06 g, 5.0 mmol,
61%) was obtained as a mixture of isomers.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.04 (s, 6 H, 1-CH
3
), 1.86 (s, 3 H, 5-CH
3
), 2.09 (m, 2 H, 2-H), 2.21 (s, 3 H,
9-CH
3
), 5.20 (s, 1 H, 10-H), 5.81 (dt, J = 4.2 Hz/9.7 Hz, 1 H, 3-H), 5.86 (d, J = 9.7 Hz, 1 H, 4-H), 6.27 (d, J = 16.1 Hz,
1 H, 8-H), 6.56 (d, J = 16.1 Hz, 1 H, 7-H).
13C NMR (75 MHz, CDCl
3






), 33.8 (C-1), 39.7 (C-2), 96.3 (C-10),
117.9 (C-11), 122.0 (C-3), 126.7 (C-5), 129.4 (C-4), 131.7 (C-7), 134.2 (C-8), 140.3 (C-6), 156.8 (C-9). 
A solution of 3-methyl-5-(2,6,6-trimethylcyclohexa-1,3-dienyl)-penta-2,4-dienitrile (1.06 g, 5.0 mmol) in dry
PE was cooled to -60°C and Dibal-H (6.5 mL, 6.5 mmol) was added. The mixture was warmed to RT in 1 h,




O (11.3 g) was added, and the mixture






were added, the solids were removed by fi ltration and washed
with diethyl ether. The solvents were removed in vacuo, and the product was purifi ed on a silica-gel column
(20% diethyl ether/PE) to give 3-methyl-5-(2,6,6-trimethylcyclohexa-1,3-dienyl)-penta-2,4-dienal (1.03 g,







1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.06 (s, 6 H, 1-CH
3
), 1.88 (s, 3 H, 5-CH
3
), 2.12 (d, J = 4.2 Hz, 2 H, 2-H), 2.33
(s, 3 H, 9-CH
3
), 5.82 (dt, J = 4.2 Hz/9.6 Hz, 1 H, 3-H), 5.88 (d, J = 9.6 Hz, 4-H), 5.94 (d, J = 8.2 Hz, 1 H, 10-H), 6.33
(d, J = 16.5 Hz, 1 H, 8-H), 6.73 (d, J = 16.5 Hz, 1 H, 7-H), 10.13 (d, J = 8.2 Hz, 1 H, 11-H).
13C NMR (75 MHz, CDCl
3






), 33.7 (C-1), 39.5 (C-2), 126.4 (C-3),
127.4 (C-5), 128.5 (C-10), 129.5 (C-4), 133.7 (C-7), 134.5 (C-8), 136.9 (C-6), 154.1 (C-9), 190.5 (C-11).
C
5
-phosphonate 12 (1.24 g, 5.7 mmol) in dry THF (10 mL) was added to a suspension of washed NaH (0.25 g,
6.2 mmol) in dry THF at 0°C. After stirring at RT for 30 min the NaH had reacted with the phosphonate and
3-methyl-5-(2,6,6-trimethylcyclohex-1,3-dienyl)-penta-2,4-dienal (1.03 g, 4.8 mmol) in THF was added to
the formed phosphonate anion at 0°C. The solution was stirred overnight, and NH
4
Cl (sat) was added. The
mixture was extracted three times with diethyl ether, the combined organic layers were washed with NaCl
(sat) and dried with MgSO
4
. The solid was removed by fi ltration and the fi ltrate concentrated in vacuo to
give, after column purifi cation (10% diethyl ether/PE) 3,7-dimethyl-9-(2,6,6-trimethylcyclohexa-1,3-dienyl)-
nona-2,4,6,8-tetraenenitrile (1.3 g, 4.6 mmol, 96%) as a mixture of isomers.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.04 (s, 6 H, 1-CH
3
), 1.86 (s, 3 H, 5-CH
3
), 2.02 (s, 3 H, 9-CH
3
), 2.09 (d, J
= 4.4 Hz, 2 H, 2-H), 2.20 (s, 3 H, 13-CH
3
), 5.17 (s, 1 H, 14-H), 5.75 (dt, J = 4.4 Hz/9.4 Hz, 1 H, 3-H), 5.85 (d, J =
9.4 Hz, 1 H, 4-H), 6.15 (d, J = 11.4 Hz, 1 H, 10-H), 6.29 (d, J = 15.0 Hz, 1 H, 12-H), 6.31 (2s, 2 H, 7-H/8-H), 6.95
(dd, J = 11.4 Hz/15.0 Hz, 1 H, 11-H). 
13C NMR (75 MHz, CDCl
3








), 33.7 (C-1), 39.7
(C-2), 96.3 (C-14), 117.8 (C-15), 125.3 (C-3), 127.4 (C-5), 128.1 (C-7), 129.2 (C-10), 129.6 (C-4), 132.2 (C-11),
133.8 (C-12), 136.8 (C-8), 137.9 (C-6), 140.8 (C-9), 156.6 (C-13).
The 3,4-didehydro-C
20
-nitrile (1.27 g, 4.6 mmol) was dissolved in dry toluene and Dibal-H (6.0 mL, 6.0 mmol)




O (10.5 g) was added.






were added. The solids were removed by fi l-
tration, washed with diethyl ether and the solvents were removed in vacuo. After column chromatography
(20% diethyl ether/PE) 3,4-didehydroretinal 2 (1.2 g, 4.3 mmol, 94%) was obtained as a mixture of isomers.
1H NMR (400 MHz, CDCl
3
) δ (ppm) = 1.05 (s, 6 H, 1-CH
3
), 1.88 (s, 3 H, 5-CH
3
), 2.04 (s, 3 H, 9-CH
3
), 2.09 (dd, J =
4.3 Hz, 2 H, 2-H), 2.33 (s, 3 H, 13-CH
3
), 5.76 (dt, J = 4.3 Hz/9.5 Hz, 1 H, 3-H), 5.86 (d, J = 9.5 Hz, 1 H, 4-H), 5.97
(d, J = 8.1 Hz, 14-H), 6.23 (d, J = 11.5 Hz, 1 H, 10-H), 6.33 (2s, 2 H, 7-H/8-H), 6.38 (d, J = 15.1 Hz, 1 H, 12-H), 7.15
(dd, J = 11.5 Hz/15.1 Hz, 1 H, 11-H), 10.11 (d, J = 8.1 Hz, 1 H, 15-H). 
13C NMR (100 MHz, CDCl
3








), 33.9 (C-1), 39.8
(C-2), 125.5 (C-3), 127.7 (C-5), 128.4 (C-7), 128.9 (C-14), 129.8 (C-4), 129.8 (C-10), 132.4 (C-11), 134.6 (C-12),
136.4 (C-8), 138.1 (C-6), 141.0 (C-9), 154.6 (C-13), 190.9 (C-15). 
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(3RS)-Hydroxyretinal (3)
3-Methyl-5-(4-hydroxy-2,6,6-trimethylcyclohex-1-enyl)-penta-2,4-dienal
In a procedure similar to the one described above, C
5
-phosphonate 12 (2.59 g, 11.9 mmol) in THF was added
to a suspension of washed NaH (0.91 g, 22.8 mmol) in dry THF at 0°C. After 30 min at RT, the suspension
was cooled back to 0°C and 4-hydroxy-2,6,6-trimethylcyclohex-1-enecarbaldehyde 11 (1.67 g, 9.9 mmol) in
THF (10 mL) was added. After stirring overnight at RT, NH
4
Cl (sat) was added and the mixture was extracted
three times with diethyl ether. The organic layer was washed with NaCl (sat), dried with MgSO
4
, fi ltered and
concentrated. Column purifi cation (60% diethyl ether/PE) yielded 3-methyl-5-(4-hydroxy-2,6,6-trimethyl-
cyclo hex-1-enyl)-penta-2,4-dienitrile (0.96 g, 4.2 mmol, 42%) as a mixture of isomers.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.06/1.07 (2s, 6 H, 1-CH
3
), 1.4 (m, 1 H, 2-H
ax





), 2.0 (m, 1 H, 4-H
ax
), 2.20 (s, 3 H, 9-CH
3
), 2.4 (m, 1 H, 4-H
eq
), 2.72 (br. s, 1 H, OH), 3.96 (m, 1 H, 3-H),
5.19 (s, 1 H, 10-H), 6.15 (d, J = 16.1 Hz, 1 H, 8-H), 6.69 (d, J = 16.1 Hz, 1 H, 7-H).
13C NMR (75 MHz, CDCl
3






), 35.2 (C-1), 40.6 (C-4), 45.1
(C-2), 64.0 (C-3), 96.4 (C-10), 117.1 (C-11), 126.3 (C-5), 134.7 (C-7), 136.1 (C-8), 139.2 (C-6), 156.9 (C-9).
In a similar Dibal-H reduction to the one described earlier, 3-methyl-5-(4-hydroxy-2,6,6-trimethylcyclohex-
1-enyl)-penta-2,4-dienitrile (0.82 g, 3.6 mmol) was reduced with Dibal-H (8.2 mL, 8.2 mmol) in dry toluene
to give, after column purifi cation (60% diethyl ether/PE), the corresponding 3-methyl-5-(4-hydroxy-2,6,6-
trimethylcyclohex-1-enyl)-penta-2,4-dienal (0.75 g, 3.2 mmol, 90%) as a mixture of isomers.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.09/1.10 (2s, 6 H, 1-CH
3
), 1.5 (m, 1 H, 2-H
ax





), 2.0 (m, 1 H, 4-H
ax
), 2.33 (s, 3 H, 9-CH
3
), 2.4 (m, 1 H, 4-H
eq
), 3.15 (br. s, 1 H, OH), 3.98 (m, 1 H, 3-H),
5.95 (d, J = 8.4 Hz, 1 H, 10-H), 6.22 (d, J = 16.1 Hz, 1 H, 8-H), 6.73 (d, J = 16.1 Hz, 1 H, 7-H), 10.10 (d, J = 8.4 Hz,
1 H, 11-H).
13C NMR (75 MHz, CDCl
3






), 36.5 (C-1), 42.1 (C-4), 47.7
(C-2), 63.7 (C-3), 128.6 (C-10), 129.4 (C-5), 134.8 (C-7), 136.7 (C-8), 139.6 (C-6), 154.8 (C-9), 191.2 (C-11).
By using a similar method as described above for (2), the anion of C
5
-phosphonate 12, formed by adding
12 (0.83 g, 3.8 mmol) to a suspension of washed NaH (0.29 g, 7.3 mmol) in dry THF at 0°C, reacted with
3-methyl-5-(4-hydroxy-2,6,6-trimethylcyclohex-1-enyl)-penta-2,4-dienal (0.75 g, 3.2 mmol). After workup
and purifi cation (silica gel, 60% diethyl ether/PE), 3,7-dimethyl-9-(4-hydroxy-2,6,6-trimethylcyclohex-1-
enyl)-nona-2,4,6,8-tetraenenitrile (0.65 g, 2.2 mmol, 69%) was obtained as a mixture of isomers.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.03/1.08 (2s, 6 H, 1-CH
3
), 1.4 (m, 1 H, 2-H
ax





), 2.01 (s, 3 H, 9-CH
3
), 2.1 (m, 1 H, 4-H
ax
), 2.20 (s, 3 H, 13-CH
3
), 2.4 (m, 1 H, 4-H
eq
), 2.99 (br. s, 1 H, OH),
3.96 (m, 1 H, 3-H), 5.20 (s, 1 H, 14-H), 6.13 (d, J = 11.6 Hz, 1 H, 10-H), 6.14 (d, J = 16.0 Hz, 1 H, 8-H), 6.27 (d, J =
16.0 Hz, 1 H, 7-H), 6.31 (d, J = 15.0 Hz, 1 H, 12-H), 6.96 (dd, J = 11.6 Hz/15.0 Hz, 1 H, 11-H).
13C NMR (75 MHz, CDCl
3









42.2 (C-4), 48.0 (C-2), 64.2 (C-3), 96.3 (C-14), 117.2 (C-15), 127.1 (C-5), 128.4 (C-7), 131.3 (C-10), 132.3 (C-11),









-nitrile (0.54 g, 1.8 mmol) was reduced to the corresponding aldehyde 3 with Dibal-H (4.5 mL,
4.5 mmol) in dry toluene, using the same procedure as described before. After purifi cation on a silica-gel
column (60% diethyl ether/PE) 3-hydroxy-retinal (3) (0.48 g, 1.6 mmol, 89%) was obtained as a mixture of 
isomers. 
1H NMR (600 MHz, CDCl
3
) δ (ppm) = 1.03/1.08 (2s, 6 H, 1-CH
3
), 1.50 (t, J = 12.0 Hz, 1 H, 2-H
ax
), 1.74 (s, 3 H,
5-CH
3
), 1.79 (t, J = 4.1 Hz, 1 H, 2-H
eq
), 2.03 (s, 3 H, 9-CH
3
), 2.08 (t, J = 10.3 Hz, 1 H, 4-H
ax
), 2.33 (s, 3 H, 13-CH
3
),
2.40 (d, J = 5.2 Hz, 1 H, 4-H
eq
), 2.90 (br. s, 1 H, OH), 4.00 (m, 1 H, 3-H), 5.97 (d, J = 8.2 Hz, 1 H, 14-H), 6.16 (d, J =
16.1 Hz, 1 H, 8-H), 6.20 (d, J = 11.5 Hz, 1 H, 10-H), 6.29 (d, J = 16.1 Hz, 1 H, 7-H), 6.38 (d, J = 15.0 Hz, 1 H, 12-H),
7.15 (dd, J = 11.5 Hz/15.0 Hz, 1 H, 11-H), 10.08 (d, J = 8.2 Hz, 1 H, 15-H).
13C NMR (150 MHz, CDCl
3




), 21.4 (C-18), 28.5/30.0 (1-CH
3
), 36.8 (C-1),
42.3 (C-4), 48.0 (C-2), 64.3 (C-3), 127.3 (C-5), 128.5/128.7 (C-7/C-14), 129.6 (C-10), 132.3 (C-11), 134.5 (C-12),
137.1 (C-6), 137.4 (C-8), 140.8 (C-9), 154.8 (C-13), 191.0 (C-15)
(4RS)-Hydroxyretinal (4)
3-Methyl-5-(3-hydroxy-2,6,6-trimethylcyclohex-1-enyl)-penta-2,4-dienal
In a similar way to that described above, C
5
-phosphonate 12 (1.14 g, 5.3 mmol) was deprotonated with
NaH (0.4 g, 10.1 mmol) and coupled to 3-hydroxy-2,6,6-trimethylcyclohex-1-enecarbaldehyde 9 (0.74 g,
4.4 mmol). After purifi cation (50% diethyl ether/PE), 3-methyl-5-(3-hydroxy-2,6,6-trimethylcyclohex-1-
enyl)-penta-2,4-dienitrile (0.82 g, 3.6 mmol, 81%) was obtained as a mixture of isomers. 
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.01/1.04 (2s, 6 H, 1-CH
3
), 1.4 (m, 1 H, 2-H
eq





1.81 (s, 3 H, 5-CH
3
), 1.9 (m, 1 H, 3-H
eq
), 2.20 (s, 3 H, 9-CH
3
), 2.64 (br. s, 1 H, OH), 3.99 (br. s, 1 H, 4-H), 5.21 (s, 1 H,
10-H), 6.17 (d, J = 16.0 Hz, 1 H,8-H), 6.52 (d, J = 16.0 Hz, 1 H, 7-H).
13C NMR (75 MHz, CDCl
3






), 28.3 (C-3), 34.0 (C-2), 34.0
(C-1), 69.1 (C-4), 96.6 (C-10), 117.1 (C-11), 131.8 (C-5), 133.1 (C-7), 134.5 (C-8), 139.4 (C-6), 156.3 (C-9).
By using the same procedure as described before, 3-methyl-5-(3-hydroxy-2,6,6-trimethylcyclohex-1-enyl)-
penta-2,4-dienitrile (0.60 g, 2.6 mmol) in dry toluene was reduced with Dibal-H (6 mL, 6.0 mmol). After
purifi cation on a silica-gel column (60% diethyl ether/PE) 3-methyl-5-(3-hydroxy-2,6,6-trimethylcyclohex-
1-enyl)-penta-2,4-dienal (0.57 g, 2.4 mmol, 94%) was obtained as a mixture of isomers.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.03/1.06 (2s, 6 H, 1-CH
3
), 1.4 (m, 1 H, 2-H
eq





1.84 (s, 3 H, 5-CH
3
), 1.9 (m, 1 H, 3-H
eq
), 2.32 (s, 3 H, 9-CH
3
), 2.70 (br. s, 1 H, OH), 3.99 (br. s, 1 H, 4-H), 5.92 (d, J =
7.9 Hz, 1 H, 10-H), 6.23 (d, J = 16.0 Hz, 1 H, 8-H), 6.70 (d, J = 16.0 Hz, 1 H, 7-H), 10.11 (d, J = 7.9 Hz, 1 H, 11-H).
13C NMR (75 MHz, CDCl
3






), 28.7 (C-3), 34.4 (C-2), 34.6
(C-1), 69.6 (C-4), 129.0 (C-10), 132.3 (C-5), 134.8 (C-7), 136.6 (C-8), 140.3 (C-6), 154.5 (C-9), 191.3 (C-11).
C
5
-phosphonate 12 (0.63 g, 2.9 mmol) in dry THF (10 mL) was added to a suspension of NaH (0.22 g,
5.6 mmol) in dry THF at 0°C. After 30 min at RT, 3-methyl-5-(3-hydroxy-2,6,6-trimethylcyclohex-1-enyl)-2,4-
pentadienal (0.57 g, 2.4 mmol) in THF was added and the mixture was stirred overnight at RT. After workup
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and purifi cation by column chromatography (60% diethyl ether/PE), 3,7-dimethyl-9-(3-hydroxy-2,6,6-tri-
methylcyclohex-1-enyl)-nona-2,4,6,8-tetraenenitrile (0.60 g, 2.0 mmol, 83%) was obtained as a mixture of 
isomers.
1H NMR (300 MHz, CDCl
3
) δ (ppm) = 1.02/1.06 (2s, 6 H, 1-CH
3
), 1.43 (m, 1 H, 2-H
eq
), 1.69 (m, 1 H, 2-H
ax
), 1.72
(m, 1 H, 3-H
ax
), 1.84 (s, 3 H, 5-CH
3
), 1.90 (m, 1 H, 3-H
eq
), 2.01 (s, 3 H, 9-CH
3
), 2.20 (s, 3 H, 13-CH
3
), 3.12 (br. s, 1 H,
OH), 4.00 (m, 1 H, 4-H), 5.20 (s, 1 H, 14-H), 6.09 (d, J = 11.5 Hz, 1 H, 10-H), 6.18 (d, J = 16.3 Hz, 1 H, 8-H), 6.28 (d,
J = 16.3 Hz, 1 H, 7-H), 6.31 (d, J = 15.1 Hz, 1 H, 12-H), 6.95 (dd, J = 11.5 Hz/15.1 Hz, 1 H, 11-H).
13C NMR (75 MHz, CDCl
3









34.4 (C-2), 34.5 (C-1), 69.7 (C-4), 96.4 (C-14), 117.8 (C-15), 128.5 (C-7), 129.2 (C-10), 129.2 (C-12), 130.5 (C-5),
131.4 (C-11), 137.7 (C-8), 140.6 (C-9), 140.9 (C-6), 156.7 (C-13).
By using the same procedure as described above for (2), reduction of the 4-hydroxy-C
20
-nitrile (0.60 g,
2.0 mmol) in dry toluene with Dibal-H (5 mL, 5 mmol) gave, after purifi cation (60% diethyl ether/PE), the
corresponding 4-hydroxy-retinal 4 (0.53 g, 1.8 mmol, 87%) of as a mixture of isomers.
1H NMR (400 MHz, CDCl
3
) δ (ppm) = 1.03/1.06 (2s, 6 H, 1-CH
3
), 1.43 (m, 1 H, 2-H
eq
), 1.68 (m, 1 H, 2-H
ax
), 1.73
(m, 1 H, 3-H
ax
), 1.85 (s, 3 H, 5-CH
3
), 1.89 (m, 1 H, 3-H
eq
), 2.03 (s, 3 H, 9-CH
3
), 2.33 (s, 3 H, 13-CH
3
), 2.90 (br. s, 1 H,
OH), 4.02 (m, 1 H, 4-H), 5.97 (d, J = 8.1 Hz, 1 H, 14-H), 6.19 (d, J = 16.0 Hz, 1 H, 8-H), 6.21 (d, J = 11.3 Hz, 1 H,
10-H), 6.31 (d, J = 16.0 Hz, 1 H, 7-H), 6.38 (d, J = 15.1 Hz, 1 H, 12-H), 7.14 (dd, J = 11.3 Hz/15.1 Hz, 1 H, 11-H),
10.07 (d, J = 8.1 Hz, 1 H, 15-H).
13C NMR (100 MHz, CDCl
3









34.4 (C-2), 34.4 (C-1), 69.6 (C-4), 128.6/128.7 (C-7/C-14), 129.5 (C-10), 130.7 (C-5), 132.2 (C-11), 134.6 (C-12),




(0.3 g, 1.6 mmol) was added to dry THF under argon, LiAlH
4
(0.03 g, 0.8 mmol) was added to the sus-
pension and the mixture was stirred for 2 h at RT. 3,4-Didehydro-retinal (0.23 g, 0.8 mmol) in THF was slowly
added and the mixture was stirred overnight at RT. The reaction was quenched by adding HCl (1 M) and
the mixture was extracted twice with diethyl ether. The combined organic layers were washed with NaCl
(sat), dried with MgSO
4
and concentrated in vacuo. After purifi cation on a silica-gel column (10% diethyl
ether/PE) 3,4,3’,4’-didehydro-β,β-carotene 13 (0.1 g, 0.2 mmol, 50%) was obtained.
1H NMR (600 MHz, CDCl
3
) δ (ppm) = 1.04 (s, 12 H, 16-H/16’-H/17-H/17’-H), 1.88 (s, 6 H, 18-H/18’-H), 1.98 (s,
12 H, 19-H/19’-H/20-H/20’-H), 2.08 (2d, J = 4.6 Hz, 4 H, 2-H/2’-H), 5.72 (dt, J = 4.6 Hz/9.5 Hz, 2 H, 3-H/3’-H),
5.86 (d, J = 9.5 Hz, 2 H, 4-H/4’-H), 6.16 (m, 2 H, 10-H/10’-H), 6.18 (d, J = 15.1 Hz, 2 H, 7-H/7’-H), 6.30 (m, 4 H,
12-H/12’-H/14-H/14’-H), 6.37 (d, J = 15.1 Hz, 2 H, 8-H/8’-H), 6.64 (m, 4 H, 11-H/11’-H/15-H/15’-H).
13C NMR (150 MHz, CDCl
3
) (ppm) = 12.7 (C-19/C19’), 12.8 (C-20/C-20’), 20.3 (C-18/C-18’), 26.8 (C-16/C-16’/
C-17/C-17’), 34.0 (C-1/C-1’), 39.9 (C-2/C-2’), 124.9 (C-3/C-3’/C-11/C-11’), 125.6 (C-7/C-7’), 126.7 (C-5/C-5’),
130.0 (C-4/C-4’/C-15/C-15’), 131.5 (C-10/C-10’), 132.6 (C-14/C-14’), 135.9 (C-9/C-9’), 135.9 (C-13/C-13’), 137.3










 (0.22 g, 1.4 mmol) was added to dry THF under argon, LiAlH
4
(0.04 g, 1.1 mmol) was added to the
suspension and the mixture was stirred for 2 h at RT. 3-Hydroxyretinal (0.21 g, 0.7 mmol) in THF was slowly
added and the mixture was stirred overnight at RT. HCl (1 M) was added and the mixture was extracted
twice with diethyl ether. The combined organic layers were washed with NaCl (sat), dried with MgSO
4
 and





/EtOH, -20°C), pure all-E zeaxanthin 14 (0.02 g, 0.04 mmol, 10%) was obtained.
1H NMR (600 MHz, CDCl
3


















), 4.00 (m, 2 H, 3-H/3’-H), 6.12 (s, 4 H, 7-H/7’-H/8-H/8’-H), 6.16 (d, J = 11.5 Hz, 2 H,
10-H/10’-H), 6.26 (d, J = 9.7 Hz, 2 H, 14-H/14’-H), 6.36 (d, J = 14.9 Hz, 2 H, 12-H/12’-H), 6.63 (m, 11-H/11’-
H/15-H/15’-H).
13C NMR (150 MHz, CDCl
3
) δ (ppm) = 12.8 (C-19/C-19’/C-20/C-20’), 21.6 (C-18/C-18’), 28.7/30.3 (C-16/
C-16’/C-17/C-17’), 37.1 (C-1/C-1’), 42.6 (C-4/C-4’), 48.5 (C-2/C-2’), 65.1 (C-3/C-3’), 124.9 (C-11/C-11’), 125.6
(C-7/C-7’), 126.2 (C-5/C-5’), 130.1 (C-15/C-15’), 131.3 (C-10/C-10’), 132.6 (C-14/C-14’), 135.7 (C-9/C-9’), 136.4
(C-13/C-13’), 137.6 (C-12/C-12’), 137.8 (C-6/C-6’), 138.5 (C-8/C-8’).
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6.1 αCRUSTACYANIN
α-Crustacyanin is the carotenoprotein complex that is responsible for the blue color of the liv-
ing lobster (λ
max
= 632 nm). When the lobster is cooked the denaturation of this protein complex
leads to the release of free astaxanthin that gives a deep red color (λ
max
= 472 nm). α-Crustacya-
nin can be irreversibly dissociated in eight β-crustacyanin units (λ
max
= 586 nm).
Recently the X-ray structure of β-crustacyanin has been published at 3.2 Å resolution.1 The X-
ray structure reveals that two astaxanthin units are situated in parallel planes in β-crustacyanin.
They cross off -center at a distance of 7Å with an angle of 120˚ of the axes of the astaxanthin
units. In contrast to free astaxanthin, which occurs in a non-planar 6s,6’s-cis conformation,
astaxanthin in β-crustacyanin has a planar 6s,6’s-trans conformation. The 3,3’ hydroxyl and 4,4’ 
carbonyl groups are positioned such that they can form hydrogen bonds with nearby histi-
dines.
α-Crustacyanin can be irreversibly dissociated in eight β-crustacyanin units. In β-crusta-
cyanin the bathochromic shift is two-thirds of the value found for α-crustacyanin. The simplest
assumption is that the structure of α-crustacyanin corresponds to the known structure of β-
crustacyanin and that the bathochromic shift from 586 nm to 632 nm should be explained by
the aggregation of the eight β-crustacyanin dimers to form α-crustacyanin. The bathochromic
shift of astaxanthin in β- and α-crustacyanin compared to free astaxanthin can be due to (i)
astaxanthin-protein interactions in the electronic ground state or (ii) interactions between the
excited singlet state of astaxanthin and the protein or (iii) exciton interactions between the two
excited states or (iv) combinations of these interactions.
Earlier investigations with solid-state 13C NMR spectroscopy on α-crustacyanin with 13C-
enriched astaxanthin have given an indication that double protonation of the 4,4’ carbonyl
groups of astaxanthin in the ground state, caused by the protein, might be the basis of the
bathochromic shift. Based on the protonation hypothesis the positive charge should be delo-
calized mostly on the sp2 carbon atoms near the six-membered rings of astaxanthin. The X-ray
structure shows that presumably no acidic sites are present near the 4,4’ carbonyl groups of 
astaxanthin in β-crustacyanin, which makes the protonation model unlikely.





α-crustacyanin as an essential complement to the earlier
studies is described. The conclusion of the present work is that there is very little electronic
perturbation of astaxanthin by the protein in the electronic ground state. This conclusion is
nicely supported by Kildahl-Andersen et al.2 who reported a 13C NMR study of protonated can-
thaxanthins. In their system large changes in chemical shifts of 6,6’,8,8’ are clearly present when
canthaxanthin is protonated at both carbonyl groups. Since this is not observed for astaxanthin
in α-crustacyanin, it is now clear from our study that protonation of the 4,4’ carbonyl groups







The resonance Raman study of [8,8’,9,9’,10,10’,11,11’,19,19’]-13C
10
α-crustacyanin and the cor-
responding free astaxanthin has lead to the conclusion that the conjugation in α-crustacyanin
should be more extended than in free astaxanthin, since in α-crustacyanin also vibrations of 
the conjugated part next to the central part contribute, which is not the case in any other carot-
enoid. This is can be explained by the extended conjugation of the 6s,6’s-trans conformation of 
astaxanthin in β-crustacyanin.
Finally, time-dependent density functional theory has shown that hydrogen bonds to the
nearby histidines and the planar 6s,6’s-trans confi guration that gives astaxanthin in β-crus-
tacyanin its more extended conjugation are responsible for about 30% of the bathochromic
shift of β-crustacyanin. The largest contribution (~70%) is the exciton splitting by the transition
dipole-dipole interaction. The geometry of the pair of astaxanthin units in β-crustacyanin is in
agreement with the strong negative exciton splitting in the CD-spectrum of β-crustacyanin.
Compared to β-crustacyanin, the bathochromic shift of α-crustacyanin increases by 50%. In
addition, the CD-spectrum of α-crustacyanin is more symmetric and shifts to longer wave-
length.3 This means that stacking of the eight β-crustacyanin units in α-crustacyanin gives
additional positive exciton interactions. 
Using the combination of techniques as described above, the basis for the bathochromic
shift of astaxanthin in α-crustacyanin and β-crustacyanin has now been established.
6.2 SYNTHESIS OF 13CLABELED CAROTENOIDS
Several synthons are now available for the synthesis of compounds with site-directed 13C label-
ing at any postion or combination of positions. Recently, Creemers et al.4 have developed more
effi  cient schemes for the synthesis of carotenoids and retinoids. The syntheses are based on
a modular strategy, to effi  ciently introduce 13C labels at the desired positions in carotenoids






A synthetic scheme was developed for the preparation of 2,7-dimethylocta-2,4,6-triene-1,8-
dial, the C
10
-dialdehyde that is the common synthetic building block for the central part of all







the presented synthetic scheme for the synthesis of the C
10
-dialdehyde allows a quick and easy
preparation of any carotenoid with symmetrical 13C labeling in the central part.
Complementary to the development of a convergent synthesis for the labeling of the central
part of carotenoids, methods were developed to effi  ciently introduce functionalities in the six-
membered ring. This is essential for the synthesis of functionalised carotenoids like zeaxanthin
and lutein, which are abundant in our food and are involved, for example in prevention of 
cancer, cardiovascular disease and age-related macular degeneration and cataract. With pre-
vention being the only way to reduce health care costs in an aging population, the importance
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of the chemistry and chemical technology behind such preventive nutrients is diffi  cult to
underestimate.
Based on our modular strategy to prepare 13C isotopomers of all-E carotenoids, we inves-
tigated modifi cation of the α-cyclocitral module for the synthesis of 13C-labeled carotenoids
with functionalities in the six-membered ring. An effi  cient strategy has been developed for the
preparation of 13C-enriched 3,4-didehydro-, 3-hydroxy- and 4-hydroxy cyclocitral. The function-











strategy the corresponding functionalized carotenoids can be
prepared, with >99% 13C enrichment at any position or combination of positions.





 McMurry-dimerization of retinal-derivatives to obtain the corresponding symmetrical







be the preferred method for the introduction of 13C labels at specifi c positions in symmetrical
carotenoids.
So far the McMurry-dimerization was mainly used for the synthesis of β-carotene, but
recently it has also been used for the coupling of aldehydes with diff erent functional groups.5-7
In Chapter 5 is described the yet unpublished synthesis of zeaxanthin from 3-hydroxyretinal
and 3,4,3’,4’-tetradehydro-β,β-carotene from 3,4-didehydroretinal, indicating the potential of 
this method for the synthesis of functionalized carotenoids. 
In conclusion, more effi  cient methods for the synthesis of carotenoids with >99% 13C enrich-
ment at any position or combination of positions have been developed, both for 13C labels in
the central part of carotenoids as in the end-ring. The synthesis of diff erent 13C-labeled carot-
enoids via the same general scheme is now feasible, leading to reduction of labour and costs of 
13C-labeled starting materials. Our advances in the synthesis of 13C-labeled carotenoids expand
the possibilities to study the role of carotenoids in various essential aspects of the life processes
in man, animals and plants.
6.3 PROSPECTS
6.3.1 The Study of Photochemical Processes in Nature
The research strategy discussed in this thesis for the elucidation of the factors that contribute
to the bathochromic shift of α-crustacyanin can provide a general method for the study of 
chromophore-protein interactions. Using a combination of isotope-sensitive techniques and
isotope labeling, can give information of chromophores in a natural system at the atomic level.
However, most available analytical techniques only give structural information on the electronic
ground-state of a system. Information of the electronically excited-state can be obtained from







Just as we have found for the bathochromic shift of astaxanthin in the active site of β-
crustacyanin, information on the structural properties of the excited state may be essential
to understand photochemical processes. An example is the photochemistry of rhodopsin
and isorhodopsin, retinal-containing proteins essential for vision. Very recently Matthies and
co-workers have described femtosecond time resolved stimulated Raman spectroscopy as the
fi rst experimental method that has given time resolved vibrational information of electronically
excited states.8-10 Application of this technique after excitation with a femtosecond light-pulse
will give time resolved vibrational information of electronically excited state on a femtosecond
time-scale. Recently, Touw et al. have reported ab initio modelling of the spatial, electronic and
vibrational structure of Schiff  base models for visual photoreceptors. This method allows theo-
retical calculations of the vibrational frequencies, supplementary to the experimental results
obtained by Raman spectroscopy.11 In principle, the same method can be extended for ab initio
calculation of the intensities of the vibrational modes, and vibrational analysis of the excited
states formed during photochemical processes. For interpretation of a complete vibrational
analysis a full set of 13C-enriched isotopomers is necessary.
Combining these analytical and theoretical techniques gives structural information of both
the ground state and electronically excited-states during chemical photochemical processes.
This way, in the near future the photochemistry of rhodopsin and isorhodopsin can be unrav-
elled in structural detail at the atomic level. There will be in principle no limitation to extend this
approach to other photochemical processes.
6.3.2 The Use of 13C-Labeled Carotenoids in Food and Health Studies
Carotenoids in the diet of humans show benefi cial health eff ects, playing a role in prevention of 
cancer, cardiovascular diseases and eye degradation. Man and animals are unable to synthesize
carotenoids de novo, and depend on food for their required carotenoids. Up to about 100 dif-
ferent carotenoids are present in a varied human diet, and, of these around 20 can be detected
in human blood and tissue, e.g. α-carotene, β-carotene, lycopene, zeaxanthin, canthaxanthin,
astaxanthin and lutein.12 Based on the diff erence in mass between natural and 13C-enriched
compounds, a LC-MS method has recently been described that allows study of all aspects of the
uptake of [12,12’,13,13’,14,14’,15,15’,19,19’,20,20’] 13C
10
β-carotene from food and the metabolism
in living persons at the physiological level in real time.13,14 This study shows that the conversion
of β-carotene to vitamin A is more effi  cient than formerly assumed. Expanding this method to
all carotenoids that are available from food will give essential information about the role of the
various carotenoids in humans and animals. 
Via resonance Raman studies the food-derived carotenoid levels in single living lymphocytes
have been quantifi ed.15 It has been found that the carotenoid concentration in lymphocyte gall
bodies is lower in older persons. The carotenoid levels from lung cancer patients are even lower
than those in healthy elderly people. These studies have been carried out with carotenoids
with natural abundant isotopes. However, all nutritional important carotenoids show within
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experimental error the same resonance Raman spectrum. Carotenoids with 99% 13C
10
labeling
in the central part show resonance Raman spectra which are clearly distinct from unlabeled
carotenoids. Adding one of the nutritionally important carotenoids with central 99% 13C
10
labeling at the 1%-10% level of the normal physiological amount will allow, via a combined
study with LC-MS and resonance Raman spectroscopy, a quantitative study of the dynamics of 
carotenoid uptake from food, its metabolism and dynamic uptake in various living cells. Per-
forming these studies on healthy and diseased persons of various ages will allow more insight
in the health eff ects of carotenoids in humans.This approach will allow the determination of 
the contribution of specifi c carotenoids in nutrition on maintaining the health of individuals
and possible prevention of age related diseases and improvement of health by addition of 
carotenoids to the diet.
In this thesis general schemes are described that give access to 13C-labeled carotenoids. The
central part of carotenoids can now be labeled up to 13C
10
. Besided 13C-enriched β-carotene,
now also zeaxanthin, canthaxanthin and astaxanthin can be prepared with 13C labels at any
position or combination of positions. All other nutritionally important carotenoids are acces-
sible in less steps and reasonable yield by combining general synthetic methods with new
conversions developed by Khachik.16-19 13C isotopomers of carotenoids can be used for further
exploration of carotenoproteins with isotope sensitive, non-invasive techniques, as has been
discussed for the study of bathochromic shift of α- and β-crustacyanin in this thesis. Specifi c
labeling of nutritionally important carotenoids will be essential to quantitatively elucidate the
role of each carotenoid in maintaining health of man and animals, prevention of age-related
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SUMMARY
Carotenoids constitute a class of natural colorants, ranging from pale yellow to deep purple,
with important biological functions. Besides being natural colorants, carotenoids have an
essential function in plants by protecting the photosynthetic reaction centers against formation
of destructive singlet oxygen. In humans carotenoids are converted to vitamin A, which is vital
for vision. Recent research suggests that carotenoids reduce the risk of age-related macular
degradation and cataract, the leading cause of blindness in the western world. Carotenoids in
the human diet have a benefi cial health eff ect, playing a role in the prevention of cardiovascular
disease and cancer.
In nature, many carotenoids are bound to proteins, to form carotenoproteins. Often this
binding to proteins is accompanied by a remarkable change in color. α-Crustacyanin is the
carotenoprotein responsible for the dark blue color of lobsters. Upon heat treatment the dark 
blue protein denatures and the red carotenoid astaxanthin is released. In order to resolve the





astaxanthin using a modular






scheme commonly used for synthesis of carot-





are described in Chapter 2. 
The 13C-labeled astaxanthins were reconstituted with α-crustacyanin and the 13C-enriched
carotenoproteins were analyzed with solid-state 13C NMR and resonance Raman spectroscopy.
The experimental data were complemented with time-dependent density functional theory
calculations on several models based on the structural information available for β-crustacyanin.
The data rule out major changes and strong polarization eff ects in the ground-state electron
density of astaxanthin upon binding to the protein. Conformational changes in the chromo-
phore and hydrogen-bond interactions between the astaxanthin and the protein can account
only for about one-third of the total bathochromic shift in α-crustacyanin. The exciton splitting
due to the proximity of the astaxanthin chromophores is found to be large, supporting early
suggestions that aggregation eff ects in the protein represent the primary source of the color
change. This study of the bathochromic shift in α-crustacyanin is described in Chapter 3.
Information on which carotenoids are present in the human body, and in what amounts,
is necessary to study the health eff ects of carotenoids. Resonance Raman spectroscopy can
be used to determine the amounts of carotenoids in living human tissue and cells. When







can be used to distinguish between diff erent carotenoids and determine their presence and
amounts in humans in vivo in a non-invasive way.
Recently a method was published to quantify, without perturbation, the nutritional status
of β-carotene at the physiological level in individuals, via addition of 13C
10
 β-carotene to their
food. Using mass spectrometry the levels of the isotopically labeled 13C
10
β-carotene and its
metabolites could be monitored. Extending the use of mass spectrometry and resonance
Raman spectroscopy methods to other carotenoids that are present in our diet is now of utmost
importance to be able to study the presence, quantity, bioconversion and bioavailability of 
carotenoids in individuals. Therefore, there is great need for 13C-labeled carotenoids, and for an
effi  cient synthetic strategy applicable to a range of carotenoids. 
Chapter 4 describes an effi  cient synthetic scheme for 13C-enrichment in the central part of 
carotenoids. Starting from acetic acid and methyl iodide 13C-enriched C
10
-dialdehyde can be
prepared up to the 13C
10
 level. The C
10
-dialdehyde is a suitable building block for the central part






 scheme. Using a modular total organic syn-
thetic strategy, now 13C labels can be introduced at any position or combination of positions. By
varying the end groups, a library of multifold 13C-labeled carotenoids can easily be obtained.
In Chapter 5 a modular synthetic scheme is described for the synthesis of 13C-labeled
naturally occurring visual pigment chromophores: 3,4-didehydroretinal, 3-hydroxyretinal and
4-hydroxyretinal. These compounds can now be made with >99% 13C enrichment at any posi-






 scheme for the synthesis
of retinals, and by making variations in the C
10
 part we can now prepare the desired retinal
derivatives with selective or uniform 13C enrichment. The developed scheme also allows for the










 McMurry reaction was successfully applied to obtain
zeaxanthin directly by dimerization of 3-hydroxyretinal, and 3,4,3’,4’-didehydro-β-carotene from
3,4-didehydroretinal, showing potential as a complementary strategy for effi  cient synthesis of 
symmetric 13C-labeled carotenoids with functional groups in the six-membered rings.
The impact of the work described in this thesis and prospects for further research are dis-
cussed in Chapter 6. The approach that was used for the study of the bathochromic shift of 
α-crustacyanin can be applied to other natural systems. Combining this strategy with available
analytical and theoretical techniques that give structural information of both the ground state
and electronically excited-state can be used to study photochemical processes at the atomic
level. For these studies the access of various isotopomers is essential. These isotope-labeled
systems are only accessible via total organic synthetic schemes. 
The synthetic methods described in this thesis for preparation of isotopomers of carotenoids
allow access to all nutritionally important carotenoids, which is a prerequisite for further




Carotenoïden zijn een klasse van natuurlijke kleurstoff en, variërend van licht geel tot diep paars,
met belangrijke biologische functies. Zo beschermen carotenoïden de fotosynthese Reactie
Centra tegen de vorming van het schadelijke singlet zuurstof. In de mens worden carotenoïden
omgezet tot vitamine A, wat essentieel is voor het zien. Verder blijkt uit recent onderzoek dat
carotenoïden waarschijnlijk het risico verkleinen op cataract (staar) en macula degeneratie, de
belangrijkste oorzaken van blindheid in de Westerse wereld. Daarnaast spelen carotenoïden in
de voeding van mensen een rol in de preventie van kanker en hart- en vaatziekten.
In de natuur zijn carotenoïden vaak gebonden aan eiwitten, waarbij carotenoproteinen wor-
den gevormd. Vaak gaat deze binding aan een eiwit gepaard met een opmerkelijke kleurveran-
dering. α-Crustacyanine is het carotenoprotein dat verantwoordelijk is voor de donkerblauwe
kleur van de schaal van de levende kreeft. Tijdens het koken van de kreeft denatureert het eiwit
en het rode carotenoïde astaxanthine komt vrij, wat de kreeft de karakteristieke rode kleur geeft.
Om het moleculaire mechanisme van de kleurverandering van de kreeft te doorgronden, zijn
>99% 13C-verrijkt [6,6’,7,7’]-13C
4
astaxanthine en [8,8’,9,9’,10,10,11,11’, 19,19’]-13C
10
 astaxanthine







meen wordt gebruikt voor de synthese van C
40
-carotenoiden. De synthese en 1H NMR en 13C
NMR karakterisatie van 13C
4
 astaxanthine en 13C
10
 astaxanthine is beschreven in Hoofdstuk 2.
De 13C-gelabelde astaxanthines zijn uitgewisseld tegen natuurlijk astaxanthine in α-crusta-
cyanine en de verkregen 13C-verrijkte carotenoproteinen zijn vervolgens geanalyseerd met
vaste-stof 13C NMR en resonantie Raman spectroscopie. De experimenteel verkregen gegevens
zijn aangevuld met theoretische berekeningen van verschillende modellen die gebaseerd zijn
op de structurele informatie van β-crustacyanine. De verkregen gegevens sluiten de eerdere
hypothese uit dat een sterk ladingseff ect optreedt bij binding van astaxanthine aan het eiwit.
Verandering van conformatie van de chromofoor en waterstofbrug-vorming tussen astaxan-
thine en het eiwit verklaren ongeveer een derde van de totale kleurverandering. Een grote
exciton splitsing als gevolg van de nabijheid van de astaxanthines in het eiwit treedt op, wat
eerdere aanwijzingen bevestigt dat aggregatie eff ecten in het eiwit de voornaamste oorzaak 
zijn van de kleurverschuiving. Het onderzoek aan de kleurverschuiving van α-crustacyanine is
beschreven in Hoofdstuk 3. 
Meer gegevens over het gehalte aan verschillende carotenoïden in het menselijk lichaam en
de organen tot op cellulair niveau is van groot belang om de gezondheidseff ecten van carote-









aan carotenoïden te bepalen in cellen of in levend menselijk weefsel, bijvoorbeeld van de huid
of het netvlies. Wanneer 13C-gelabelde carotenoïden worden toegevoegd aan de voeding van
personen, kan met resonantie Raman spectroscopie onderscheid worden gemaakt tussen
verschillende carotenoïden, en het gehalte hiervan worden bepaald op niet-invasieve wijze.
Recent is een methode gepubliceerd waarmee het metabolisme van β-caroteen in personen
kan worden gevolgd tot op fysiologisch niveau, door het toevoegen van 13C
10
 β-caroteen aan
hun voeding. Via massa spectrometrie kan het gehalte aan isotoop-verrijkt 13C
10
 β-caroteen en
de daaruit gevormde metabolieten worden bepaald. Toepassing van massa spectrometrie en
resonantie Raman spectroscopie voor onderzoek aan andere carotenoïden in ons dagelijks
voedsel is van groot belang om de aanwezigheid, het gehalte, de bioconversie en de biobe-
schikbaarheid van carotenoïden in het menselijk lichaam te bepalen. Hiervoor is dringend
behoefte aan 13C-gelabelde carotenoïden, en effi  ciënte synthetische methoden voor 13C labe-
ling van een scala aan carotenoïden. 
Hoofdstuk 4 beschrijft een effi  ciënt synthetisch schema voor 13C verrijking van het centrale
deel van carotenoïden. Het C
10
-dialdehyde dat wordt gebruikt als bouwsteen voor het centrale






schema kan, uitgaande van 13C-gelabeld azijnzuur
en 13C-gelabeld methyl jodide, worden verrijkt tot 10 13C labels. Gebruik makend van een
modulaire organische synthese kunnen 13C labels specifi ek worden geïntroduceerd op iedere
positie en combinatie van posities. Door variatie van de C
15
eindgroepen kan een scala aan
meervoudig 13C-gelabelde carotenoïden worden verkregen.
In Hoofdstuk 5 is een modulair synthetisch schema beschreven voor de synthese van 13C-
gelabelde natuurlijk voorkomende visuele chromoforen; 3,4-didehydroretinal, 3-hydroxyretinal
en 4-hydroxyretinal. Deze verbindingen kunnen nu worden gemaakt met >99% 13C verrijking






schema is gebruikt voor
de synthese van deze retinallen, en door variaties in de C
10
eindgroep kunnen nu de gewenste
retinal derivaten worden gesynthetiseerd met selectieve of uniforme 13C verrijking. Het ontwik-
kelde schema kan ook worden gebruikt voor de synthese van 13C-gelabelde carotenoïden met











reactie was succesvol voor de synthese van zeaxanthine en 3,3’,4,4’-didehydrocaroteen via
dimerizatie van respectievelijk 3-hydroxyretinal en 3,4-dehydroretinal. Dit geeft aan dat deze
methode kan dienen als alternatieve strategie voor de synthese van 13C-gelabelde carotenoïden
met functionele groepen in de 6-ring.
Het werk beschreven in dit proefschrift wordt in een breder kader geplaatst in Hoofdstuk 6,
waar tevens wordt ingegaan op de mogelijkheden die dit werk biedt voor toekomstig onderzoek.
De aanpak die is gebruikt voor het onderzoek naar de kleurverschuiving van α-crustacyanine
kan ook worden toegepast op andere natuurlijke systemen. Een combinatie van deze aanpak 
met beschikbare analytische en theoretische technieken die inzicht geven in de structuur van
zowel de grondtoestand als de aangeslagen toestand kan worden gebruikt om fotochemische
processen te onderzoeken op atomair niveau. Voor dit onderzoek is de beschikbaarheid van
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diverse isotopomeren essentieel. De methoden beschreven in dit proefschrift maken de syn-
these van isotopomeren van alle carotenoïden in onze voeding mogelijk, wat van groot nut is
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